
<html lang="en"     class="pb-page"  data-request-id="030cad97-9b97-43dd-b00a-5251416719d0"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2002.45.issue-6;article:article:10.1021/jm011022e;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Novel 4-Anilinoquinazolines with C-7 Basic Side Chains:  Design and Structure Activity Relationship of a Series of Potent, Orally Active, VEGF Receptor Tyrosine Kinase Inhibitors" /></meta><meta name="dc.Creator" content="Laurent F.  Hennequin,*,†" /></meta><meta name="dc.Creator" content="Elaine S. E.  Stokes,‡" /></meta><meta name="dc.Creator" content="Andrew P.  Thomas,‡" /></meta><meta name="dc.Creator" content="Craig  Johnstone,‡" /></meta><meta name="dc.Creator" content="Patrick A.  Plé,†" /></meta><meta name="dc.Creator" content="Donald J.  Ogilvie,‡" /></meta><meta name="dc.Creator" content="Michael  Dukes,‡" /></meta><meta name="dc.Creator" content="Stephen R.  Wedge,‡" /></meta><meta name="dc.Creator" content="Jane  Kendrew,‡ and" /></meta><meta name="dc.Creator" content="Jon O.  Curwen‡" /></meta><meta name="dc.Description" content="We have previously shown that 4-anilinoquinazolines can be potent inhibitors of vascular endothelial growth factor (VEGF) receptor (Flt-1 and KDR) tyrosine kinase activity. A novel subseries of 4-a..." /></meta><meta name="Description" content="We have previously shown that 4-anilinoquinazolines can be potent inhibitors of vascular endothelial growth factor (VEGF) receptor (Flt-1 and KDR) tyrosine kinase activity. A novel subseries of 4-a..." /></meta><meta name="dc.Publisher" content=" American Chemical Society " /></meta><meta name="dc.Date" scheme="WTN8601" content="February 19, 2002" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm011022e" /></meta><meta name="dc.Identifier" scheme="crossover-key" content="JMCMAr-45-6-1300" /></meta><meta name="dc.Identifier" scheme="pii" content="S0022-2623(01)01022-6" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2002 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm011022e" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm011022e" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm011022e" /></link>
        
    
    

<title>Novel 4-Anilinoquinazolines with C-7 Basic Side Chains:  Design and Structure Activity Relationship of a Series of Potent, Orally Active, VEGF Receptor Tyrosine Kinase Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm011022e" /></meta><meta property="og:title" content="Novel 4-Anilinoquinazolines with C-7 Basic Side Chains:  Design and Structure Activity Relationship of a Series of Potent, Orally Active, VEGF Receptor Tyrosine Kinase Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-6/jm011022e/production/images/large/jm011022en00001.jpeg" /></meta><meta property="og:description" content=" We have previously shown that 4-anilinoquinazolines can be potent inhibitors of vascular endothelial growth factor (VEGF) receptor (Flt-1 and KDR) tyrosine kinase activity. A novel subseries of 4-anilinoquinazolines that possess basic side chains at the C-7 position of the quinazoline nucleus have been synthesized. This subseries contains potent, nanomolar inhibitors of KDR (median IC50 0.02 μM, range 0.001−0.04 μM), which are comparatively less potent vs Flt-1 tyrosine kinase (median IC50 0.55 μM, range 0.02−1.6 μM). The compounds also retain some inhibitory activity against the tyrosine kinase associated to the endothelial growth factor receptor (EGFR) (median IC50 0.2 μM, range 0.075−0.8 μM) but demonstrate selectivity vs that associated to the FGF receptor 1 (median IC50 2.5 μM, range 0.9−19 μM). This selectivity profile is also evident in a growth factor-stimulated human endothelial cell (HUVEC) proliferation assay (i.e., inhibition of VEGF &gt; EGF &gt; FGF), with inhibition of VEGF-induced proliferation being achieved at nanomolar concentrations (median IC50 0.06 μM). Further examination of compound 2 (ZD6474) in recombinant enzyme assays revealed excellent selectivity for the inhibition of KDR tyrosine kinase (IC50 0.04 μM) vs the kinase activity of erbB2, MEK, CDK-2, Tie-2, IGFR-1R, PDK, PDGFRβ, and AKT (IC50 range: 1.1 to &gt;100 μM). Anilinoquinazolines possessing basic C-7 side chains exhibited markedly improved aqueous solubility over previously described anilinoquinazolines possessing neutral C-7 side chains (up to 500-fold improvement at pH 7.4). In addition, aqueous solubility of the neutral fraction present at pH 7.4 of the basic subseries of anilinoquinazoline proved to be higher than that of the neutral analogue 1 (ZD4190). Oral administration of representative compounds to mice (50 mg/kg) produced plasma levels between 0.2 and 3 μM at 24 h after dosing. Our development candidate 2 demonstrated a very attractive in vitro profile combined with excellent solubility (330 μM at pH 7.4) and good oral bioavailability in rat and dog (&gt;80 and &gt;50%, respectively). This compound demonstrated highly significant, dose-dependent, antitumor activity in athymic mice. Once daily oral administration of 100 mg/kg of compound 2 for 21 days inhibited the growth of established Calu-6 lung carcinoma xenografts by 79% (P &lt; 0.001, Mann Whitney rank sum test), and substantial inhibition (36%, P &lt; 0.02) was evident with 12.5 mg/kg/day.  " /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm011022e"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm011022e">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm011022e&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm011022e&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm011022e&amp;href=/doi/10.1021/jm011022e" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2002</span><span class="cit-fg-volume">, 45</span><span class="cit-fg-issue">, 6</span><span class="cit-fg-pageRange">, 1300-1312</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/45/6" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm011020u" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm010418n" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Novel 4-Anilinoquinazolines with C-7 Basic Side Chains:  Design and Structure Activity Relationship of a Series of Potent, Orally Active, VEGF Receptor Tyrosine Kinase Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Laurent+F.++Hennequin">Laurent F. Hennequin</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Elaine+S.+E.++Stokes">Elaine S. E. Stokes</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrew+P.++Thomas">Andrew P. Thomas</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Craig++Johnstone">Craig Johnstone</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Patrick+A.++Pl%C3%A9">Patrick A. Plé</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Donald+J.++Ogilvie">Donald J. Ogilvie</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Dukes">Michael Dukes</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephen+R.++Wedge">Stephen R. Wedge</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jane++Kendrew">Jane Kendrew</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jon+O.++Curwen">Jon O. Curwen</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">AstraZeneca, Centre de Recherches, Z.I. La Pompelle, B.P. 1050, Chemin de Vrilly, 51689 Reims, Cedex 2, France, and AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom </span></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="JMCMAr" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm011022e&amp;href=/doi/10.1021%2Fjm011022e" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2002</span></span><span class="cit-volume">, 45</span><span class="cit-issue">, 6</span><span class="cit-pageRange">, 1300–1312</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 19, 2002</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>15 August 2001</li><li><span class="item_label"><b>Published</b> online</span>19 February 2002</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 1 March 2002</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm011022e" title="DOI URL">https://doi.org/10.1021/jm011022e</a></div><div class="article_header-article-copyright"><strong>Copyright © 2002 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1300%26pageCount%3D13%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DLaurent%2BF.%2BHennequin%252C%2BElaine%2BS.%2BE.%2BStokes%252C%2BAndrew%2BP.%2BThomas%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D45%26issueNum%3D6%26contentID%3Djm011022e%26title%3DNovel%2B4-Anilinoquinazolines%2Bwith%2BC-7%2BBasic%2BSide%2BChains%253A%25E2%2580%2589%2BDesign%2Band%2BStructure%2BActivity%2BRelationship%2Bof%2Ba%2BSeries%2Bof%2BPotent%252C%2BOrally%2BActive%252C%2BVEGF%2BReceptor%2BTyrosine%2BKinase%2BInhibitors%26numPages%3D13%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1312%26publicationDate%3DMarch%2B2002">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm011022e"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3103</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">217</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm011022e" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Novel 4-Anilinoquinazolines with C-7 Basic Side Chains:  Design and Structure Activity Relationship of a Series of Potent, Orally Active, VEGF Receptor Tyrosine Kinase Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Laurent&quot;,&quot;last_name&quot;:&quot;F. Hennequin&quot;},{&quot;first_name&quot;:&quot;Elaine&quot;,&quot;last_name&quot;:&quot;S. E. Stokes&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;P. Thomas&quot;},{&quot;first_name&quot;:&quot;Craig&quot;,&quot;last_name&quot;:&quot;Johnstone&quot;},{&quot;first_name&quot;:&quot;Patrick&quot;,&quot;last_name&quot;:&quot;A. Plé&quot;},{&quot;first_name&quot;:&quot;Donald&quot;,&quot;last_name&quot;:&quot;J. Ogilvie&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Dukes&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;R. Wedge&quot;},{&quot;first_name&quot;:&quot;Jane&quot;,&quot;last_name&quot;:&quot;Kendrew&quot;},{&quot;first_name&quot;:&quot;Jon&quot;,&quot;last_name&quot;:&quot;O. Curwen&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2002&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;19&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;volume&quot;:&quot;45&quot;,&quot;pages&quot;:&quot;1300-1312&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm011022e&quot;},&quot;abstract&quot;:&quot;We have previously shown that 4-anilinoquinazolines can be potent inhibitors of vascular endothelial growth factor (VEGF) receptor (Flt-1 and KDR) tyrosine kinase activity. A novel subseries of 4-anilinoquinazolines that possess basic side chains at the C-7 position of the quinazoline nucleus have been synthesized. This subseries contains potent, nanomolar inhibitors of KDR (median IC50 0.02 μM, range 0.001−0.04 μM), which are comparatively less potent vs Flt-1 tyrosine kinase (median IC50 0.55 μM, range 0.02−1.6 μM). The compounds also retain some inhibitory activity against the tyrosine kinase associated to the endothelial growth factor receptor (EGFR) (median IC50 0.2 μM, range 0.075−0.8 μM) but demonstrate selectivity vs that associated to the FGF receptor 1 (median IC50 2.5 μM, range 0.9−19 μM). This selectivity profile is also evident in a growth factor-stimulated human endothelial cell (HUVEC) proliferation assay (i.e., inhibition of VEGF &gt; EGF &gt; FGF), with inhibition of VEGF-induced proliferation bein&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm011022e&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm011022e" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm011022e&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm011022e" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm011022e&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm011022e" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm011022e&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm011022e&amp;href=/doi/10.1021/jm011022e" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm011022e" /></input><a href="/doi/pdf/10.1021/jm011022e" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (140 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm011022e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm011022e%26sid%3Dliteratum%253Aachs%26pmid%3D11881999%26genre%3Darticle%26aulast%3DHennequin%26date%3D2002%26atitle%3DNovel%2B4-Anilinoquinazolines%2Bwith%2BC-7%2BBasic%2BSide%2BChains%253A%25E2%2580%2589%2BDesign%2Band%2BStructure%2BActivity%2BRelationship%2Bof%2Ba%2BSeries%2Bof%2BPotent%252C%2BOrally%2BActive%252C%2BVEGF%2BReceptor%2BTyrosine%2BKinase%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D45%26issue%3D6%26spage%3D1300%26epage%3D1312%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/45/6" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-6/jm011022e/production/images/medium/jm011022en00001.gif" alt="" id="_i2" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-6/jm011022e/production/images/large/jm011022en00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm011022e&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">We have previously shown that 4-anilinoquinazolines can be potent inhibitors of vascular endothelial growth factor (VEGF) receptor (Flt-1 and KDR) tyrosine kinase activity. A novel subseries of 4-anilinoquinazolines that possess basic side chains at the C-7 position of the quinazoline nucleus have been synthesized. This subseries contains potent, nanomolar inhibitors of KDR (median IC<sub>50</sub> 0.02 <i>μ</i>M, range 0.001−0.04 <i>μ</i>M), which are comparatively less potent vs Flt-1 tyrosine kinase (median IC<sub>50</sub> 0.55 <i>μ</i>M, range 0.02−1.6 <i>μ</i>M). The compounds also retain some inhibitory activity against the tyrosine kinase associated to the endothelial growth factor receptor (EGFR) (median IC<sub>50</sub> 0.2 <i>μ</i>M, range 0.075−0.8 <i>μ</i>M) but demonstrate selectivity vs that associated to the FGF receptor 1 (median IC<sub>50</sub> 2.5 <i>μ</i>M, range 0.9−19 <i>μ</i>M). This selectivity profile is also evident in a growth factor-stimulated human endothelial cell (HUVEC) proliferation assay (i.e., inhibition of VEGF > EGF > FGF), with inhibition of VEGF-induced proliferation being achieved at nanomolar concentrations (median IC<sub>50</sub> 0.06 <i>μ</i>M). Further examination of compound <b>2</b> (ZD6474) in recombinant enzyme assays revealed excellent selectivity for the inhibition of KDR tyrosine kinase (IC<sub>50</sub> 0.04 <i>μ</i>M) vs the kinase activity of erbB2, MEK, CDK-2, Tie-2, IGFR-1R, PDK, PDGFRβ, and AKT (IC<sub>50</sub> range: 1.1 to >100 <i>μ</i>M). Anilinoquinazolines possessing basic C-7 side chains exhibited markedly improved aqueous solubility over previously described anilinoquinazolines possessing neutral C-7 side chains (up to 500-fold improvement at pH 7.4). In addition, aqueous solubility of the neutral fraction present at pH 7.4 of the basic subseries of anilinoquinazoline proved to be higher than that of the neutral analogue <b>1</b> (ZD4190). Oral administration of representative compounds to mice (50 mg/kg) produced plasma levels between 0.2 and 3 <i>μ</i>M at 24 h after dosing. Our development candidate <b>2</b> demonstrated a very attractive in vitro profile combined with excellent solubility (330 <i>μ</i>M at pH 7.4) and good oral bioavailability in rat and dog (>80 and >50%, respectively). This compound demonstrated highly significant, dose-dependent, antitumor activity in athymic mice. Once daily oral administration of 100 mg/kg of compound <b>2 </b>for 21 days inhibited the growth of established Calu-6 lung carcinoma xenografts by 79% (<i>P</i> < 0.001, Mann Whitney rank sum test), and substantial inhibition (36%, <i>P</i> < 0.02) was evident with 12.5 mg/kg/day. </p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec fnGroup"><div class="fnGroupItem" id="jm011022eAF1"><span><h4><span class="NLM_fn-symbol">*</span></h4></span><span><p class="last">  Corresponding author. Current address:  AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom. Tel:  (44)1625 230836. Fax:  (44)1625 513910. E-mail:  <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="8ee2effbfcebe0faa0e6ebe0e0ebfffbe7e0ceeffdfafceff4ebe0ebedefa0ede1e3a0">[email protected]</a></p></span></div><div class="fnGroupItem" id="jm011022eAF2"><span><h4><span class="NLM_fn-symbol">†</span></h4></span><span><p class="last">  AstraZeneca, Centre de Recherches.</p></span></div><div class="fnGroupItem" id="jm011022eAF3"><span><h4><span class="NLM_fn-symbol">‡</span></h4></span><span><p class="last">  AstraZeneca Pharmaceuticals.</p></span></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85885" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85885" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Angiogenesis is an important component of certain normal physiological processes such as embryogenesis, wound healing, and the female reproductive cycle but also contributes to some pathological disorders and in particular to tumor growth.<sup><a onclick="showRef(event, 'jm011022eb00001 jm011022eb00002'); return false;" href="javascript:void(0);" class="ref jm011022eb00001 jm011022eb00002">1,2</a></sup> VEGF-A (vascular endothelial growth factor A) has been identified as a key factor promoting neovascularization of many tumors.<sup><a onclick="showRef(event, 'jm011022eb00003 jm011022eb00004 jm011022eb00005 jm011022eb00006 jm011022eb00007'); return false;" href="javascript:void(0);" class="ref jm011022eb00003 jm011022eb00004 jm011022eb00005 jm011022eb00006 jm011022eb00007">3-7</a></sup> VEGF activates endothelial cells by signaling through two high affinity receptors, the fms-like tyrosine kinase receptor, Flt-1, and the kinase insert domain-containing receptor, KDR.<sup><a onclick="showRef(event, 'jm011022eb00008 jm011022eb00009'); return false;" href="javascript:void(0);" class="ref jm011022eb00008 jm011022eb00009">8,9</a></sup> These signaling responses are critically dependent upon receptor dimerization and activation of intrinsic receptor tyrosine kinase (RTK) activity. </div><div class="NLM_p">Several approaches, currently being evaluated in the clinic, are directed at blocking either the interaction of VEGF with its receptors (VEGF-Ab,<sup><a onclick="showRef(event, 'jm011022eb00010'); return false;" href="javascript:void(0);" class="ref jm011022eb00010">10</a></sup> VEGF-receptor-Ab)<sup><a onclick="showRef(event, 'jm011022eb00011 jm011022eb00012'); return false;" href="javascript:void(0);" class="ref jm011022eb00011 jm011022eb00012">11,12</a></sup> or the intracellular signaling process that follows receptor activation (RTK inhibitors). </div><div class="NLM_p">Three orally bioavailable small molecules that can interfere with VEGF RTK activity, the phthalazine CGP79787/PTK787 (Flt-1 ∼ KDR),<sup><a onclick="showRef(event, 'jm011022eb00013 jm011022eb00014'); return false;" href="javascript:void(0);" class="ref jm011022eb00013 jm011022eb00014">13,14</a></sup> the indolinone SU6668<sup><a onclick="showRef(event, 'jm011022eb00015 jm011022eb00016'); return false;" href="javascript:void(0);" class="ref jm011022eb00015 jm011022eb00016">15,16</a></sup> (predominantly a c-kit, PDGFRβ inhibitor; PDGFR ≫ KDR), and the anilinoquinazoline<b> 2</b> (ZD6474),<sup><a onclick="showRef(event, 'jm011022eb00017'); return false;" href="javascript:void(0);" class="ref jm011022eb00017">17</a></sup> are being examined in patients with several types of cancer (Figure 1<a data-tab="pane-pcw-Figures" href="#jm011022ef00001" id="" class=" internalNav"></a>). The discovery and properties of compound <b>2</b> are described in this paper. <div id="_i4"><figure id="jm011022ef00001" data-index="1" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-6/jm011022e/production/images/medium/jm011022ef00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-6/jm011022e/production/images/large/jm011022ef00001.jpeg" id="_i5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 1 </p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-6/jm011022e/production/images/large/jm011022ef00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm011022e&amp;id=jm011022ef00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p last">We recently reported<sup><a onclick="showRef(event, 'jm011022eb00018 jm011022eb00019'); return false;" href="javascript:void(0);" class="ref jm011022eb00018 jm011022eb00019">18,19</a></sup> that 4-anilinoquinazolines can be potent nanomolar inhibitors of the Flt-1 and KDR enzymes. We showed that both of these enzymes are quite tolerant with regard to the nature and size of the substituent present at the C-7 position of the quinazoline nucleus (Figure 2<a data-tab="pane-pcw-Figures" href="#jm011022ef00002" id="" class=" internalNav"></a>). In this paper, we focus on the <a name="jm004500601301" id="jm004500601301"></a> physicochemical properties, in vitro profile, and in vivo activity of a series of anilinoquinazolines that possess basic side chains at the C-7 position of the quinazoline nucleus (Figure 2). <div id="_i6"><figure id="jm011022ef00002" data-index="2" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-6/jm011022e/production/images/medium/jm011022ef00002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-6/jm011022e/production/images/large/jm011022ef00002.jpeg" id="_i7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 2   </p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-6/jm011022e/production/images/large/jm011022ef00002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm011022e&amp;id=jm011022ef00002"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84610" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84610" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The compounds described in Table 1<a class="ref showTableEvent internalNav" data-ID="jm011022et00001" href="#jm011022et00001"></a> were usually prepared by two main routes described in Schemes 1−3. The first route involves the coupling of 7-hydroxy anilinoquinazoline <b>39</b>,<sup>18</sup><b> 40</b>,<sup>18</sup><b> 44</b>,<sup>18</sup> and <b>41</b>−<b>43</b> with a range of alcohols R<sup>2</sup>-H (see Table 1) under Mitsunobu conditions. The second route is based on displacing the chlorine atom of the C-4-activated quinazoline <b>64 </b>and<b> 65</b> (Scheme 3<a data-tab="pane-pcw-Figures" href="#jm011022eh00001" id="" class=" internalNav"></a><a data-tab="pane-pcw-Figures" href="#jm011022eh00002" id="" class=" internalNav"></a><a data-tab="pane-pcw-Figures" href="#jm011022eh00003" id="" class=" internalNav"></a>) with different anilines (see Table 1). <div id="_i9"><figure id="jm011022eh00001" data-index="3" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-6/jm011022e/production/images/medium/jm011022eh00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-6/jm011022e/production/images/large/jm011022eh00001.jpeg" id="_i10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 1 <i><sup>a,b</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents:  (a) R<sup>1</sup>-Ar-NH<sub>2</sub>/<i>i</i>PrOH/HCl/reflux (procedure A or G) or R<sup>1</sup>-Ar-NH<sub>2</sub>/NaH/DMF (procedure H). <i><sup>b</sup></i><sup></sup> TFA (procedure L or J).</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-6/jm011022e/production/images/large/jm011022eh00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm011022e&amp;id=jm011022eh00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="jm011022eh00002" data-index="4" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-6/jm011022e/production/images/medium/jm011022eh00002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-6/jm011022e/production/images/large/jm011022eh00002.jpeg" id="_i11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 2 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents:  (a) DMF/K<sub>2</sub>CO<sub>3</sub> (procedure M). (b) i. Ph<sub>3</sub>P/DEAD; ii. TFA (procedure I). (c) R<sup>2</sup>OH (see Table 1)/<i>n</i>-Bu<sub>3</sub>P/ADDP (procedure C) or Ph<sub>3</sub>P/DEAD (procedure E or F). (d) 1-(3-Chloropropyl)pyrrolidine/DMF/K<sub>2</sub>CO<sub>3</sub> (procedure D). (e) TFA (procedure J or L). </p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-6/jm011022e/production/images/large/jm011022eh00002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm011022e&amp;id=jm011022eh00002"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="jm011022eh00003" data-index="5" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-6/jm011022e/production/images/medium/jm011022eh00003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-6/jm011022e/production/images/large/jm011022eh00003.jpeg" id="_i12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 3 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents:  (a) <b>54</b>:  Ph<sub>3</sub>P/CH<sub>2</sub>Cl<sub>2</sub>/DEAD. (b) <b>55</b>:  K<sub>2</sub>CO<sub>3</sub>/DMF. (c) TFA. (d) MeOH/THF/HCHO/NaBH<sub>3</sub>CN. (e) HCHO/NaB(OAc)<sub>3</sub>/AcOH. (f) MeOH/NH<sub>3</sub>. (g) SOCl<sub>2</sub>/DMF. (h) R<sup>1</sup>-Ar-NH<sub>2</sub>/<i>i</i>PrOH/HCl (procedure A or G). (i) NaH/DMF (procedure H).</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-6/jm011022e/production/images/large/jm011022eh00003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm011022e&amp;id=jm011022eh00003"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div class="NLM_table-wrap" id="jm011022et00001"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 1.  Role of the C-7 Side Chain and Aniline Substitution on Enzyme Inhibition and HUVEC Activity<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-6/jm011022e/production/images/medium/jm011022eu00001a.gif" alt="" id="_i13" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2" colspan="3">inhibition of HUVEC growth IC<sub>50</sub> μM <i><sup>c</sup></i><sup></sup></td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2" colspan="4">R‘</td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2" colspan="4">enzyme inhibition (2 μM ATP) IC<sub>50</sub> μM <i><sup>b</sup></i><sup></sup></td><td class="colsep2 rowsep2" colspan="2">stimulated by</td><td class="colsep2 rowsep2">unstimulated</td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">no.</td><td class="colsep2 rowsep2">2‘</td><td class="colsep2 rowsep2">4‘</td><td class="colsep2 rowsep2">5‘</td><td class="colsep2 rowsep2">6‘</td><td class="colsep2 rowsep2">R<sup>2</sup></td><td class="colsep2 rowsep2">proced</td><td class="colsep2 rowsep2">formula <i><sup>a</sup></i><sup></sup></td><td class="colsep2 rowsep2">Flt-1</td><td class="colsep2 rowsep2">KDR</td><td class="colsep2 rowsep2">FGFR</td><td class="colsep2 rowsep2">EGFR</td><td class="colsep2 rowsep2">VEGF</td><td class="colsep2 rowsep2">EGF</td><td class="colsep2 rowsep2">Basal </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>1</b></td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">Br </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">1-(1,2,3-triazolyl)-(CH<sub>2</sub>)<sub>2</sub>O </td><td class="colsep2 rowsep2">ref 18 </td><td class="colsep2 rowsep2">ref 18 </td><td class="colsep2 rowsep2">0.7 </td><td class="colsep2 rowsep2">0.03 </td><td class="colsep2 rowsep2">>100 </td><td class="colsep2 rowsep2">0.4 </td><td class="colsep2 rowsep2">0.05 </td><td class="colsep2 rowsep2">0.05 </td><td class="colsep2 rowsep2">>10 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>2</b></td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">Br </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">MeN(CH<sub>2</sub>CH<sub>2</sub>)<sub>2</sub>CH-CH<sub>2</sub>O </td><td class="colsep2 rowsep2">A </td><td class="colsep2 rowsep2">C<sub>22</sub>H<sub>24</sub>N<sub>4</sub>O<sub>2</sub>BrF, 0.5H<sub>2</sub>O, 1.8HCl </td><td class="colsep2 rowsep2">1.6 </td><td class="colsep2 rowsep2">0.04 </td><td class="colsep2 rowsep2">3.6 </td><td class="colsep2 rowsep2">0.5 </td><td class="colsep2 rowsep2">0.06 </td><td class="colsep2 rowsep2">0.17 </td><td class="colsep2 rowsep2">>3 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>3</b></td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">MeO(CH<sub>2</sub>)<sub>2</sub>O </td><td class="colsep2 rowsep2">ref 18 </td><td class="colsep2 rowsep2">ref 18 </td><td class="colsep2 rowsep2">0.4 </td><td class="colsep2 rowsep2">0.007 </td><td class="colsep2 rowsep2">27 </td><td class="colsep2 rowsep2">0.1 </td><td class="colsep2 rowsep2">0.04 </td><td class="colsep2 rowsep2">0.1 </td><td class="colsep2 rowsep2">5 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>4</b></td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">4-Me-piperazinyl-(CH<sub>2</sub>)<sub>3</sub>O </td><td class="colsep2 rowsep2">B </td><td class="colsep2 rowsep2">C<sub>23</sub>H<sub>27</sub>N<sub>5</sub>O<sub>2</sub>ClF, 0.7H<sub>2</sub>O, 2.75HCl </td><td class="colsep2 rowsep2">0.6 </td><td class="colsep2 rowsep2">0.02 </td><td class="colsep2 rowsep2">2.1 </td><td class="colsep2 rowsep2">0.075 </td><td class="colsep2 rowsep2">0.05 </td><td class="colsep2 rowsep2">0.1 </td><td class="colsep2 rowsep2">5 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>5</b></td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">Br </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">4-Me-piperazinyl-(CH<sub>2</sub>)<sub>3</sub>O </td><td class="colsep2 rowsep2">B </td><td class="colsep2 rowsep2">C<sub>23</sub>H<sub>27</sub>N<sub>5</sub>O<sub>2</sub>BrF, 1H<sub>2</sub>O, 2.6HCl </td><td class="colsep2 rowsep2">0.55 </td><td class="colsep2 rowsep2">0.009 </td><td class="colsep2 rowsep2">2.0 </td><td class="colsep2 rowsep2">0.1 </td><td class="colsep2 rowsep2">0.03 </td><td class="colsep2 rowsep2">0.09 </td><td class="colsep2 rowsep2">>1 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>6</b></td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">4-Me-piperazinyl-(CH<sub>2</sub>)<sub>2</sub>-O </td><td class="colsep2 rowsep2">C </td><td class="colsep2 rowsep2">C<sub>22</sub>H<sub>25</sub>N<sub>5</sub>O<sub>2</sub>ClF </td><td class="colsep2 rowsep2">0.3 </td><td class="colsep2 rowsep2">0.03 </td><td class="colsep2 rowsep2">8 </td><td class="colsep2 rowsep2">0.2 </td><td class="colsep2 rowsep2">0.1 </td><td class="colsep2 rowsep2">0.2 </td><td class="colsep2 rowsep2">10 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>7</b></td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">4-morpholinyl-(CH<sub>2</sub>)<sub>3</sub>O </td><td class="colsep2 rowsep2">ref 18 </td><td class="colsep2 rowsep2">ref 18 </td><td class="colsep2 rowsep2">0.2 </td><td class="colsep2 rowsep2">0.009 </td><td class="colsep2 rowsep2">6.7 </td><td class="colsep2 rowsep2">0.1 </td><td class="colsep2 rowsep2">0.05 </td><td class="colsep2 rowsep2">0.2 </td><td class="colsep2 rowsep2">2 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>8</b></td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">4-morpholinyl-(CH<sub>2</sub>)<sub>2</sub>O </td><td class="colsep2 rowsep2">ref 18 </td><td class="colsep2 rowsep2">ref 18 </td><td class="colsep2 rowsep2">1.1 </td><td class="colsep2 rowsep2">0.04 </td><td class="colsep2 rowsep2">19 </td><td class="colsep2 rowsep2">0.4 </td><td class="colsep2 rowsep2">0.3 </td><td class="colsep2 rowsep2">0.3 </td><td class="colsep2 rowsep2">5 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>9</b></td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">1-pyrrolidinyl-(CH<sub>2</sub>)<sub>3</sub>O </td><td class="colsep2 rowsep2">D </td><td class="colsep2 rowsep2">C<sub>22</sub>H<sub>24</sub>N<sub>4</sub>O<sub>2</sub>ClF, 1.8H<sub>2</sub>O, 1.5HCl </td><td class="colsep2 rowsep2">0.2 </td><td class="colsep2 rowsep2">0.03 </td><td class="colsep2 rowsep2">4.2 </td><td class="colsep2 rowsep2">0.1 </td><td class="colsep2 rowsep2">0.008 </td><td class="colsep2 rowsep2">0.1 </td><td class="colsep2 rowsep2">5 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>10</b></td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">(CH<sub>2</sub>)<sub>4</sub>N−CH<sub>2</sub>CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CH−CH<sub>2</sub>O </td><td class="colsep2 rowsep2">E </td><td class="colsep2 rowsep2">C<sub>23</sub>H<sub>24</sub>N<sub>4</sub>O<sub>2</sub>ClF, 0.6H<sub>2</sub>O, 1.85HCl </td><td class="colsep2 rowsep2">0.75 </td><td class="colsep2 rowsep2">0.04 </td><td class="colsep2 rowsep2">1.9 </td><td class="colsep2 rowsep2">0.09 </td><td class="colsep2 rowsep2">0.04 </td><td class="colsep2 rowsep2">0.08 </td><td class="colsep2 rowsep2">1 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>11</b></td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">Br </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">(CH<sub>2</sub>)<sub>4</sub>N−CH<sub>2</sub>CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CH−CH<sub>2</sub>O </td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">C<sub>23</sub>H<sub>24</sub>N<sub>4</sub>O<sub>2</sub>BrF, 0.5H<sub>2</sub>O, 2HCl </td><td class="colsep2 rowsep2">0.65 </td><td class="colsep2 rowsep2">0.008 </td><td class="colsep2 rowsep2">2.1 </td><td class="colsep2 rowsep2">0.1 </td><td class="colsep2 rowsep2">0.03 </td><td class="colsep2 rowsep2">0.09 </td><td class="colsep2 rowsep2">5 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>12</b></td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">CN </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">(CH<sub>2</sub>)<sub>4</sub>N−CH<sub>2</sub>CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CH−CH<sub>2</sub>O </td><td class="colsep2 rowsep2">E </td><td class="colsep2 rowsep2">ND<i><sup>d</sup></i><sup></sup></td><td class="colsep2 rowsep2">3.9 </td><td class="colsep2 rowsep2">0.23 </td><td class="colsep2 rowsep2">19 </td><td class="colsep2 rowsep2">0.8 </td><td class="colsep2 rowsep2">0.5 </td><td class="colsep2 rowsep2">1.4 </td><td class="colsep2 rowsep2">10 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>13</b></td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">4-pyridyl-N(Me)-(CH<sub>2</sub>)<sub>2</sub>O </td><td class="colsep2 rowsep2">ref 18 </td><td class="colsep2 rowsep2">ref 18 </td><td class="colsep2 rowsep2">0.1 </td><td class="colsep2 rowsep2">0.006 </td><td class="colsep2 rowsep2">1.6 </td><td class="colsep2 rowsep2">0.3 </td><td class="colsep2 rowsep2">0.2 </td><td class="colsep2 rowsep2">0.2 </td><td class="colsep2 rowsep2">5 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>14</b></td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">MeN(CH<sub>2</sub>CH<sub>2</sub>)<sub>2</sub>CH-O </td><td class="colsep2 rowsep2">ref 18 </td><td class="colsep2 rowsep2">ref 18 </td><td class="colsep2 rowsep2">1.5 </td><td class="colsep2 rowsep2">1.5 </td><td class="colsep2 rowsep2">50 </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>15</b></td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">MeN(CH<sub>2</sub>CH<sub>2</sub>)<sub>2</sub>CH-CH<sub>2</sub>O </td><td class="colsep2 rowsep2">A </td><td class="colsep2 rowsep2">C<sub>22</sub>H<sub>24</sub>N<sub>4</sub>O<sub>2</sub>ClF, 0.4H<sub>2</sub>O, 2HCl </td><td class="colsep2 rowsep2">2 </td><td class="colsep2 rowsep2">0.015 </td><td class="colsep2 rowsep2">4.3 </td><td class="colsep2 rowsep2">0.3 </td><td class="colsep2 rowsep2">0.05 </td><td class="colsep2 rowsep2">0.1 </td><td class="colsep2 rowsep2">5 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>16</b></td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">Me </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">MeN(CH<sub>2</sub>CH<sub>2</sub>)<sub>2</sub>CH-CH<sub>2</sub>O </td><td class="colsep2 rowsep2">G </td><td class="colsep2 rowsep2">C<sub>23</sub>H<sub>27</sub>N<sub>4</sub>O<sub>2</sub>F, 0.3H<sub>2</sub>O </td><td class="colsep2 rowsep2">0.5 </td><td class="colsep2 rowsep2">0.025 </td><td class="colsep2 rowsep2">13.5 </td><td class="colsep2 rowsep2">1 </td><td class="colsep2 rowsep2">0.065 </td><td class="colsep2 rowsep2">0.4 </td><td class="colsep2 rowsep2">>5 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>17</b></td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">OH </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">MeN(CH<sub>2</sub>CH<sub>2</sub>)<sub>2</sub>CH-CH<sub>2</sub>O </td><td class="colsep2 rowsep2">A </td><td class="colsep2 rowsep2">C<sub>22</sub>H<sub>24</sub>N<sub>4</sub>O<sub>3</sub>ClF,<sub> </sub>2HCl, 0.5C<sub>3</sub>H<sub>8</sub>O, 0.8 H<sub>2</sub>O </td><td class="colsep2 rowsep2">0.02 </td><td class="colsep2 rowsep2">0.008 </td><td class="colsep2 rowsep2">0.9 </td><td class="colsep2 rowsep2">0.1 </td><td class="colsep2 rowsep2">0.003 </td><td class="colsep2 rowsep2">0.07 </td><td class="colsep2 rowsep2">0.5 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>18</b></td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">Me </td><td class="colsep2 rowsep2">OH </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">MeN(CH<sub>2</sub>CH<sub>2</sub>)<sub>2</sub>CH-CH<sub>2</sub>O </td><td class="colsep2 rowsep2">A </td><td class="colsep2 rowsep2">C<sub>23</sub>H<sub>27</sub>N<sub>4</sub>O<sub>3</sub>F, 1.95HCl, 0.65C<sub>3</sub>H<sub>8</sub>O, 1H<sub>2</sub>O </td><td class="colsep2 rowsep2">0.025 </td><td class="colsep2 rowsep2">0.007 </td><td class="colsep2 rowsep2">1.5 </td><td class="colsep2 rowsep2">0.3 </td><td class="colsep2 rowsep2">0.003 </td><td class="colsep2 rowsep2">0.2 </td><td class="colsep2 rowsep2">0.8 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>19</b></td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">MeN(CH<sub>2</sub>CH<sub>2</sub>)<sub>2</sub>CH-CH<sub>2</sub>O </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">C<sub>22</sub>H<sub>23</sub>N<sub>4</sub>O<sub>2</sub>ClF<sub>2</sub></td><td class="colsep2 rowsep2">0.3 </td><td class="colsep2 rowsep2">0.025 </td><td class="colsep2 rowsep2">1.7 </td><td class="colsep2 rowsep2">0.45 </td><td class="colsep2 rowsep2">0.06 </td><td class="colsep2 rowsep2">0.3 </td><td class="colsep2 rowsep2">>5 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>20</b></td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">Br </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">MeN(CH<sub>2</sub>CH<sub>2</sub>)<sub>2</sub>CH-CH<sub>2</sub>O </td><td class="colsep2 rowsep2">C </td><td class="colsep2 rowsep2">C<sub>22</sub>H<sub>23</sub>N<sub>4</sub>O<sub>2</sub>BrF<sub>2</sub></td><td class="colsep2 rowsep2">0.5 </td><td class="colsep2 rowsep2">0.01 </td><td class="colsep2 rowsep2">1.5 </td><td class="colsep2 rowsep2">0.3 </td><td class="colsep2 rowsep2">0.1 </td><td class="colsep2 rowsep2">0.4 </td><td class="colsep2 rowsep2">>1 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>21</b></td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">HN(CH<sub>2</sub>CH<sub>2</sub>)<sub>2</sub>CH-CH<sub>2</sub>O </td><td class="colsep2 rowsep2">I </td><td class="colsep2 rowsep2">C<sub>21</sub>H<sub>22</sub>N<sub>4</sub>O<sub>2</sub>ClF, 2.25HCl </td><td class="colsep2 rowsep2">1 </td><td class="colsep2 rowsep2">0.05 </td><td class="colsep2 rowsep2">5.0 </td><td class="colsep2 rowsep2">0.3 </td><td class="colsep2 rowsep2">0.06 </td><td class="colsep2 rowsep2">0.1 </td><td class="colsep2 rowsep2">5 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>22</b></td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">Br </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">HN(CH<sub>2</sub>CH<sub>2</sub>)<sub>2</sub>CH-CH<sub>2</sub>O </td><td class="colsep2 rowsep2">J </td><td class="colsep2 rowsep2">C<sub>21</sub>H<sub>22</sub>N<sub>4</sub>O<sub>2</sub>BrF </td><td class="colsep2 rowsep2">0.9 </td><td class="colsep2 rowsep2">0.07 </td><td class="colsep2 rowsep2">6 </td><td class="colsep2 rowsep2">0.2 </td><td class="colsep2 rowsep2">0.025 </td><td class="colsep2 rowsep2">0.1 </td><td class="colsep2 rowsep2">5 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>23</b></td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">Me </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">HN(CH<sub>2</sub>CH<sub>2</sub>)<sub>2</sub>CH-CH<sub>2</sub>O </td><td class="colsep2 rowsep2">J </td><td class="colsep2 rowsep2">ND<i><sup>d</sup></i><sup></sup></td><td class="colsep2 rowsep2">0.7 </td><td class="colsep2 rowsep2">0.03 </td><td class="colsep2 rowsep2">12.3 </td><td class="colsep2 rowsep2">0.5 </td><td class="colsep2 rowsep2">0.25 </td><td class="colsep2 rowsep2">0.45 </td><td class="colsep2 rowsep2">>5 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>24</b></td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">HN(CH<sub>2</sub>CH<sub>2</sub>)<sub>2</sub>CH-CH<sub>2</sub>O </td><td class="colsep2 rowsep2">J </td><td class="colsep2 rowsep2">ND<i><sup>d</sup></i><sup></sup></td><td class="colsep2 rowsep2">0.45 </td><td class="colsep2 rowsep2">0.04 </td><td class="colsep2 rowsep2">2.5 </td><td class="colsep2 rowsep2">0.5 </td><td class="colsep2 rowsep2">0.1 </td><td class="colsep2 rowsep2">0.6 </td><td class="colsep2 rowsep2">>1 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>25</b></td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">Br </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">HN(CH<sub>2</sub>CH<sub>2</sub>)<sub>2</sub>CH-CH<sub>2</sub>O </td><td class="colsep2 rowsep2">J </td><td class="colsep2 rowsep2">ND<i><sup>d</sup></i><sup></sup></td><td class="colsep2 rowsep2">0.8 </td><td class="colsep2 rowsep2">0.015 </td><td class="colsep2 rowsep2">1.9 </td><td class="colsep2 rowsep2">0.45 </td><td class="colsep2 rowsep2">0.07 </td><td class="colsep2 rowsep2">0.4 </td><td class="colsep2 rowsep2">3 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>26</b></td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">MeN(CH<sub>2</sub>CH<sub>2</sub>)<sub>2</sub>CH-CH<sub>2</sub>CH<sub>2</sub>O </td><td class="colsep2 rowsep2">A </td><td class="colsep2 rowsep2">ND<i><sup>d</sup></i><sup></sup></td><td class="colsep2 rowsep2">0.5 </td><td class="colsep2 rowsep2">0.055 </td><td class="colsep2 rowsep2">4.1 </td><td class="colsep2 rowsep2">0.3 </td><td class="colsep2 rowsep2">0.07 </td><td class="colsep2 rowsep2">0.2 </td><td class="colsep2 rowsep2">3 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>27</b></td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">Br </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">MeN(CH<sub>2</sub>CH<sub>2</sub>)<sub>2</sub>CH-CH<sub>2</sub>CH<sub>2</sub>O </td><td class="colsep2 rowsep2">K </td><td class="colsep2 rowsep2">C<sub>23</sub>H<sub>26</sub>N<sub>4</sub>O<sub>2</sub>BrF, 0.1H<sub>2</sub>O, 0.15C<sub>4</sub>H<sub>10</sub>O </td><td class="colsep2 rowsep2">0.15 </td><td class="colsep2 rowsep2">0.006 </td><td class="colsep2 rowsep2">2.1 </td><td class="colsep2 rowsep2">0.2 </td><td class="colsep2 rowsep2">0.06 </td><td class="colsep2 rowsep2">0.15 </td><td class="colsep2 rowsep2">3 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>28</b></td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">Br </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">HN(CH<sub>2</sub>CH<sub>2</sub>)<sub>2</sub>CH-CH<sub>2</sub>CH<sub>2</sub>O </td><td class="colsep2 rowsep2">L </td><td class="colsep2 rowsep2">C<sub>22</sub>H<sub>24</sub>N<sub>4</sub>O<sub>2</sub>BrF, 0.54H<sub>2</sub>O, 0.26CH<sub>4</sub>O </td><td class="colsep2 rowsep2">0.2 </td><td class="colsep2 rowsep2">0.04 </td><td class="colsep2 rowsep2">2.7 </td><td class="colsep2 rowsep2">0.2 </td><td class="colsep2 rowsep2">0.04 </td><td class="colsep2 rowsep2">0.08 </td><td class="colsep2 rowsep2">3 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>29</b></td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">(R) MeN(CH<sub>2</sub>)(CH<sub>2</sub>)<sub>3</sub>CH-CH<sub>2</sub>O </td><td class="colsep2 rowsep2">E </td><td class="colsep2 rowsep2">C<sub>22</sub>H<sub>24</sub>N<sub>4</sub>O<sub>2</sub>ClF<i><sup>e</sup></i><sup></sup></td><td class="colsep2 rowsep2">0.7 </td><td class="colsep2 rowsep2">0.005 </td><td class="colsep2 rowsep2">1.8 </td><td class="colsep2 rowsep2">0.1 </td><td class="colsep2 rowsep2">0.08 </td><td class="colsep2 rowsep2">0.15 </td><td class="colsep2 rowsep2">5 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>30</b></td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">Br </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">(R) MeN(CH<sub>2</sub>)(CH<sub>2</sub>)<sub>3</sub>CH-CH<sub>2</sub>O </td><td class="colsep2 rowsep2">E </td><td class="colsep2 rowsep2">C<sub>22</sub>H<sub>24</sub>N<sub>4</sub>O<sub>2</sub>BrF </td><td class="colsep2 rowsep2">0.5 </td><td class="colsep2 rowsep2">0.001 </td><td class="colsep2 rowsep2">1.8 </td><td class="colsep2 rowsep2">0.2 </td><td class="colsep2 rowsep2">0.06 </td><td class="colsep2 rowsep2">0.15 </td><td class="colsep2 rowsep2">10 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>31</b></td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">Br </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">(S) MeN(CH<sub>2</sub>)(CH<sub>2</sub>)<sub>3</sub>CH-CH<sub>2</sub>O </td><td class="colsep2 rowsep2">E </td><td class="colsep2 rowsep2">C<sub>22</sub>H<sub>24</sub>N<sub>4</sub>O<sub>2</sub>BrF </td><td class="colsep2 rowsep2">0.5 </td><td class="colsep2 rowsep2">0.01 </td><td class="colsep2 rowsep2">5.0 </td><td class="colsep2 rowsep2">0.1 </td><td class="colsep2 rowsep2">0.04 </td><td class="colsep2 rowsep2">0.15 </td><td class="colsep2 rowsep2">1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> C, H, and N analyses were obtained for every compound and were within ±0.4% of the theoretical value unless otherwise stated.<i><sup>b</sup></i><sup></sup> Values are averages from at least three independent dose−response curves; variation was generally ±10% for Flt-1 and ±20% for KDR, EGFR, and FGFR.<i><sup>c</sup></i><sup></sup> Values are averages from at least three independent dose−response curves; variation was generally ±15% for VEGF and EGF.<i><sup>d</sup></i><sup></sup> ND, not determined. Purity was assessed as >98 ± 3% by <sup>1</sup>H NMR at 400 MHz.<i><sup>e</sup></i><sup></sup> C:  calcd, 61.3%; found, 60.7%.</p></div></div></div><div class="NLM_p last">The 7-benzyloxy-4-chloro-6-methoxyquinazoline (<b>32</b>)<sup>18</sup> was reacted with anilines under acid catalysis in a protic solvent in the case of anilines with high or moderate nucleophilic character (2‘-F, 4‘-Cl; 2‘-F, 4‘-Br; 2‘-F, 4‘-Me). In the case of weakly nucleophilic anilines (2‘,6‘-F<sub>2</sub>, 4‘-Cl; 2‘,6‘-F<sub>2</sub>, 4‘-Br; 2‘-F, 4‘-CN), the sodium salts of the anilines were preformed in situ (NaH, dimethylformamide (DMF)) and then reacted with <b>32</b><sup>18</sup> to give the corresponding C-7-benzyloxyanilinoquinazolines <b>33</b>,<sup>18</sup><b>34</b>,<sup>18</sup><b>38</b>,<sup>18</sup> and <b>35</b>−<b>37</b> (Scheme 1). Deprotection of the C-7-benzyl moiety was subsequently achieved using trifluoroacetyl (TFA) and led to the key intermediate 7-hydroxy-4-anilinoquinazolines <b>39</b>,<sup>18</sup><b> 40</b>,<sup>18</sup><b> 44</b>,<sup>18</sup> and <b>41</b>−<b>43</b> (Scheme 1). Reaction of <b>39</b>−<b>43</b> with a range of alcohols under Mitsunobu conditions using either diethyl or di-<i>tert</i>-butyl azodicarboxylate or the more hydrophilic 1,1‘-(azodicarbonyl)dipiperidine led to <b>6</b>, <b>10</b>−<b>12</b>, and <b>29</b>−<b>31</b> (Scheme 2). Using similar reaction conditions, the N-protected piperidines <b>52</b><sup><a onclick="showRef(event, 'jm011022eb00020'); return false;" href="javascript:void(0);" class="ref jm011022eb00020">20</a></sup> and <b>53</b><sup>20</sup> were coupled with <b>39</b>−<b>41</b>, <b>43</b>, and <b>44</b><sup>18</sup> to give <b>21</b> and<b> 46</b>−<b>49</b>. Compound <b>45</b> was obtained by coupling the 7-hydroxy-anilinoquinazoline <b>40</b><sup>18</sup> with the tosylate piperidine <b>54</b><sup><a onclick="showRef(event, 'jm011022eb00021'); return false;" href="javascript:void(0);" class="ref jm011022eb00021">21</a></sup> under alkylation conditions (K<sub>2</sub>CO<sub>3</sub>, DMF). The <i>t</i>-BOC protecting group of <b>45</b>−<b>49</b> was subsequently removed by treatment with TFA to release the basic piperidine nitrogen (Scheme 2). Compounds <b>2</b>,<b> 15</b>−<b>20</b>, and <b>26</b> were prepared as described in Scheme 3. The N-protected 4-piperidine methanol side chains <b>52</b> and <b>53</b><sup>20</sup> or their tosylate-activated counterparts <b>54</b><sup>21</sup> and <b>55</b><sup><a onclick="showRef(event, 'jm011022eb00022'); return false;" href="javascript:void(0);" class="ref jm011022eb00022">22</a></sup> were first coupled at the C-7 position of the N-3-POM-protected quinazolone <b>51</b><sup>18</sup> to give <b>56</b> and <b>57</b>. Subsequent selective deprotection of the <i>t</i>-Boc group of <b>56</b> and <b>57</b> led to <b>58 </b>and <b>59</b>. N-methylation of the piperidine nitrogen using formaldehyde under reducing conditions led, respectively, to <b>60</b> and <b>61</b>. The quinazolone moiety of <b>60 </b>and <b>61</b> was then unmasked using ammonia in methanol to give <b>62 </b>and <b>63</b>, and the C-4 position of these quinazolones was subsequently chlorinated using thionyl chloride and DMF to give <b>64</b> and <b>65</b> (Scheme 3). Reaction of <b>64</b> and <b>65</b> with a range of aniline under either acid-catalyzed or basic conditions as described previously led to <b>2</b>, <b>15</b>−<b>20</b>, and<b> 26</b> (Scheme 3). Compound <b>27</b> was obtained directly from <b>28</b> by methylating the piperidine nitrogen under Eschweiler−Clarke conditions (HCOOH, HCHO, reflux; Scheme 4<a data-tab="pane-pcw-Figures" href="#jm011022eh00004" id="" class=" internalNav"></a>). The anilinoquinazolines<b> 4</b> and <b>5</b> were synthesized from the pivotal intermediates <b>39</b><sup>18</sup> and <b>40.</b><sup>18</sup> Alkylation of the C-7 position of <b>39</b><sup>18</sup> and <b>40</b><sup>18</sup> with 1-bromo-3-chloropropane gave <b>66</b> and <b>67</b>, respectively. Subsequent nucleophilic displacement of the aliphatic chlorine of <b>66</b> and <b>67 </b>by heating in an excess of <i>N</i>-methylpiperazine led to the expected anilinoquinazolines (Scheme 5). <div id="_i14"><figure id="jm011022eh00004" data-index="6" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-6/jm011022e/production/images/medium/jm011022eh00004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-6/jm011022e/production/images/large/jm011022eh00004.jpeg" id="_i15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 4 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> HCOOH, HCHO, reflux (procedure K).</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-6/jm011022e/production/images/large/jm011022eh00004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm011022e&amp;id=jm011022eh00004"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27146" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27146" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">For clarity of discussion, data on only a limited, representative set of compounds are presented in Table 1 and used to describe the structure−activity relationship (SAR). When some trends are exemplified by single pairs of compounds, it is to be understood that more examples<sup><a onclick="showRef(event, 'jm011022eb00023 jm011022eb00024 jm011022eb00025'); return false;" href="javascript:void(0);" class="ref jm011022eb00023 jm011022eb00024 jm011022eb00025">23-25</a></sup> exist to support the SAR described below. Where cited, selectivity ratios refer to the quotients of the respective IC<sub>50</sub> values for enzyme (or cell growth) inhibition. </div><div class="NLM_p"><b>i. Inhibition of Receptor Kinase Activity in Vitro.</b> As previously reported,<sup>18</sup> one of the preferred patterns of substitution of the aniline ring to optimize inhibition of the target enzymes consists of a small lipophilic, electron-deficient substituent at the C-2‘ position combined with a larger lipophilic, electron-withdrawing atom at the C-4‘ position such as chlorine or bromine. The same patterns were apparent with basic C-7 side chains. As shown by comparison of the 4‘-cyano and 4‘-bromo derivatives <b>12</b> and <b>11 </b>(Table 1), replacement of hydrophilic electron-withdrawing substituents that possess marked π-character, by more lipophilic substituents with moderate electron-withdrawing <a name="jm004500601303" id="jm004500601303"></a> character, led to marked improvement in both Flt-1 and KDR inhibition (up to 350-fold). A previous development candidate (<b>1</b>, ZD4190;<sup>18</sup> Table 1) possessed one of the preferred substitution patterns (C-2‘-F, C-4‘-Br) and proved to be a very potent inhibitor of KDR (Table 1). It also inhibited, but to a lesser extent, the TK associated with the endothelial growth factor receptor (EGFR) (KDR:EGFR selectivity ratio ∼ 13). This pattern of substitution also led in the C-7 neutral series to high selectivity for KDR against FGFR-1 (fibroblast growth factor receptor TK) (<b>1</b> and <b>3</b>:  selectivity ratios > 1000; Table 1). Introduction of a hydroxyl substituent at the meta position of the aniline led to an improvement in Flt-1 inhibition by 20−100-fold (comparison of <b>15</b>−<b>18</b>) while improving KDR inhibition by only 2−4-fold. Introduction of an additional fluorine atom at the C-6‘ position of the aniline in general increased the activity against Flt-1 over KDR (2−7-fold; comparison of <b>19</b>, <b>20</b>, and <b>24 </b>and <b>15</b>, <b>2</b>, and <b>21</b>). </div><div class="NLM_p">The 1,2,3-triazole-ethoxy side chain present at the C-7 position of <b>1 </b>is a typical neutral side chain commonly used in medicinal chemistry. This side chain confers on <b>1 </b>high and sustained plasma levels in mouse following oral administration (13 <i>μ</i>M at 24 h following 100 mg/kg).<sup>18,19</sup> Such plasma levels combined with nanomolar inhibition of growth factor-stimulated endothelial cell proliferation led to profound inhibition of growth of human tumor xenografts in athymic mice with once daily chronic oral administration.<sup>18,19</sup> However, the neutral nature of the 1,2,3-triazole-ethoxy side chain conferred on <b>1</b> suboptimal physicochemical properties that we believe were principally responsible for variable pharmacokinetic properties across species (see the sections on physicochemical properties and PK properties, Tables 3<a class="ref showTableEvent internalNav" data-ID="jm011022et00002" href="#jm011022et00002"></a><a class="ref showTableEvent internalNav" data-ID="jm011022et00003" href="#jm011022et00003"></a><a data-tab="pane-pcw-Figures" href="#jm011022eh00005" id="" class=" internalNav"></a><a class="ref showTableEvent internalNav" data-ID="jm011022et00004" href="#jm011022et00004"></a>−5<a class="ref showTableEvent internalNav" data-ID="jm011022et00005" href="#jm011022et00005"></a>). We therefore turned our attention to C-7 side chains that might provide VEGF RTK inhibitors with improved physical properties. <div id="_i17"><figure id="jm011022eh00005" data-index="7" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-6/jm011022e/production/images/medium/jm011022eh00005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-6/jm011022e/production/images/large/jm011022eh00005.jpeg" id="_i18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 5 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents:  (a) Cl-(CH<sub>2</sub>)<sub>3</sub>-Br/K<sub>2</sub>CO<sub>3</sub>/DMF. (b) <i>N</i>-Methylpiperazine/100 °C (procedure B).</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-6/jm011022e/production/images/large/jm011022eh00005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm011022e&amp;id=jm011022eh00005"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div class="NLM_table-wrap" id="jm011022et00002"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 2.  Selectivity Profile in a Panel of Kinase Enzymes of Compounds <b>1</b> and <b>2</b></p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2" colspan="12">enzyme inhibition<i><sup>a</sup></i><sup></sup> (IC<sub>50</sub> <i>μ</i>M<i><sup>b</sup></i><sup></sup>)</td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">no.</td><td class="colsep2 rowsep2">Flt-1</td><td class="colsep2 rowsep2">KDR</td><td class="colsep2 rowsep2">EGFR</td><td class="colsep2 rowsep2">Tie-2</td><td class="colsep2 rowsep2">FGFR-1</td><td class="colsep2 rowsep2">PDGFRβ</td><td class="colsep2 rowsep2">erbB2</td><td class="colsep2 rowsep2">MEK</td><td class="colsep2 rowsep2">CDK2</td><td class="colsep2 rowsep2">IGF-1R</td><td class="colsep2 rowsep2">AKT</td><td class="colsep2 rowsep2">PDK </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>1</b></td><td class="colsep2 rowsep2">0.7 ± 0.06 </td><td class="colsep2 rowsep2">0.03 ± 0.004 </td><td class="colsep2 rowsep2">0.4 ± 0.1 </td><td class="colsep2 rowsep2">>100 </td><td class="colsep2 rowsep2">>100 </td><td class="colsep2 rowsep2">3.4 ± 0.3 </td><td class="colsep2 rowsep2">>100 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">>20 </td><td class="colsep2 rowsep2">>20 </td><td class="colsep2 rowsep2">>20 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>2</b></td><td class="colsep2 rowsep2">1.6 ± 0.4 </td><td class="colsep2 rowsep2">0.04 ± 0.01 </td><td class="colsep2 rowsep2">0.5 ± 0.1 </td><td class="colsep2 rowsep2">2.5 ± 1.2 </td><td class="colsep2 rowsep2">3.6 ± 0.9 </td><td class="colsep2 rowsep2">1.1 ± 0.3 </td><td class="colsep2 rowsep2">>20 </td><td class="colsep2 rowsep2">>20 </td><td class="colsep2 rowsep2">>20 </td><td class="colsep2 rowsep2">>20 </td><td class="colsep2 rowsep2">>20 </td><td class="colsep2 rowsep2">>20</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> ATP concentrations used are all <Km and ranged from 0.2 to 8 <i>μ</i>M; for details for each enzyme, see Experimental Section.<i><sup>b</sup></i><sup></sup> Values are averages of at least three independent dose−response curves.</p></div></div><div class="NLM_table-wrap" id="jm011022et00003"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 3.  Physicochemical Parameters of Representative Anilino-Quinazolines</p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">no.</td><td class="colsep2 rowsep2">C7 side chain functionality</td><td class="colsep2 rowsep2">p<i>K</i><sub>a</sub>'s</td><td class="colsep2 rowsep2">LogD<i><sup>a</sup></i><sup></sup></td><td class="colsep2 rowsep2">LogP<i><sup>b</sup></i><sup></sup></td><td class="colsep2 rowsep2">aqueous solubility at pH 7.4<i><sup>c,d</sup></i><sup></sup> (<i>μ</i>M)</td><td class="colsep2 rowsep2">relative calculated solubility of the neutral form<i><sup>e</sup></i><sup></sup></td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>1</b></td><td class="colsep2 rowsep2">triazole </td><td class="colsep2 rowsep2">5.3 </td><td class="colsep2 rowsep2">4.6 </td><td class="colsep2 rowsep2">4.6 </td><td class="colsep2 rowsep2">0.7 </td><td class="colsep2 rowsep2">1 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>7</b></td><td class="colsep2 rowsep2">morpholine </td><td class="colsep2 rowsep2">7.2−5.2 </td><td class="colsep2 rowsep2">3.4 </td><td class="colsep2 rowsep2">3.6 </td><td class="colsep2 rowsep2">20 </td><td class="colsep2 rowsep2"> </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>4</b></td><td class="colsep2 rowsep2">piperazine </td><td class="colsep2 rowsep2">7.9−5.4 </td><td class="colsep2 rowsep2">2.4<i><sup>f</sup></i><sup></sup></td><td class="colsep2 rowsep2">3.3 </td><td class="colsep2 rowsep2">60<i><sup>g</sup></i><sup></sup></td><td class="colsep2 rowsep2"> </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>2</b></td><td class="colsep2 rowsep2">piperidine </td><td class="colsep2 rowsep2">9.4−5.3 </td><td class="colsep2 rowsep2">2.6<i><sup>f</sup></i><sup></sup></td><td class="colsep2 rowsep2">5.0 </td><td class="colsep2 rowsep2">330 </td><td class="colsep2 rowsep2">17<i><sup>h</sup></i><sup></sup></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> Measured at pH 7.4 unless otherwise stated.<i><sup>b</sup></i><sup></sup> Calculated from LogD and p<i>K</i><sub>a</sub>.<i><sup>c</sup></i><sup></sup> Average of at least three measurements using the free base.<i><sup>d</sup></i><sup></sup> Measured at 3 days unless otherwise stated.<i><sup>e</sup></i><sup></sup> Solubility of the neutral form normalized to the solubility of the neutral form of <b>1</b>.<i><sup>f</sup></i><sup></sup> Measured at pH 7.<i><sup>g</sup></i><sup></sup> Measured at 1 day.<i><sup>h</sup></i><sup></sup> Solubility of the neutral form of compound <b>2</b> was measured at pH 12.7.</p></div></div><div class="NLM_table-wrap" id="jm011022et00004"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 4.  Mouse Plasma Levels Following Administration of 50 or 100 mg/kg Po<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-6/jm011022e/production/images/medium/jm011022eu00004a.gif" alt="" id="_i19" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2" colspan="2">plasma levels (<i>μ</i>M)<i><sup>a</sup></i><sup></sup></td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">no.</td><td class="colsep2 rowsep2">R<sup>1</sup></td><td class="colsep2 rowsep2">R<sup>2</sup></td><td class="colsep2 rowsep2">dose (mg/kg)</td><td class="colsep2 rowsep2">at 6 h</td><td class="colsep2 rowsep2">at 24 h </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>1</b></td><td class="colsep2 rowsep2">Br </td><td class="colsep2 rowsep2">1-(1,2,3-triazolyl)-(CH<sub>2</sub>)<sub>2</sub>O </td><td class="colsep2 rowsep2">50 </td><td class="colsep2 rowsep2">14 </td><td class="colsep2 rowsep2">0.2 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>2</b></td><td class="colsep2 rowsep2">Br </td><td class="colsep2 rowsep2">MeN(CH<sub>2</sub>CH<sub>2</sub>)<sub>2</sub>CH-CH<sub>2</sub>O </td><td class="colsep2 rowsep2">50 </td><td class="colsep2 rowsep2">5.5 </td><td class="colsep2 rowsep2">3 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>3</b></td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">MeO-(CH<sub>2</sub>)<sub>2</sub>-O </td><td class="colsep2 rowsep2">100 </td><td class="colsep2 rowsep2">12 </td><td class="colsep2 rowsep2"><0.1 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>4</b></td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">4-Me-piperazinyl-(CH<sub>2</sub>)<sub>3</sub>O </td><td class="colsep2 rowsep2">50 </td><td class="colsep2 rowsep2">5 </td><td class="colsep2 rowsep2">3 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>7</b></td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">4-morpholinyl-(CH<sub>2</sub>)<sub>3</sub>O </td><td class="colsep2 rowsep2">100 </td><td class="colsep2 rowsep2">4 </td><td class="colsep2 rowsep2">0.8 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>8</b></td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">4-morpholinyl-(CH<sub>2</sub>)<sub>2</sub>O </td><td class="colsep2 rowsep2">100 </td><td class="colsep2 rowsep2">12 </td><td class="colsep2 rowsep2">0.5 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>13</b></td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">4-pyridyl-N(Me)-(CH<sub>2</sub>)<sub>2</sub>O </td><td class="colsep2 rowsep2">100 </td><td class="colsep2 rowsep2">4.6 </td><td class="colsep2 rowsep2">2 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>27</b></td><td class="colsep2 rowsep2">Br </td><td class="colsep2 rowsep2">MeN(CH<sub>2</sub>CH<sub>2</sub>)<sub>2</sub>CH-CH<sub>2</sub>CH<sub>2</sub>O </td><td class="colsep2 rowsep2">50 </td><td class="colsep2 rowsep2">3 </td><td class="colsep2 rowsep2">2 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>30</b></td><td class="colsep2 rowsep2">Br </td><td class="colsep2 rowsep2">(<i>R</i>)-MeN(CH<sub>2</sub>)(CH<sub>2</sub>)<sub>3</sub>CH-CH<sub>2</sub>O </td><td class="colsep2 rowsep2">50 </td><td class="colsep2 rowsep2">5.5 </td><td class="colsep2 rowsep2">2.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> Variation was generally ±15%.</p></div></div><div class="NLM_table-wrap" id="jm011022et00005"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 5.  Pharmacokinetic Parameters in Rat and Dog of <b>1</b> and <b>2</b></p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2" colspan="2">rat <i><sup>a</sup></i><sup></sup></td><td class="colsep2 rowsep2" colspan="2">dog<i><sup>a</sup></i><sup></sup></td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">no.</td><td class="colsep2 rowsep2">IV <i>t</i><sub>1/2</sub> (h)</td><td class="colsep2 rowsep2">F (%)</td><td class="colsep2 rowsep2">IV <i>t</i><sub>1/2</sub> (h)</td><td class="colsep2 rowsep2">F (%) </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>1</b></td><td class="colsep2 rowsep2">∼1.3 ± 0.2<i><sup>b</sup></i><sup></sup></td><td class="colsep2 rowsep2">>80<i><sup>b</sup></i><sup></sup></td><td class="colsep2 rowsep2">1.1 ± 0.2<i><sup>c</sup></i><sup></sup></td><td class="colsep2 rowsep2"><5<i><sup>c</sup></i><sup></sup></td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>2</b></td><td class="colsep2 rowsep2">∼15 ± 0.2<i><sup>b</sup></i><sup></sup></td><td class="colsep2 rowsep2">>50<i><sup>b</sup></i><sup></sup></td><td class="colsep2 rowsep2">8.3 ± 1.8<i><sup>b</sup></i><sup></sup></td><td class="colsep2 rowsep2">>50<i><sup>b</sup></i><sup></sup></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> Measured on the free base. For dose and vehicles, see Experimental Section.<i><sup>b</sup></i><sup></sup> Average of three males.<i><sup>c</sup></i><sup></sup> Average of four males.</p></div></div></div><div class="NLM_p">Introduction of nitrogen-containing, basic residues in <a name="jm004500601304" id="jm004500601304"></a> the C-7 side chain covering a range of p<i>K</i><sub>a</sub>'s from 7 to 9.5 (Table 3), as illustrated by the morpholines (<b>7</b> and <b>8</b>),<sup>18</sup> the pyrrolidine (<b>9</b>), and the piperidine (<b>30</b>, <b>2</b>), retained an excellent level of KDR inhibition (median IC<sub>50</sub> 0.02 <i>μ</i>M, range 0.001−0.03 <i>μ</i>M; Table 1). The KDR enzyme proved to be consistently more sensitive than Flt-1 (median IC<sub>50</sub> 0.55 <i>μ</i>M, range 0.02−1.6 <i>μ</i>M) with Flt-1:KDR selectivity ratios ranging from 5 to 500. The most marked separation was observed with the cyclic <i>N</i>-methylpiperidine, and in particular piperidine methoxy derivative <b>30</b>, due to a slightly weaker activity against Flt-1 (comparison of <b>15</b> and <b>2</b> with <b>9</b> and <b>24</b>). C-7 side chains containing nitrogens that can be protonated or hydrated tend to be slightly more potent against Flt-1 (comparison of <b>1</b> and <b>3 </b>with <b>7</b>, <b>4</b>, <b>9</b>, and <b>24</b>). Basic heteroaromatic nuclei, as illustrated by the pyridine-containing derivative <b>13</b>,<sup>18</sup> were also potent inhibitors of KDR. </div><div class="NLM_p"><a name="jm004500601305" id="jm004500601305"></a>The <i>N</i>-methylpiperidine nucleus proved to be particularly interesting. When directly linked to the C-7 position of the quinazoline, it resulted in a weaker inhibitor of both Flt-1 and KDR (compound <b>14</b>:<sup>18</sup> IC<sub>50</sub> 1.5 <i>μ</i>M). An increase in flexibility of the side chain, resulting from the insertion of a single methylene between the piperidine ring and the C7−O atom, provided a 38−100-fold increase in potency against KDR with no enhancement of activity against Flt-1 (comparison of <b>14</b><sup>18</sup> with <b>2</b> and <b>15</b>); insertion of two methylenes (<b>27</b>) increased potency against KDR 250-fold and Flt-1 by 10-fold. 3-Piperidinyl isomers were more potent than their 4-isomers (compare <b>2</b>, <b>30</b>, and <b>31</b>), and chirality of the 3-piperidine side chain also influenced potency, the (<i>R</i>)-enantiomer <b>30</b> being 10-fold more potent of an inhibitor than the (<i>S</i>)-enantiomer <b>31</b>. In the 2‘-F, 4‘-Cl, or 4‘-Br series, alkylation of the C-7 side chain piperidine−nitrogen suggests an increase in selectivity of 3−7-fold for KDR over Flt-1 (Flt-1/KDR IC<sub>50</sub> ratio's, respectively, 40- and 13-fold for <b>2</b> and <b>22</b>; 133- and 20-fold for <b>15</b> and <b>21</b>; and 25- and 5-fold for <b>27 </b>and <b>28</b>). This effect is not apparent in the difluorinated series (2‘-F, 4‘-F, 4‘-Cl, or 4‘-Br series: comparison of <b>19</b> and <b>24</b> and <b>20</b> and <b>25</b>). </div><div class="NLM_p">All of the compounds described in this paper are also inhibitors of the EGFR enzyme (median IC<sub>50</sub> 0.2 <i>μ</i>M, range 0.075−0.8 <i>μ</i>M), but in all cases, potency against KDR was greater (KDR:EGFR selectivity ratios 3−200). Inhibition of the FGFR-1 enzyme was consistently weaker (median IC<sub>50</sub> 2.5 <i>μ</i>M, range 0.9−19 <i>μ</i>M; KDR:FGFR selectivity ratios 33−1800; Table 1), but by comparison with the C-7 neutral side chain series (e.g., <b>1</b> and <b>3</b>), selectivity with respect to FGFR is slightly reduced in the basic side chain series. </div><div class="NLM_p">Selectivity of representative compounds, and <b>2</b> in particular, against a broad panel of kinases, has also been investigated. As shown in Table 2, compounds such <a name="jm004500601306" id="jm004500601306"></a> as <b>2</b> and <b>1</b> possess good selectivity profiles and are devoid of significant activity against kinases such as MEK, AKT, and erbB2 or kinases involved in cell cycle regulation such as CDK-2. Similarly, no significant activity was detected against the kinase enzymes associated with the angiopoietin receptor (Tie-2) and the IGF-1 receptor. </div><div class="NLM_p"><b>ii. Inhibition of Endothelial Cell Proliferation.</b> Selectivity for the VEGF, EGF, and FGF pathways in whole endothelial cells was investigated using growth factor-stimulated human endothelial cells (HUVECs). Inhibition of proliferation was again achieved with nanomolar concentrations (median IC<sub>50</sub> vs VEGF 0.06 <i>μ</i>M, range 0.003−0.5 <i>μ</i>M), and the selectivity profile observed in the kinase assays was reasonably conserved in HUVECS (VEGF > EGF; Table 1), the median IC<sub>50</sub> vs EGF being 0.15 <i>μ</i>M (range 0.07−1.4 <i>μ</i>M). The best selectivity ratios were observed with the <i>meta</i>-hydroxy derivatives <b>17</b> and <b>18 </b>(VEGF:EGF ratios of 23 and 66, respectively). Selectivity for VEGF vs FGF inhibition was also confirmed in these cells. In the case of<b> 1</b> and <b>2</b>, concentrations of 1.5 and 0.8 <i>μ</i>M were necessary to reduce FGF-stimulated growth by 50% giving VEGF:FGF selectivity ratios of 30 and 13, respectively. The slight changes in selectivity occasionally observed between recombinant enzyme and whole cell data can be attributed to differences (e.g., ATP concentration) between the two assays. </div><div class="NLM_p">The compounds presented in this paper do not significantly affect basal, unstimulated growth of HUVECs (IC<sub>50</sub> range:  1 to >10 <i>μ</i>M; Table 1), which clearly suggests that activity is specifically directed to the receptor-activated signaling pathways and that the compounds do not impart any direct cytostatic or cytotoxic effect. </div><div class="NLM_p"><b>iii. Physicochemical Properties.</b> As shown in Table 3, the lipophilic character of <b>1</b> as well as the neutral nature of its C-7 side chain (1-(1,2,3-triazolyl)ethoxy) confers low aqueous solubility on this compound (∼0.7 <i>μ</i>M). Nevertheless, good plasma levels were seen in mouse following oral dosing.<sup>18,19</sup> Its bioavailability in rats was also good, but in higher species, it was found to be low and variable. The low aqueous solubility of <b>1</b> was thought to be the major factor contributing to this inconsistency (see the section on pharmacokinetics). C-7 basic side chains proved extremely effective for increasing both solubility and dissolution rate. As expected, aqueous solubility increased proportionally to the p<i>K</i><sub>a</sub> of the basic function present at C-7. Side chains such as the morpholinyl-propoxy and the <i>N</i>-methylpiperazinyl-propoxy (compounds <b>4</b> and <b>7</b>, Table 3) led to 30- and ∼80-fold, respectively, increases in solubility relative to <b>1</b>. This is attributed to partial protonation at pH 7.4 and a reduction in overall lipophilicity of these molecules as compared to <b>1</b>. Introducing more basic functions, such as <i>N</i>-methylpiperidine methoxy (compound <b>2</b>, Table 3), that are almost completely protonated at physiological pH increased aqueous solubility even more markedly. For compound <b>2</b>, solubility (>5 mM at pH 3.6 and ∼330 <i>μ</i>M at pH 7.4) was ∼470-fold that of <b>1</b>. As compounds are absorbed through the gut wall predominantly in the nonprotonated form, it was also advantageous if the solubility of the neutral form present at the site of absorption was improved over compounds such as <b>1</b>. As shown in Table 3, the 4-methylpiperidine-methoxy side chain in <b>2</b> also provided a 17-fold improvement in aqueous solubility of the neutral form as compared to <b>1</b>. At intestinal pH (∼6.5), the solubility of <b>2</b> is ∼650 <i>μ</i>M (310 μg/mL). </div><div class="NLM_p"><b>iv. Serum Protein Binding (SPB) in Different Species.</b> Introduction of a basic function at the C-7 position of the anilinoquinazoline nucleus, such as the 4-methylpiperidine-methoxy (p<i>K</i><sub>a</sub>, 9.4) of <b>2</b>, led to good levels of free drug in rodent plasma, in part by virtue of the positive charge present on the C-7 side chain at physiological pH. Comparison of the neutral (<b>1)</b> and basic (<b>2</b>) anilinoquinazolines indicates a 2-fold higher level of unbound basic drug despite a slight (∼0.4 unit) increase in logP (Mouse SPB: <b>1</b>, 98 ± 0.5%; <b>2</b>, 96 ± 0.5%. Rat SPB:<b> 1</b>, 95 ± 0.5%; <b>2</b>,<sup><a onclick="showRef(event, 'jm011022eb00026'); return false;" href="javascript:void(0);" class="ref jm011022eb00026">26</a></sup> 90 ± 0.5%; mean ± SE, <i>n</i> = 5). Free plasma levels were consistently about 2-fold higher in rat than in mouse. </div><div class="NLM_p"><b>v. Blood Levels in Mice Following Oral and Intravenous Administration.</b> We reported that anilinoquinazolines with neutral or weakly basic C-7 side chains and <b>1</b> in particular were orally bioavailable in mice.<sup>18</sup> Anilinoquinazolines possessing more basic C-7 moieties also yielded good plasma levels in mice following oral administration (Table 4), which declined more slowly than those with neutral or weakly basic side chains (compare 24 h levels of <b>1</b>,<b> 3</b>, and <b>8</b> with those of <b>2</b>, <b>4</b>, <b>13</b>,<sup>18</sup> and <b>30</b>). As we previously reported,<sup>19</sup> prolonged exposure combined with good intrinsic potency was particularly important for good efficacy in the Calu-6 tumor xenograft model with once daily oral administration. </div><div class="NLM_p"><b>vi. Bioavailability and Half-Lives in Rat and Dog.</b> The pharmacokinetic profile of <b>1</b> in the mouse following oral dosing at 50 mg/kg suggested rapid elimination in this species. This was confirmed in the rat where rapid clearance (CL ∼ 3.2 L/hr/kg), moderate plasma half-life (<i>t</i><sub>1/2</sub> ∼ 1.3 h), and a low volume of distribution (∼1.2 L/kg) were observed. The half-life of <b>1</b> was also short in the dog (Table 5), and its bioavailability was low (<5%) and variable. Attempts to increase the aqueous solubility and bioavailability of <b>1</b> by making salts was successful in these respects but introduced stability and hygroscopicity issues that did not auger well for development. </div><div class="NLM_p">In the case of the more soluble 4-anilinoquinazolines possessing C-7 basic side chains such as <b>2</b>, the improvement in physicochemical properties, in particular better aqueous solubility, was accompanied by good (>50%) and more consistent bioavailability in rat and dog (Table 5). Moreover, and probably as a consequence of protonation of the C-7 basic moiety, plasma half-lives in rat and dog proved to be longer than those observed in the neutral side chain series. For example, in rat and dog, <b>2</b> had half-lives 12- and 8-fold, respectively, higher than <b>1</b>. </div><div class="NLM_p"><b>vii</b><b><i>.</i></b><b> In Vivo Efficacy in Mouse.</b> We have previously reported that <b>1</b> was effective at reducing the growth of a number of human tumor xenografts grown subcutaneously in athymic mice.<sup>18,19</sup> The antitumor activity of the anilinoquinazolines reported here was routinely examined using a Calu-6 lung tumor xenograft model. As shown in Table 6<a class="ref showTableEvent internalNav" data-ID="jm011022et00006" href="#jm011022et00006"></a>, once daily oral administration of <b>2</b> for 21 days inhibited the growth of established (∼0.2 <a name="jm004500601307" id="jm004500601307"></a> cm<sup>3</sup>) Calu-6 tumors in a dose-dependent manner. Tumor growth was almost completely arrested at a dose of 100 mg/kg/day and more than halved at 25 mg/kg/day. Compound <b>2 </b>has been evaluated against a range of human tumor xenografts including colon, lung, breast, prostate, and ovary tumors and has demonstrated highly significant activity in each model. <div class="NLM_table-wrap" id="jm011022et00006"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 6.  Growth Inhibition of Established Calu-6 Tumor Xenografts Implanted Subcutaneously in Athymic Mice, Measured after 21 Days of Dosing of <b>2</b></p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2" colspan="4">% inhibition of tumor growth @ mg/kg/day<i><sup>a</sup></i><sup></sup> po</td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">no.</td><td class="colsep2 rowsep2">100</td><td class="colsep2 rowsep2">50</td><td class="colsep2 rowsep2">25</td><td class="colsep2 rowsep2">12.5 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>2</b></td><td class="colsep2 rowsep2">79<i><sup>b</sup></i><sup></sup></td><td class="colsep2 rowsep2">67<i><sup>b</sup></i><sup></sup></td><td class="colsep2 rowsep2">51<i><sup>b</sup></i><sup></sup></td><td class="colsep2 rowsep2">36<i><sup>c</sup></i><sup></sup></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> Percent inhibition represents the difference between the median of 10 control (vehicle-treated) and 9−10 compound-treated mice, following 21 days of treatment; measured from start of treatment.<i><sup>b</sup></i><sup></sup> <i>p</i> < 0.001.<i><sup>c</sup></i><sup></sup> <i>p</i> < 0.02 (Mann Whitney rank sum one-tailed test).</p></div></div></div><div class="NLM_p last">Compound <b>2</b> does not inhibit the growth of Calu-6 cells directly in vitro (IC<sub>50</sub> 14 ± 0.4 <i>μ</i>M; mean ± SE, <i>n</i> = 3) at concentrations of compound likely to be freely available in vivo. Hence, the tumor growth inhibition observed in vivo, even taking into account possible accumulation of the compound at the highest doses evaluated, cannot be attributed to a direct cytotoxic or cytostatic effect on the tumor cells. Furthermore, we have shown that selective inhibitors of VEGF receptor kinases, completely devoid of EGFR inhibition (IC<sub>50</sub> > 10 <i>μ</i>M), inhibit the growth of Calu-6 tumors when administered orally,<sup>23,24,26</sup> whereas, over a similar dose range, selective EGFR inhibitors devoid of VEGF receptor inhibition (IC<sub>50</sub> > 10 <i>μ</i>M) do not. The activity observed in the Calu-6 xenograft model with a compound possessing activity against VEGF and EGF tyrosine kinase such as <b>2</b> is thus most likely attributable to the inhibition of the VEGF signaling pathway. </div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62057" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62057" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Anilinoquinazolines possessing C-7 basic side chains are potent nanomolar inhibitors of KDR tyrosine kinase, and some are also potent inhibitors of Flt-1 tyrosine kinase. Their enzyme inhibition profiles translate very well into endothelial cells as demonstrated by nanomolar inhibition of VEGF-stimulated HUVEC proliferation. The presence of a basic side chain confers excellent physicochemical properties, in particular, good aqueous solubility, improved bioavailability in rodent and dog, and reduced protein binding. The plasma half-life of this subseries of anilinoquinazolines is generally longer than that of anilinoquinazolines with neutral side chains. In view of its excellent physicochemical properties, selectivity profile, pharmacokinetics, and antitumor activity in preclinical models, <b>2</b> was preferred over <b>1</b> and replaced it in development. Compound <b>2</b> is currently undergoing phase I clinical evaluation.<sup>17</sup></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18271" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18271" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">For general procedures, see the Supporting Information section. </div><div class="NLM_p"><b><i>N</i></b><b>-(4-Bromo-2-fluorophenyl)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolin-4-a</b><b>mine (2). Procedure A.</b> A mixture of 4-chloro-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazoline<b> (64</b>; 200 mg, 0.62 mmol) and 4-bromo-2-fluoroaniline (142 mg, 0.74 mmol) in 2-propanol (3 mL) containing 6 M hydrogen chloride in 2-propanol (110 <i>μ</i>L, 0.68 mL) was heated at reflux for 1.5 h. The mixture was cooled, and the solid was filtered, washed with 2-propanol (2 mL) followed by diethyl ether (2 mL), and dried under vacuum overnight at 50 °C to give 304 mg of <b>2 </b>as an hydrochloride salt (90%). </div><div class="NLM_p">The nuclear magnetic resonance (NMR) spectrum of the protonated form of <b>2</b> hydrochloride shows the presence of two forms (A and B) in a ratio A:B of approximately 9:1 attributable to the protonation of the basic side chain. <sup>1</sup>H NMR:  δ 1.60−1.78 (m, form A 2H), 1.81−1.93 (br s, form B 4H), 1.94−2.07 (d, form A 2H), 2.08−2.23 (br s, form A 1H), 2.29−2.37 (br s, form B 1H), 2.73 (d, form A 3H), 2.77 (d, form B 3H), 2.93−3.10 (q, form A 2H), 3.21 (br s, form B 2H), 3.27 (br s, form B 2H), 3.42−3.48 (d, form A 2H), 4.04 (s, 3H), 4.10 (d, form A 2H), 4.29 (d, form B 2H), 7.49 (s, 1H), 7.53−7.61 (m, 2H), 7.78 (d, 1H), 8.47 (s, 1H), 8.81 (s, 1H), 10.48 (br s, form A 1H), 10.79 (br s, form B 1H), 11.90 (br s, 1H). Anal. (C<sub>22</sub>H<sub>24</sub>N<sub>4</sub>O<sub>2</sub>BrF, 0.5 H<sub>2</sub>O, 1.8 HCl, 0.08 2-propanol) C, H, N. </div><div class="NLM_p">For another NMR reading, some solid potassium carbonate was added into the dimethyl sulfoxide (DMSO) solution of the <b>2 </b>hydrochloride described above, to release the free base in the NMR tube. The NMR spectrum was then recorded again and showed only one form as described below. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>; solid potassium carbonate):  δ 1.30−1.45 (m, 2H), 1.75 (d, 2H), 1.70−1.90 (m, 1H), 1.89 (t, 2H), 2.18 (s, 3H), 2.80 (d, 2H), 3.98 (s, 3H), 4.0 (d, 2H), 7.20 (s, 1H), 7.48 (d, 1H), 7.55 (t, 1H), 7.68 (d, 1H), 7.80 (s, 1H), 8.35 (s, 1H), 9.75 (s, 1H). </div><div class="NLM_p">A sample of <b>2 </b>(free base) was generated from the <b>2</b> hydrochloride, prepared as described above, as follows:  <b>2 </b>hydrochloride (50 mg) was suspended in methylene chloride (2 mL) and was washed with saturated sodium hydrogen carbonate. The methylene chloride solution was dried (MgSO<sub>4</sub>), and the volatiles were removed by evaporation to give <b>2 </b>(free base). The NMR of <b>2</b> (free base) so generated shows only one form, the NMR spectrum of which is identical to that described above. <sup>1</sup>H NMR:  δ 1.30−1.45 (m, 2H), 1.76 (d, 2H), 1.70−1.90 (m, 1H), 1.90 (t, 2H), 2.19 (s, 3H), 2.80 (d, 2H), 3.95 (s, 3H), 4.02 (d, 2H), 7.20 (s, 1H), 7.48 (d, 1H), 7.55 (t, 1H), 7.68 (dd, 1H), 7.80 (s, 1H), 8.38 (s, 1H), 9.55(br s, 1H). </div><div class="NLM_p">For another NMR reading, some CF<sub>3</sub>COOD was added into the NMR DMSO solution of <b>2</b> (free base) described above and the NMR spectrum was recorded again. The spectrum of the protonated form of the trifluoroacetate salt of <b>2 </b>so obtained shows the presence of two forms (A and B) in a ratio A:B of approximately 9:1. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>; CF<sub>3</sub>COOD):  δ 1.50−1.70 (m, form A 2H), 1.93 (br s, form B 4H), 2.0−2.10 (d, form A 2H), 2.17 (br s, form A 1H), 2.35 (br s, form B 1H), 2.71 (s, form A 3H), 2.73 (s, form B 3H), 2.97−3.09 (t, form A 2H), 3.23 (br s, form B 2H), 3.34 (br s, form B 2H), 3.47−3.57 (d, form A 2H), 4.02 (s, 3H), 4.15 (d, form A 2H), 4.30 (d, form B 2H), 7.2 (s, 1H), 7.3−7.5 (m, 2H), 7.60 (d, 1H), 7.90 (s, 1H), 8.70 (s, 1H). </div><div class="NLM_p">A similar procedure was used to prepare <b>15</b>, <b>17</b>, <b>18, 26</b>, and <b>35</b>. </div><div class="NLM_p"><b><i>N</i></b><b>-(4-Chloro-2-fluorophenyl)-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinazolin-4</b><b>-amine (4). Procedure B.</b> A suspension of 4-(4-chloro-2-fluoroanilino)-7-(3-chloropropoxy)-6-methoxyquinazoline<b> (66</b>; 150 mg, 0.38 mmol) in 1-methylpiperazine (2 mL) was heated at 100 °C for 3 h. The mixture was cooled and was partitioned between an aqueous solution of sodium carbonate (pH 11.5) and ethyl acetate. The organic layer was separated, washed with brine, and dried (MgSO<sub>4</sub>), and the volatiles were removed by evaporation. The residue was dissolved in methylene chloride, and diethyl ether was added. The precipitate was filtered, washed with diethyl ether (2 mL), and dried. The solid was dissolved in methylene chloride, and 2.2 M hydrogen chloride in diethyl ether (1 mL) was added. After the solution was concentrated to half of its initial volume, the precipitate was filtered, washed with diethyl ether (2 mL), and dried under vacuum to give 158 mg of <b>4 </b>hydrochloride (75%). <sup>1</sup>HNMR (DMSO-<i>d</i><sub>6</sub>; CF<sub>3</sub>COOD; 60 °C):  δ 2.35 (m, 2H), 2.95 (s, 3H), 3.43 (t, 2H), 3.52−3.70 (m, 8H), 4.03 (s, 3H), 4.34 (t, 2H), 7.41 (s, 1H), 7.45 (d, <a name="jm004500601308" id="jm004500601308"></a> 1H), 7.60−7.70 (m, 2H), 8.11 (s, 1H), 8.80 (s, 1H). MS−EI <i>m</i>/<i>z</i>:  460 [MH]<sup>+</sup>. Anal. (C<sub>23</sub>H<sub>27</sub>N<sub>5</sub>O<sub>2</sub>ClF, 0.7 H<sub>2</sub>O, 2.75 HCl) C, H, N. </div><div class="NLM_p">A similar procedure was used to prepare <b>5</b>. </div><div class="NLM_p"><b><i>N</i></b><b>-(4-Chloro-2-fluorophenyl)-6-methoxy-7-[2-(4-methylpiperazin-1-yl)ethoxy]quinazolin-4-</b><b>amine (6). Procedure C. </b>A solution of 2-(4-methylpiperazin-1-yl)ethanol (112 mg, 0.78 mmol) in methylene chloride (1 mL) was added to a stirred suspension of <i>N</i>-(4-chloro-2-fluorophenyl)-7-hydroxy-6-methoxy-4-quinazolinylamine<b> (39</b>;<sup>18</sup> 225 mg, 0.7 mmol) and tributylphosphine (420 mg, 2.1 mmol) in methylene chloride (10 mL). 1,1‘-(Azodicarbonyl)dipiperidine (525 mg, 2.1 mmol) was then added in portions to the mixture. The resulting clear, pale yellow solution was stirred for 3.5 h and then allowed to stand overnight. The reaction mixture was quenched with diethyl ether (8 mL), and the precipitate was filtered. The solvent was removed from the filtrate by evaporation, the residue was dissolved in acetone (5 mL), and 1 M hydrogen chloride in diethyl ether was added until the hydrochloride salt precipitated. The precipitate was collected by filtration, dissolved in methanol (3 mL), and then basified with excess triethylamine. The volatiles were removed by evaporation, and the residue was purified by column chromatography eluting with methylene chloride/methanol/aqueous ammonia (100/8/1). The resulting oil was triturated with diethyl ether (1 mL), collected by filtration, and dried to give 79 mg of <b>6 </b>(25%) as a white solid; mp 173−175 °C. <sup>1</sup>H NMR:  δ 2.10 (s, 3H), 2.30 (m, 4H), 2.50 (m, 4H), 2.75 (t, 2H), 3.95 (s, 3H), 4.25 (t, 2H), 7.21 (s, 1H), 7.30 (dd, 1H), 7.50 (d, 1H), 7.55 (dd, 1H), 7.75 (s, 1H), 8.30 (s, 1H), 9.50 (s, 1H). MS−ESI <i>m</i>/<i>z</i>:  446 [MH]<sup>+</sup>. Anal. (C<sub>22</sub>H<sub>25</sub>N<sub>5</sub>O<sub>2</sub>ClF). </div><div class="NLM_p"><b><i>N</i></b><b>-(4-Chloro-2-fluorophenyl)-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine</b><b>(9). Procedure D. </b>A solution of 1-(3-chloropropyl)pyrrolidine (230 mg, 0.96 mmol) was added to <i>N</i>-(4-chloro-2-fluorophenyl)-7-hydroxy-6-methoxy-4-quinazolinylamine<b> (39</b>;<sup>18</sup> 295 mg, 0.92 mmol) and potassium carbonate (130 mg, 0.94 mmol) in DMF (8 mL). The mixture was heated at 100 °C for 90 min and allowed to cool. The volatiles were removed by evaporation, and the residues were partitioned between water (10 mL) and methylene chloride (10 mL). The organic phase was separated and passed through phase-separating paper, and the solvent was removed under reduced pressure. The residue was dissolved in acetone (2 mL), and 1 M hydrogen chloride in diethyl ether (2 mL) was added. The mixture was stirred at ambient temperature for 30 min, and the resulting precipitate was collected by filtration and dried to give 320 mg of <b>9</b> as a hydrochloride (67%). <sup>1</sup>H NMR:  δ 1.80−2.0 (m, 6H), 3.0−3.60 (m, 6H), 4.05 (s, 3H), 4.30 (t, 2H), 7.40 (m, 2H), 7.55 (d, 1H), 7.60 (m, 1H), 8.40 (s, 1H), 8.80 (s, 1H). MS−ESI <i>m</i>/<i>z</i>:  431 [MH]<sup>+</sup>. Anal. (C<sub>22</sub>H<sub>24</sub>N<sub>4</sub>O<sub>2</sub>ClF, 1.8 H<sub>2</sub>O, 1.5 HCl) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-(4-Chloro-2-fluorophenyl)-6-methoxy-7-{[(2</b><b><i>E</i></b><b>)-4-pyrrolidin-1-ylbut-2-enyl]oxy}quinazoli</b><b>n-4-amine (10). Procedure E.</b> Diethyl azodicarboxylate (5.91 mL, 37 mmol) was added dropwise to a stirred mixture of (<i>E</i>)-4-(pyrrolidin-1-yl)but-2-en-1-ol<b> (68</b>; 3.97 g, 28 mmol), <b>39</b><sup>18</sup> (3.0 g, 9 mmol)<b>, </b>and triphenylphosphine (9.84 g, 38 mmol) in methylene chloride (300 mL). The reaction mixture was stirred for 18 h at ambient temperature. The volatiles were removed by evaporation, and the residue was purified by column chromatography eluting with methylene chloride/methanol (a gradient from 80/20 to 70/30). The purified product was dissolved in methylene chloride/methanol (10 mL/10 mL), and 1 M hydrogen chloride in diethyl ether (25 mL) was added. The precipitated product was collected by filtration, washed with diethyl ether (2 mL), and dried to give 1.62 g of <b>10</b> hydrochloride (33%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>; CF<sub>3</sub>COOD):  δ 1.85−1.95 (m, 2H), 2.0−2.15 (m, 2H), 3.0−3.10 (m, 2H), 3.50−3.60 (m, 2H), 3.95 (d, 2H), 4.10 (s, 3H), 4.95 (d, 2H), 6.10 (td, 1H), 6.35 (td, 1H), 7.40 (s, 1H), 7.45 (dd, 1H), 7.60−7.70 (m, 2H), 8.15 (s, 1H), 8.90 (s, 1H). MS−EI <i>m</i>/<i>z</i>:  443 [MH]<sup>+</sup>. Anal. (C<sub>23</sub>H<sub>24</sub>N<sub>4</sub>O<sub>2</sub>ClF, 0.6 H<sub>2</sub>O, 1.85 HCl) C, H, N. </div><div class="NLM_p">A similar procedure was used to prepare <b>12</b>,<b> 29</b>−<b>31</b>, <b>46</b>, <b>47</b>, and <b>49</b>. </div><div class="NLM_p"><b><i>N</i></b><b>-(4-Bromo-2-fluorophenyl)-6-methoxy-7-{[(2</b><b><i>E</i></b><b>)-4-pyrrolidin-1-ylbut-2-enyl]oxy}quinazoli</b><b>n-4-amine (11). Procedure F.</b> Diethyl azodicarboxylate (1.55 mL, 9.89 mmol), <i>N</i>-(4-bromo-2-fluorophenyl)-7-hydroxy-6-methoxy-4-quinazolinylamine<b> (40</b>;<sup>18</sup> 1.2 g, 3.3 mmol), and a solution of <b>68 </b>(697 mg, 4.9 mmol) in methylene chloride (5 mL) were added successively to a solution of triphenylphosphine (2.59 g, 9.89 mmol) in methylene chloride (150 mL) cooled at 5 °C. The mixture was stirred at ambient temperature for 10 min, and then, methylene chloride (100 mL) was added followed successively by triphenylphosphine (432 mg, 1.6 mmol), (<i>E</i>)-4-(pyrrolidin-1-yl)but-2-en-1-ol (232 mg, 1.6 mmol), and diethyl azodicarboxylate (246 <i>μ</i>L, 1.6 mmol). The mixture was stirred at ambient temperature for 30 min, and then, the solvent was removed by evaporation. The residue was purified by column chromatography eluting with methylene chloride/methanol (80/20 followed by 70/30 and 60/40). The semipurified product was repurified by column chromatography eluting with methylene chloride/methanol (80/20 followed by 75/25). The purified product was dissolved in methylene chloride, 3.7 M hydrogen chloride in diethyl ether (3 mL) was added, and the volatiles were removed by evaporation. The residue was triturated with diethyl ether, collected by filtration, and dried under vacuum to give 600 mg of <b>11</b> hydrochloride (32%). <sup>1</sup>H NMR:  (DMSO-<i>d</i><sub>6</sub>; CF<sub>3</sub>COOD):  δ 1.80−1.90 (m, 2H), 2.0−2.10 (m, 2H), 3.0−3.10 (m, 2H), 3.45−3.55 (m, 2H), 3.88 (d, 2H), 4.01 (s, 3H), 4.90 (d, 2H), 6.0 (td, 1H), 6.30 (td, 1H), 7.41 (s, 1H), 7.5−7.65 (m, 2H), 7.82 (d, 1H), 8.13 (s, 1H), 8.88 (s, 1H). MS−EI <i>m</i>/<i>z</i>:  487 [M.]<sup>+</sup>. Anal. (C<sub>23</sub>H<sub>24</sub>N<sub>4</sub>O<sub>2</sub>BrF, 0.5 H<sub>2</sub>O, 2 HCl) C, H, N. </div><div class="NLM_p">A similar procedure was used to prepare <b>48</b>. </div><div class="NLM_p"><b><i>N</i></b><b>-(4-Methyl-2-fluorophenyl)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolin-4-</b><b>amine (16). Procedure G.</b> A suspension of 4-chloro-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazoline<b> (64</b>; 200 mg, 0.622 mmol) and 2-fluoro-4-methylaniline (94 mg, 0.764 mmol) in 2-propanol (5 mL) containing 6.2 M hydrogen chloride in 2-propanol (110 <i>μ</i>L) was stirred at 80 °C for 1.5 h. After the solution was cooled, the precipitate was collected by filtration, washed with 2-propanol (2 mL) followed by diethyl ether (2 mL), and dried under vacuum. The solid was dissolved in the minimum volume of methanol/methylene chloride/methanol (saturated with ammonia) and stirred for 5 min at ambient temperature. The volatiles were removed under vacuum. The solid was purified by column chromatography, eluting with methylene chloride/methanol (90/10) followed by methylene chloride/methanol containing 5% ammonia (90/10). Evaporation of the fractions containing the expected product gave 170 mg of <b>16</b> (61%). <sup>1</sup>H NMR:  δ 1.30−1.45 (m, 2H), 1.80 (d, 2H), 1.70−1.90 (m, 1H), 1.90 (t, 2H), 2.20 (s, 3H), 2.35 (s, 3H), 2.80 (d, 2H), 3.95 (s, 3H), 4.01 (d, 2H), 7.10 (d, 1H), 7.13 (d, 1H), 7.16 (s, 1H), 7.40 (t, 1H), 7.81 (s, 1H), 8.32 (s, 1H), 9.40 (s, 1H). MS−ESI <i>m</i>/<i>z</i>:  411 [MH]<sup>+</sup>. Anal. (C<sub>23</sub>H<sub>27</sub>N<sub>4</sub>O<sub>2</sub>F, 0.3 H<sub>2</sub>O) C, H, N. </div><div class="NLM_p">A similar procedure was used to prepare <b>36</b>. </div><div class="NLM_p"><b><i>N</i></b><b>-(4-Chloro-2,6-difluorophenyl)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolin</b><b>-4-amine (19). Procedure H. </b>Under argon, sodium hydride (60%, 76.5 mg, 1.9 mmol) was added to a solution of 4-chloro-2,6-difluoroaniline (250 mg, 1.53 mmol) in DMF (9 mL). After the solution was stirred for 30 min at ambient temperature, <b>64</b> (246 mg, 0.764 mmol) was added and stirring was continued for a further 20 h. The mixture was poured onto water (50 mL) and extracted with ethyl acetate (50 mL). The organic layer was washed with water and brine and dried (MgSO<sub>4</sub>), and the volatiles were removed by evaporation. The residue was purified by column chromatography on silica, eluting with methylene chloride/methanol (95/5) followed by methylene chloride/methanol containing 1% ammonia (90/10). The fractions containing the expected product were combined and evaporated. The residue was triturated with diethyl ether (2 mL), filtered, washed with diethyl ether (2 mL), and dried under vacuum at 50 °C to give 210 mg of <b>19</b> (61%). <sup>1</sup>H NMR:  δ 1.30−1.45 (m, 2H), 1.80 (d, 2H), 1.70−1.90 (m, 1H), 1.90 (t, 2H), 2.20 (s, 3H), 2.80 (d, 2H), 3.96 (s, 3H), 4.02 (d, 2H), 7.21 (s, 1H), 7.52 (s, 1H), 7.54 (s, <a name="jm004500601309" id="jm004500601309"></a> 1H), 7.82 (s, 1H), 8.35 (s, 1H). MS−ESI <i>m</i>/<i>z</i>:  449−451 [MH]<sup>+</sup>. Anal. (C<sub>22</sub>H<sub>23</sub>N<sub>4</sub>O<sub>2</sub>ClF<sub>2</sub>) C, H, N. </div><div class="NLM_p">A similar procedure was used to prepare <b>20</b> and<b> 37</b>. </div><div class="NLM_p"><b><i>N</i></b><b>-(4-Chloro-2-fluorophenyl)-6-methoxy-7-(piperidin-4-ylmethoxy)quinazolin-4-amine (21). </b><b>Procedure I.</b><i>tert</i>-Butyl 4-(hydroxymethyl)piperidine-1-carboxylate (<b>52</b>;<sup>20</sup> 590 mg, 2.75 mmol) followed by triphenylphosphine (1.2 g, 4.58 mmol) and diethyl azodicarboxylate (0.72 mL, 4.58 mmol) were added to a solution of <b>39</b><sup>18</sup> (585 mg, 1.83 mmol) in methylene chloride (20 mL). After the solution was stirred for 1 h at ambient temperature, further triphenylphosphine (239 mg, 0.91 mmol) and diethyl azodicarboxylate (0.14 mL, 0.91 mmol) were added. After the solution was stirred for 1.5 h, the volatiles were removed under vacuum and the residue was purified by column chromatography eluting with ethyl acetate/methylene chloride (1/1). The crude product was used directly in the next step. </div><div class="NLM_p">A solution of the crude product in methylene chloride (15 mL) containing TFA (4.5 mL) was stirred at ambient temperature for 1.5 h. The volatiles were removed under vacuum. The residue was partitioned between water and ethyl acetate. The aqueous layer was adjusted to pH 9.5 with 2 M sodium hydroxide. The organic layer was separated, washed with water followed by brine, dried (MgSO<sub>4</sub>), and evaporated to give <b>21 </b>free base. <sup>1</sup>H NMR:  δ 1.10−1.30 (m, 2H), 1.75 (d, 2H), 1.85−2.0 (br s, 1H), 2.55 (d, 2H), 2.95 (d, 2H), 3.95 (s, 3H), 4.0 (d, 2H), 7.20 (s, 1H), 7.35 (dd, 1H), 7.55 (dd, 1H), 7.60 (t, 1H), 7.80 (s, 1H), 8.35 (s, 1H), 9.55 (s, 1H). MS−ESI <i>m</i>/<i>z</i>:  417−419 [MH]<sup>+</sup>. The hydrochloride salt was made as follows:  <b>21</b> free base was dissolved in a mixture of methanol and methylene chloride (5 mL/5 mL), and 6 M hydrogen chloride in diethyl ether was added. The volatiles were removed under vacuum, and the residue was triturated with diethyl ether (5 mL), collected by filtration, washed with diethyl ether (2 mL), and dried under vacuum to give 390 mg of <b>21</b> hydrochloride (47% over 2 steps). Anal. (C<sub>21</sub>H<sub>22</sub>O<sub>2</sub>N<sub>4</sub>ClF, 2.25 HCl) </div><div class="NLM_p"><b><i>N</i></b><b>-(4-Bromo-2-fluorophenyl)-6-methoxy-7-(piperidin-4-ylmethoxy)quinazolin-4-amine (22). </b><b>Procedure J.</b> TFA (3 mL) was added to a suspension of <i>tert</i>-butyl 4-[({4-[(4-bromo-2-fluorophenyl)amino]-6-methoxyquinazolin-7-yl}oxy)methyl]piperidine-1-carboxylate<b> (45</b>; 673 mg, 1.2 mmol) in methylene chloride (10 mL). After the suspension was stirred for 1 h at ambient temperature, the volatiles were removed under vacuum. The residue was triturated with a mixture of water and diethyl ether. The organic layer was separated, and the aqueous layer was washed again with diethyl ether. The aqueous layer was adjusted to pH 10 with 2 M aqueous sodium hydroxide and then extracted with methylene chloride. The combined organic layers were dried (MgSO<sub>4</sub>), and the solvent was removed under vacuum. The solid was triturated with a mixture of diethyl ether and petroleum ether (1/1), filtered, washed with diethyl ether (2 mL), and dried under vacuum to give 390 mg of <b>22</b> (70%). <sup>1</sup>H NMR:  δ 1.13−1.30 (m, 2H), 1.75 (d, 2H), 1.87−2.0 (m, 1H), 2.50 (d, 2H), 3.0 (d, 2H), 3.96 (s, 3H), 3.98 (d, 2H), 7.20 (s, 1H), 7.50 (dd, 1H), 7.55 (t, 1H), 7.68 (dd, 1H), 7.80 (s, 1H), 8.36 (s, 1H), 9.55 (br s, 1H). MS−ESI <i>m</i>/<i>z</i>:  461−463 [MH]<sup>+</sup>. Anal. (C<sub>21</sub>H<sub>22</sub>N<sub>4</sub>O<sub>2</sub>BrF) C, H, N. </div><div class="NLM_p">A similar procedure was used to prepare <b>23</b>−<b>25</b>, <b>42</b>, and <b>43</b>. </div><div class="NLM_p"><b><i>N</i></b><b>-(4-Bromo-2-fluorophenyl)-6-methoxy-7-[2-(1-methylpiperidin-4-yl)ethoxy]quinazolin-4-a</b><b>mine (27). Procedure K.</b> Thirty-seven percent aqueous formaldehyde (480 <i>μ</i>L) was added to a solution of <i>N</i>-(4-bromo-2-fluorophenyl)-6-methoxy-7-(piperidin-4-ylmethoxy)quinazolin-4-amine<b> (28</b>; 480 mg, 1.01 mmol) in formic acid (4.8 mL). The mixture was heated at 95 °C for 4 h. The volatiles were removed under vacuum, and the residue was partitioned between water and ethyl acetate. The pH of the aqueous layer was adjusted to 11 with an aqueous solution of 2 M NaOH. The organic layer was separated, washed with water and brine, dried (MgSO<sub>4</sub>), and evaporated. The residue was purified by column chromatography, eluting with methylene chloride/methanol containing 1%ammonia (90/10). The fractions containing the expected product were combined and evaporated to give 386 mg of <b>27 </b>(78%). <sup>1</sup>H NMR:  δ 1.15−1.30 (m, 2H), 1.40−1.50 (m, 1H), 1.65−1.80 (m, 4H), 1.85 (t, 2H), 2.15 (s, 3H), 2.75 (d, 2H), 3.95 (s, 3H), 4.20 (t, 2H), 7.20 (s, 1H), 7.50 (d, 1H), 7.55 (dd, 1H), 7.80 (s, 1H), 8.38 (s, 1H), 9.55 (s, 1H). MS−ESI <i>m</i>/<i>z</i>:  489 [MH]<sup>+</sup>. Anal. (C<sub>23</sub>H<sub>26</sub>N<sub>4</sub>O<sub>2</sub>BrF, 0.1 H<sub>2</sub>O, 0.15 Et<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-(4-Bromo-2-fluorophenyl)-6-methoxy-7-(piperidin-4-ylmethoxy)quinazolin-4-amine</b><b>(28). </b><b>Procedure L. </b>A solution of <i>tert</i>-butyl 4-[2-({4-[(4-bromo-2-fluorophenyl)amino]-6-methoxyquinazolin-7-yl}oxy)ethyl]piperidine-1-carboxylate (<b>46</b>; 2.5 g, 4.3 mmol; ∼80% of purity) in methylene chloride (50 mL) containing TFA (12 mL) was stirred at ambient temperature for 1.5 h. The volatiles were removed under vacuum, and the residue was partitioned between methylene chloride (10 mL) and water (10 mL). The aqueous layer was separated, and the pH was adjusted to 11 with 2 M aqueous sodium hydroxide and then extracted with methylene chloride. The combined organic layers were washed with water and brine, dried (MgSO<sub>4</sub>), and evaporated. The residue was purified by column chromatography eluting with methylene chloride/methanol (90/10) followed by methylene chloride/methanol/methanol containing ammonia (1%, 90/5/5) followed by 80/10/10. The fractions containing the expected product were combined and evaporated. The residue was triturated with diethyl ether (10 mL), filtered, washed with diethyl ether (5 mL), and dried under vacuum to give 840 mg of <b>28 </b>(42%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, CD<sub>3</sub>COOD):  δ 1.30−1.50 (m, 2H), 1.80 (m, 3H), 1.90−2.0 (m, 2H), 2.90 (t, 2H), 3.30 (d, 2H), 3.95 (s, 3H), 4.20 (bs, 2H), 7.22 (s, 1H), 7.50 (d, 1H), 7.55 (dd, 1H), 7.65 (d, 1H), 7.80 (s, 1H), 8.38 (s, 1H). MS−ESI <i>m</i>/<i>z</i>:  475−477 [MH]<sup>+</sup>. Anal. (C<sub>22</sub>H<sub>24</sub>N<sub>4</sub>O<sub>2</sub>BrF, 0.54 H<sub>2</sub>O, 0.26 CH<sub>4</sub>O) C, H, N. </div><div class="NLM_p">A similar procedure was used to prepare <b>41</b>. </div><div class="NLM_p"><b><i>tert</i></b><b>-Butyl </b><b>4-[({4-[(4-bromo-2-fluorophenyl)amino]-6-methoxyquinazolin-7-yl}oxy)methyl]piperidine-1</b><b>-carboxylate (45). Procedure M.</b> Potassium carbonate (414 mg, 3 mmol) was added to a suspension of <i>N</i>-(4-bromo-2-fluorophenyl)-7-hydroxy-6-methoxy-4-quinazolinylamine<b> (40</b>;<sup>18</sup> 546 mg, 1.5 mmol) in DMF (5 mL). After the suspension was stirred for 10 min at ambient temperature, <i>tert</i>-butyl 4-({[(4-methylphenyl)sulfonyl]oxy}methyl)piperidine-1-carboxylate (<b>54</b>;<sup>21</sup> 636 mg, 1.72 mmol) was added and the mixture was heated at 95 °C for 2 h. After the mixture was cooled, the mixture was poured onto cooled water (20 mL). The precipitate was collected by filtration, washed with water, and dried under vacuum to give 665 mg of <b>45</b> (79%). <sup>1</sup>H NMR:  δ 1.15−1.30 (m, 2H), 1.46 (s, 9H), 1.80 (d, 2H), 2.0−2.10 (m, 1H), 2.65−2.90 (m, 2H), 3.95 (s, 3H), 4.02 (br s, 2H), 4.05 (d, 2H), 7.20 (s, 1H), 7.48 (d, 1H), 7.55 (t, 1H), 7.65 (d, 1H), 7.80 (s, 1H), 8.35 (s, 1H), 9.55 (br s, 1H). MS−ESI <i>m</i>/<i>z</i>:  561−563 [MH]<sup>+</sup>. </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)</b><b>-</b><b>(1-Methylpiperidin-3-yl)methanol (50). </b>(<i>R</i>)-Ethyl nipecotate (5.7 g, 365 mmol) was dissolved in aqueous formaldehyde (38%, 45 mL) and formic acid (90 mL), and the mixture was heated at reflux for 18 h. The mixture was allowed to cool and was added dropwise to a cooled saturated aqueous sodium hydrogen carbonate solution. The mixture was adjusted to pH 12 by the addition of saturated aqueous sodium hydroxide, and the mixture was extracted with methylene chloride (50 mL). The organic extract was washed with brine and dried (MgSO<sub>4</sub>), and the solvent was removed by evaporation to give 4.51 g of (<i>R</i>)-ethyl 1-methylpiperidine-3-carboxylate (73%) as a colorless oil. MS−ESI <i>m</i>/<i>z</i>:  172 [MH]<sup>+</sup>. </div><div class="NLM_p">A solution of (<i>R</i>)-ethyl 1-methylpiperidine-3-carboxylate (5.69 g, 33 mmol) in diethyl ether (20 mL) was added dropwise to a stirred solution of 1 M lithium aluminum hydride in THF (36.6 mL, 36.6 mmol) in ether (85 mL) and cooled to maintain the reaction temperature at 20 °C. The mixture was stirred for 1.5 h at ambient temperature, and then, water (1.4 mL), aqueous sodium hydroxide (15%, 1.4 mL), and water (4.3 mL) were added. The precipitate was removed by filtration, and the volatiles were removed from the filtrate by evaporation to give 4.02 g of<b> 50</b> (94%). <sup>1</sup>H NMR:  δ 1.06 (q, 1H), 1.51−1.94 (m, 5H), 2.04 (s, 3H), 2.34 (br s, 1H), 2.62 (m, 1H), 2.78 (d, 1H), 3.49 (m, 1H), 3.59 (m, 1H). MS−ESI <i>m</i>/<i>z</i>:  130 [MH]<sup>+</sup>. </div><div class="NLM_p"><b>7-(1-(</b><b><i>tert</i></b><b>-Butoxycarbonyl)piperidin-4-ylmethoxy)-6-methoxy-3-((pivaloyloxy)methyl)-3,4-di</b><b>hydroquinazolin-<a name="jm004500601310" id="jm004500601310"></a> 4-one (56).</b> Triphenylphosphine (1.7 g, 6.5 mmol) was added under nitrogen to a suspension of 7-hydroxy-6-methoxy-3-((pivaloyloxy)methyl)-3,4-dihydroquinazolin-4-one <b>(51</b>;<sup>18</sup> 1.53 g, 5 mmol) in methylene chloride (20 mL), followed by the addition of <i>tert</i>-butyl 4-(hydroxymethyl)piperidine-1-carboxylate<b> (52</b>;<sup>20</sup> 1.29 g, 6 mmol) and by a solution of diethyl azodicarboxylate (1.13 g, 6.5 mmol) in methylene chloride (5 mL). After the solution was stirred for 30 min at ambient temperature, the reaction mixture was poured onto a column of silica and was eluted with ethyl acetate/petroleum ether (1/1) followed by 6/5, 6/4, and 7/3. Evaporation of the fractions containing the expected product led to an oil that crystallized following trituration with pentane (5 mL). The solid was collected by filtration and dried under vacuum to give 2.32 g of <b>56</b> (92%). <sup>1</sup>H NMR (CDCl<sub>3</sub>):  δ 1.20 (s, 9H), 1.20−1.35 (m, 2H), 1.43 (s, 9H), 1.87 (d, 2H), 2.05−2.20 (m, 1H), 2.75 (t, 2H), 3.96 (d, 2H), 3.97 (s, 3H), 4.10−4.25 (br s, 2H), 5.95 (s, 2H), 7.07 (s, 1H), 7.63 (s, 1H), 8.17 (s, 1H). MS−ESI <i>m</i>/<i>z</i>:  526 [MNa]<sup>+</sup>. Anal. (C<sub>26</sub>H<sub>37</sub>N<sub>3</sub>O<sub>7</sub>) C, H, N. </div><div class="NLM_p"><b>7-(2-(1-</b><b><i>tert-</i></b><b>Butoxycarbonylpiperidin-4-yl)ethoxy)-6-methoxy-3-((pivaloyloxy)methyl)-3,4-di</b><b>hydroquinazolin-4-one (57). </b>A suspension of <b>51</b><sup>18</sup> (7 g, 23 mmol) and <i>tert</i>-butyl 4-(2-{[(4-methylphenyl)sulfonyl]oxy}ethyl)piperidine-1-carboxylate<b> (55</b>;<sup>22</sup> 11.4 g, 30 mmol) in DMF (70 mL) containing potassium carbonate (6.32 g, 46 mmol) was stirred at 100 °C for 3 h. After the suspension was cooled, the volatiles were removed under vacuum and the residue was partitioned between diethyl ether and water. The organic layer was separated, washed with water and brine, dried (MgSO<sub>4</sub>), and evaporated. The solid was triturated with pentane, filtered, and dried under vacuum to give 10.5 g of <b>57 </b>(88%). <sup>1</sup>H NMR (CDCl<sub>3</sub>):  δ 1.20 (s, 9H), 1.15−1.25 (m, 2H), 1.48 (s, 9H), 1.65−1.75 (m, 1H), 1.70 (d, 2H), 1.90 (dd, 2H), 2.72 (t, 2H), 4.0 (s, 3H), 4.0−4.20 (m, 2H), 4.20 (t, 2H), 5.95 (s, 2H), 7.10 (s, 1H), 7.65 (s, 1H), 8.20 (s, 1H). MS−ESI <i>m</i>/<i>z</i>:  540 [MNa]<sup>+</sup>. </div><div class="NLM_p"><b>6-Methoxy-7-(piperidin-4-ylmethoxy)-3-((pivaloyloxy)methyl)-3,4-dihydroquinazolin-4-one </b><b>(58).</b> A solution of <b>56</b> (2.32 g, 4.6 mmol) in methylene chloride (23 mL) containing TFA (5 mL) was stirred at ambient temperature for 1 h. The volatiles were removed under vacuum. The residue was partitioned between ethyl acetate (20 mL) and sodium hydrogen carbonate. The organic solvent was removed under vacuum, and the residue was filtered. The precipitate was washed with water and dried under vacuum. The solid was azeotroped with toluene and dried under vacuum to give 1.7 g of <b>58</b> (92%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>; CF<sub>3</sub>COOD):  δ 1.15 (s, 9H), 1.45−1.60 (m, 2H), 1.95 (d, 2H), 2.10−2.25 (m, 1H), 2.95 (t, 2H), 3.35 (d, 2H), 3.95 (s, 3H), 4.10 (d, 2H), 5.95 (s, 2H), 7.23 (s, 1H), 7.54 (s, 1H), 8.45 (s, 1H). MS−ESI <i>m</i>/<i>z</i>:  404 [MH]<sup>+</sup>. Anal. (C<sub>21</sub>H<sub>29</sub>N<sub>3</sub>O<sub>5</sub>, 1 H<sub>2</sub>O, 0.8 CF<sub>3</sub>COOH) C, H, N. </div><div class="NLM_p">A similar procedure was used to prepare <b>59</b>. </div><div class="NLM_p"><b>6-Methoxy-7-(1-methylpiperidin-4-ylmethoxy)-3-((pivaloyloxy)methyl)-3,4-dihydroquinazol</b><b>in-4-one (60).</b> A 37% aqueous solution of formaldehyde (501 <i>μ</i>L, 6 mmol) followed by sodium cyanoborohydride (228 mg, 3.6 mmol) was added in portions to a solution of<b> 58</b> (1.21 g, 3 mmol) in a mixture of THF and methanol (10 mL/10 mL). After the solution was stirred for 30 min at ambient temperature, the organic solvents were removed under vacuum and the residue was partitioned between methylene chloride (20 mL) and water (20 mL). The organic layer was separated, washed with water and brine, and dried (MgSO<sub>4</sub>), and the volatiles were removed by evaporation. The residue was triturated with diethyl ether (5 mL), and the resulting solid was collected by filtration, washed with diethyl ether (3 mL), and dried under vacuum to give 1.02 g of <b>60</b> (82%). <sup>1</sup>H NMR (CDCl<sub>3</sub>):  δ 1.19 (s, 9H), 1.40−1.55 (m, 2H), 1.90 (d, 2H), 2.0 (t, 2H), 1.85−2.10 (m, 1H), 2.30 (s, 3H), 2.92 (d, 2H), 3.96 (s, 3H), 3.99 (d, 2H), 5.94 (s, 2H), 7.08 (s, 1H), 7.63 (s, 1H), 8.17 (s, 1H). MS−ESI <i>m</i>/<i>z</i>:  418 [MH]<sup>+</sup>. Anal. (C<sub>22</sub>H<sub>31</sub>N<sub>3</sub>O<sub>5</sub>, 0.5 H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>7-(2-(1-Methylpiperidin-4-yl)ethoxy)-6-methoxy-3-((pivaloyloxy)methyl)-3,4-dihydroquinaz</b><b>olin-4-one (61).</b> To a solution of 7-(2-(piperidin-4-yl)ethoxy)-6-methoxy-3-((pivaloyloxy)methyl)-3,4-dihydroquinazolin-4-one <b>(59</b>; 6 g, 14.4 mmol) in methanol (30 mL) and methylene chloride (60 mL) was added aqueous formaldehyde (37%, 2.2 mL, 28.9 mmol) followed by acetic acid (990 <i>μ</i>L, 17.3 mmol). Sodium borohydride triacetate (4.6 g, 21.6 mmol) was added in portions. After the solution was stirred for 1 h at ambient temperature, the volatiles were removed under vacuum and the residue was partitioned between water (50 mL) and methylene chloride (50 mL). The pH of the aqueous layer was adjusted to 7, washed with water and brine, dried (MgSO<sub>4</sub>), and evaporated. The solid was triturated with diethyl ether (5 mL), filtered, washed with diethyl ether (5 mL), and dried under vacuum to give 4.2 g of <b>61</b> (68%). <sup>1</sup>H NMR (CDCl<sub>3</sub>):  δ 1.22 (s, 9H), 1.68 (br s, 3H), 1.90 (m, 4H), 2.32 (br s, 2H), 2.52 (s, 3H), 3.18 (d, 2H), 4.0 (s, 3H), 4.20 (t, 2H), 5.95 (s, 2H), 7.10 (s, 1H), 7.65 (s, 1H), 8.20 (s, 2H). MS−ESI <i>m</i>/<i>z</i>:  432 [MH]<sup>+</sup>. </div><div class="NLM_p"><b>6-Methoxy-7-[(1-methylpiperidin-4-yl)methoxy]-3,4-dihydroquinazolin-4-one (62). </b>A saturated solution of ammonia in methanol (14 mL) was added to a solution of<b> 60</b> (1.38 g, 3.3 mmol) in methanol (5 mL). After the solution was stirred for 20 h at ambient temperature, the suspension was diluted with methylene chloride (10 mL) and filtered. The filtrate was evaporated under vacuum, and the residue was triturated with diethyl ether (3 mL), filtered, washed with diethyl ether (2 mL), and dried under vacuum to give 910 mg of <b>62</b> (83%). <sup>1</sup>H NMR:  δ 1.30−1.45 (m, 2H), 1.75 (d, 2H), 1.70−1.85 (m, 1H), 1.90 (t, 2H), 2.20 (s, 3H), 2.80 (d, 2H), 3.90 (s, 3H), 4.0 (d, 2H), 7.13 (s, 1H), 7.45 (s, 1H), 7.99 (s, 1H). MS−ESI <i>m</i>/<i>z</i>:  304 [MH]<sup>+</sup>. </div><div class="NLM_p">A similar procedure was used to prepare <b>63</b>. </div><div class="NLM_p"><b>4-Chloro-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazoline (64).</b> A solution of <b>62</b> (2.8 g, 9.24 mmol) in thionyl chloride (28 mL) containing DMF (280 <i>μ</i>L) was refluxed at 85 °C for 1 h. After the solution was cooled, the volatiles were removed by evaporation. The precipitate was triturated with diethyl ether (5 mL), filtered, washed with diethyl ether (3 mL), and dried under vacuum. The solid was dissolved in methylene chloride (15 mL), and saturated aqueous sodium hydrogen carbonate was added. The organic layer was separated, washed with water and brine, dried (MgSO<sub>4</sub>), and evaporated to give 2.9 g of <b>64</b> (98%). <sup>1</sup>H NMR:  δ 1.30−1.50 (m, 2H), 1.75−1.90 (m, 3H), 2.0 (t, 1H), 2.25 (s, 3H), 2.85 (d, 2H), 4.02 (s, 3H), 4.12 (d, 2H), 7.41 (s, 1H), 7.46 (s, 1H), 8.90 (s, 1H). MS−ESI <i>m</i>/<i>z</i>:  322 [MH]<sup>+</sup>. Anal. (C<sub>16</sub>H<sub>20</sub>N<sub>3</sub>O<sub>2</sub>Cl, 0.3 H<sub>2</sub>O, 0.1 CH<sub>2</sub>Cl<sub>2</sub>) C, H, N. </div><div class="NLM_p">A similar procedure was used to prepare <b>65</b>. </div><div class="NLM_p"><b><i>N</i></b><b>-(4-Chloro-2-fluorophenyl)-7-(3-chloropropoxy)-6-methoxyquinazolin-4-amine (66). </b>A mixture of <b>39</b><sup>18</sup> (957 mg, 3 mmol), 1-bromo-3-chloropropane (2.36 g, 15 mmol), and potassium carbonate (2.1 g, 15 mmol) in DMF (20 mL) was heated at 40 °C for 1.5 h. The mixture was cooled, diluted with water, and extracted with ethyl acetate. The organic extracts were combined, washed with water and brine, and dried (MgSO<sub>4</sub>), and the volatiles were removed by evaporation. The residue was triturated with hexane/ethyl acetate (5 mL/5 mL), filtered, and dried under vacuum to give 650 mg of <b>66</b> (55%). <sup>1</sup>H NMR:  δ 2.26 (m, 2H), 3.82 (t, 2H), 3.95 (s, 3H), 4.26 (t, 2H), 7.20 (s, 1H), 7.32 (dd, 1H), 7.48−7.60 (m, 2H), 7.80 (s, 1H), 8.35 (s, 1H), 9.52 (s, 1H). MS−EI <i>m</i>/<i>z</i>:  396 [MH]<sup>+</sup>. </div><div class="NLM_p"><b><i>N</i></b><b>-(4-Bromo-2-fluorophenyl)-7-(3-chloropropoxy)-6-methoxyquinazolin-4-amine (67). </b>A solution of <b>40</b><sup>18</sup> (0.5 g, 1.37 mmol) and 1-bromo-3-chloropropane (0.165 mL, 1.65 mmol) in DMF (7.5 mL) containing potassium carbonate (0.475 g, 3.43 mmol) was stirred at ambient temperature overnight. The mixture was poured onto water. The precipitate was filtered, washed with water followed by diethyl ether (3 mL), and dried under vacuum to give 425 mg of <b>67</b> (70%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>; CF<sub>3</sub>COOD):  δ 2.30−2.40 (m, 2H), 3.85 (t, 2H), 4.02 (s, 3H), 4.35 (t, 2H), 7.37 (s, 1H), 7.52−7.64 (m, 2H), 7.82 (d, 1H), 8.09 (s, 1H), 8.88 (s, 1H). MS−ESI <i>m</i>/<i>z</i>:  441 [M.]<sup>+</sup>. </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-4-(Pyrrolidin-1-yl)but-2-en-1-ol (68). </b>A solution of 4-pyrrolidin-1-ylbut-2-yn-1-ol<sup><a onclick="showRef(event, 'jm011022eb00027'); return false;" href="javascript:void(0);" class="ref jm011022eb00027">27</a></sup> (4.3 g, 31 mmol) in THF (20 mL) was added dropwise to a suspension of lithium aluminum hydride (2.35 g, 62 mmol) in anhydrous THF (8 mL), and the mixture was stirred and heated at 60 °C for 2 h. The mixture <a name="jm004500601311" id="jm004500601311"></a> was cooled to 5 °C, and 2 M aqueous sodium hydroxide solution (28 mL) was added dropwise. The resulting suspension was filtered, and the filtrate was evaporated under vacuum. The residue was dissolved in a mixture of methylene chloride/ethyl acetate (20 mL/20 mL) and dried (MgSO<sub>4</sub>), and the solvent was removed by evaporation. The residue was purified by column chromatography on aluminum oxide eluting with methylene chloride/methanol (97/3) to give 3.09 g of <b>68</b> (70%). <sup>1</sup>H NMR (CDCl<sub>3</sub>):  δ 1.82 (m, 4H), 2.61 (m, 4H), 3.17 (m, 2H), 4.13 (s, 2H), 5.84 (m, 2H). </div><div class="NLM_p"><b>Biological Evaluation</b><b>.</b> IC<sub>50</sub> values reported are the average of 3−5 independent measurements, depending on compound potency. Experimental details for the in vitro receptor TK inhibition assays, in vitro HUVEC proliferation assay, mouse plasma pharmacokinetic assay, and human tumor xenograft test have been previously reported.<sup>18,19</sup> For the in vitro HUVEC proliferation assay, EGF 0.3 ng/mL was used. Adenosine 5‘-triphosphate (ATP) concentrations used in the enzyme assays were 2 <i>μ</i>M for Flt-1, KDR, EGFR, PDGFRβ, FGFR1, and erbB2; 0.2 <i>μ</i>M for CDK2; 0.8 <i>μ</i>M for AKT; 2.5 <i>μ</i>M for IGF-1R; 5 <i>μ</i>M for Tie-2; 7.5 <i>μ</i>M for PDK; and 8 <i>μ</i>M for MEK. The concentration of ATP used was below the respective Km for ATP in all cases. </div><div class="NLM_p">Alignment of protein sequences indicates a very high degree of homology between the kinase domain of the human KDR receptor and the murine equivalent (from <i>mus musculus</i>; similarity >96% and identity > 95%) as well as between the human Flt-1 receptor and the murine equivalent (from <i>mus musculus</i>; similarity > 94% and identity > 92%). </div><div class="NLM_p last"><b>Rat and Dog Pharmacokinetics.</b> Compounds were dosed as free bases. Rat: <b>1</b> and <b>2</b> were dosed iv and po to groups of 3 males. Compound <b>1</b> was dosed iv at 5 mg/kg using a 2 mg/mL solution in 25% HP β cyclodextrin and po at 50 mg/kg using a 2 mg/mL ball-milled suspension in poly(vinylpyrrolidone) (PVP)/sodium lauryl sulfate (SLS) solution. Compound <b>2</b> was dosed iv at 5 mg/kg using a solution in DMSO (10%), cremophor (10%), and physiological saline (80%) and po at 50 mg/kg of a suspension of 5 mg/mL in polysorbate 80 (1%). Dog: <b>1 </b>was dosed iv and po to 4 males, and <b>2</b> was dosed iv and po to 3 males. Compound <b>1</b> was dosed iv at 5 mg/kg of a 3.5 mg/mL solution in 45% HP β-cyclodextrin and po at 30 mg/kg of a 10 mg/mL suspension in PVP (1 mg/mL)/SLS (0.2 mg/mL) solution. Compound <b>2</b> was dosed iv at 5 mg/kg of a 5 mg/mL solution in 45% (w/v) HP β-cyclodextrin in pH 7 Sorenson's phosphate buffer and po at 25 mg/kg of a 5 mg/mL milled suspension in HPMC/polysorbate 80. </div></div><div class="NLM_back"><div class="article_supporting-info" id=""><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm011022e/suppl_file/jm011022e_s.pdf">jm011022e_s.pdf (697.16 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm011022e" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45145" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45145" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><ul></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laurent F. Hennequin</span> - <span class="hlFld-Affiliation affiliation">AstraZeneca, Centre de Recherches, Z.I. La Pompelle, B.P. 1050, Chemin de Vrilly, 51689 Reims, Cedex 2, France, and AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elaine S. E. Stokes</span> - <span class="hlFld-Affiliation affiliation">AstraZeneca, Centre de Recherches, Z.I. La Pompelle, B.P. 1050, Chemin de Vrilly, 51689 Reims, Cedex 2, France, and AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew P. Thomas</span> - <span class="hlFld-Affiliation affiliation">AstraZeneca, Centre de Recherches, Z.I. La Pompelle, B.P. 1050, Chemin de Vrilly, 51689 Reims, Cedex 2, France, and AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Craig Johnstone</span> - <span class="hlFld-Affiliation affiliation">AstraZeneca, Centre de Recherches, Z.I. La Pompelle, B.P. 1050, Chemin de Vrilly, 51689 Reims, Cedex 2, France, and AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patrick A. Plé</span> - <span class="hlFld-Affiliation affiliation">AstraZeneca, Centre de Recherches, Z.I. La Pompelle, B.P. 1050, Chemin de Vrilly, 51689 Reims, Cedex 2, France, and AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Donald J. Ogilvie</span> - <span class="hlFld-Affiliation affiliation">AstraZeneca, Centre de Recherches, Z.I. La Pompelle, B.P. 1050, Chemin de Vrilly, 51689 Reims, Cedex 2, France, and AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Dukes</span> - <span class="hlFld-Affiliation affiliation">AstraZeneca, Centre de Recherches, Z.I. La Pompelle, B.P. 1050, Chemin de Vrilly, 51689 Reims, Cedex 2, France, and AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen R. Wedge</span> - <span class="hlFld-Affiliation affiliation">AstraZeneca, Centre de Recherches, Z.I. La Pompelle, B.P. 1050, Chemin de Vrilly, 51689 Reims, Cedex 2, France, and AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jane Kendrew</span> - <span class="hlFld-Affiliation affiliation">AstraZeneca, Centre de Recherches, Z.I. La Pompelle, B.P. 1050, Chemin de Vrilly, 51689 Reims, Cedex 2, France, and AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jon O. Curwen</span> - <span class="hlFld-Affiliation affiliation">AstraZeneca, Centre de Recherches, Z.I. La Pompelle, B.P. 1050, Chemin de Vrilly, 51689 Reims, Cedex 2, France, and AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom </span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11050" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11050" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The technical assistance of Janet Jackson, Brenda Curry, Cath Grundy, Claire Barnes, Jodie Sharples, Rosemary Chester, Sarah Boffey, Karen Malbon, Paula Valentine, Jonathan Mills, Dick Glarvey, Janet Culshaw, Glynn Chesterton, Steve Glossop, Scott Lamont, David Milnes, Georges Pasquet, Myriam Didelot, Dominique Boucherot, Pascal Boutron, Francoise Magnien, Sylvie Piva-Leblanc, Nicolas Warin, Delphine Dorison-Duval, Jean-Paul Zimmerman, and Christian Delvare is gratefully acknowledged. </p></div><div class="refs-header-label"></div><p class="references-count">
            This article references 27 other publications.
        </p><ol id="references" class="useLabel"><li id="jm011022eb00001"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm011022eb00001'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="jm011022eb00001_1"><span><span class="NLM_string-ref">Fan, T. P. D.; Jaggar, R.; Bicknell, R. Controlling the vasculature:  angiogenesis, anti-angiogenesis, and vascular targetting of gene therapy. <i>  Trends Pharmacol. Sci.</i><b>1995</b>, <i>16</i>, 57−66.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1995&pages=66&author=T.+P.+D.+Fan&author=R.+Jaggar&author=R+Bicknell&title=Controlling+the+vasculature%3A%E2%80%89+angiogenesis%2C+anti-angiogenesis%2C+and+vascular+targetting+of+gene+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00001_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DT.%2BP.%2BD.%26atitle%3DControlling%2520the%2520vasculature%253A%25E2%2580%2589%2520angiogenesis%252C%2520anti-angiogenesis%252C%2520and%2520vascular%2520targetting%2520of%2520gene%2520therapy%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1995%26volume%3D16%26spage%3D66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm011022eb00002"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm011022eb00002'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="jm011022eb00002_1"><span><span class="NLM_string-ref">Folkman, J. Angiogenesis in cancer, vascular, rheumtoid and other disease. <i>  Nat. Med.</i><b>1995</b>, <i>1</i>, 27−31.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1995&pages=31&author=J+Folkman&title=Angiogenesis+in+cancer%2C+vascular%2C+rheumtoid+and+other+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00002_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFolkman%26aufirst%3DJ%26atitle%3DAngiogenesis%2520in%2520cancer%252C%2520vascular%252C%2520rheumtoid%2520and%2520other%2520disease%26jtitle%3DNat.%2520Med.%26date%3D1995%26volume%3D1%26spage%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm011022eb00003"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm011022eb00003'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="jm011022eb00003_1"><span><span class="NLM_string-ref">Jakeman, L. B.; Armanini, M.; Phillips, H. S.; Ferrara, N. Developmental expression of binding sites and messenger ribonucleic acid for vascular endothelial growth factor suggests a role for this protein in vasculogenesis and angiogenesis. <i>  Endocrinology</i><b>1993</b>, <i>133</i>, 848−859.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=1993&pages=859&author=L.+B.+Jakeman&author=M.+Armanini&author=H.+S.+Phillips&author=N+Ferrara&title=Developmental+expression+of+binding+sites+and+messenger+ribonucleic+acid+for+vascular+endothelial+growth+factor+suggests+a+role+for+this+protein+in+vasculogenesis+and+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00003_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJakeman%26aufirst%3DL.%2BB.%26atitle%3DDevelopmental%2520expression%2520of%2520binding%2520sites%2520and%2520messenger%2520ribonucleic%2520acid%2520for%2520vascular%2520endothelial%2520growth%2520factor%2520suggests%2520a%2520role%2520for%2520this%2520protein%2520in%2520vasculogenesis%2520and%2520angiogenesis%26jtitle%3DEndocrinology%26date%3D1993%26volume%3D133%26spage%3D859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm011022eb00004"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm011022eb00004'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="jm011022eb00004_1"><span><span class="NLM_string-ref">Connolly, D. T.; Olander, J. V.; Heuvelman, D.; Nelson, R.; Monsell, R.; Siegel, N.; Haymore, B. L.; Leimgruber, R.; Feder, J. Human vascular permeability factor. Isolation from U937 cells. <i>  J. Biol. Chem</i>. <b>1989</b>, <i>264</i>, 20017−20024.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=264&publication_year=1989&pages=20024&author=D.+T.+Connolly&author=J.+V.+Olander&author=D.+Heuvelman&author=R.+Nelson&author=R.+Monsell&author=N.+Siegel&author=B.+L.+Haymore&author=R.+Leimgruber&author=J+Feder&title=Human+vascular+permeability+factor.+Isolation+from+U937+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00004_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DConnolly%26aufirst%3DD.%2BT.%26atitle%3DHuman%2520vascular%2520permeability%2520factor.%2520Isolation%2520from%2520U937%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1989%26volume%3D264%26spage%3D20024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm011022eb00005"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm011022eb00005'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="jm011022eb00005_1"><span><span class="NLM_string-ref">Plowman, G. D.; Ullrich, A.; Shawver, L. K. Receptor tyrosine kinases as targets for drug intervention. <i>  Drug News Perspect.</i><b>1994</b>, <i>7</i>, 334−339.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1994&pages=339&author=G.+D.+Plowman&author=A.+Ullrich&author=L.+K+Shawver&title=Receptor+tyrosine+kinases+as+targets+for+drug+intervention"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00005_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPlowman%26aufirst%3DG.%2BD.%26atitle%3DReceptor%2520tyrosine%2520kinases%2520as%2520targets%2520for%2520drug%2520intervention%26jtitle%3DDrug%2520News%2520Perspect.%26date%3D1994%26volume%3D7%26spage%3D339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm011022eb00006"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm011022eb00006'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="jm011022eb00006_1"><span><span class="NLM_string-ref">Straw, L. M.; Shawver, L. K. Tyrosine kinases in disease: overview of kinase inhibitors as therapeutic agents and current drugs in clinical trials. <i>  Exp. Opin. Invest. Drugs </i><b>1998</b>, <i>7</i>, 553−573.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1998&pages=573&author=L.+M.+Straw&author=L.+K+Shawver&title=Tyrosine+kinases+in+disease%3A+overview+of+kinase+inhibitors+as+therapeutic+agents+and+current+drugs+in+clinical+trials"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00006_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStraw%26aufirst%3DL.%2BM.%26atitle%3DTyrosine%2520kinases%2520in%2520disease%253A%2520overview%2520of%2520kinase%2520inhibitors%2520as%2520therapeutic%2520agents%2520and%2520current%2520drugs%2520in%2520clinical%2520trials%26jtitle%3DExp.%2520Opin.%2520Invest.%2520Drugs%26date%3D1998%26volume%3D7%26spage%3D573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm011022eb00007"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm011022eb00007'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="jm011022eb00007_1"><span><span class="NLM_string-ref">Shawver, L. K.; Lipson, K. E.; Fong, T. A. T.; McMahon, G.; Plowman, G. D.; Strawn, L. M. Receptor tyrosine kinases as targets for inhibition of angiogenesis. <i>  Drug Discov. Today</i><b>1997</b>, <i>2</i>, 50−63.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1997&pages=63&author=L.+K.+Shawver&author=K.+E.+Lipson&author=T.+A.+T.+Fong&author=G.+McMahon&author=G.+D.+Plowman&author=L.+M+Strawn&title=Receptor+tyrosine+kinases+as+targets+for+inhibition+of+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00007_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShawver%26aufirst%3DL.%2BK.%26atitle%3DReceptor%2520tyrosine%2520kinases%2520as%2520targets%2520for%2520inhibition%2520of%2520angiogenesis%26jtitle%3DDrug%2520Discov.%2520Today%26date%3D1997%26volume%3D2%26spage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm011022eb00008"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm011022eb00008'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="jm011022eb00008_1"><span><span class="NLM_string-ref">De Vries, C.; Escobedo, J. A.; Ueno, H.; Houck, K.; Ferrara, N.; Williams, L. T. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. <i>  Science</i><b>1992</b>, <i>255</i>, 989−991.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=255&publication_year=1992&pages=991&author=C.+De+Vries&author=J.+A.+Escobedo&author=H.+Ueno&author=K.+Houck&author=N.+Ferrara&author=L.+T+Williams&title=The+fms-like+tyrosine+kinase%2C+a+receptor+for+vascular+endothelial+growth+factor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00008_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BVries%26aufirst%3DC.%26atitle%3DThe%2520fms-like%2520tyrosine%2520kinase%252C%2520a%2520receptor%2520for%2520vascular%2520endothelial%2520growth%2520factor%26jtitle%3DScience%26date%3D1992%26volume%3D255%26spage%3D991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm011022eb00009"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm011022eb00009'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="jm011022eb00009_1"><span><span class="NLM_string-ref">Terman, B. I.; Dougher-Vermazen, M.; Carrion, M. E.; Dimitrov, D.; Armellino, D. C.; Gospodarowicz, D.; Bohlen, P. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. <i>  Biochem. Biophys. Res. Commun.</i><b>1992</b>, <i>187</i>, 1579−1586.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=187&publication_year=1992&pages=1586&author=B.+I.+Terman&author=M.+Dougher-Vermazen&author=M.+E.+Carrion&author=D.+Dimitrov&author=D.+C.+Armellino&author=D.+Gospodarowicz&author=P+Bohlen&title=Identification+of+the+KDR+tyrosine+kinase+as+a+receptor+for+vascular+endothelial+cell+growth+factor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00009_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTerman%26aufirst%3DB.%2BI.%26atitle%3DIdentification%2520of%2520the%2520KDR%2520tyrosine%2520kinase%2520as%2520a%2520receptor%2520for%2520vascular%2520endothelial%2520cell%2520growth%2520factor%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1992%26volume%3D187%26spage%3D1586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm011022eb00010"><div class="reference"><div class="NLM_citation" id="jm011022eb00010_1"><span><span class="NLM_string-ref">(a) Kim, K. L.; Li, B.; Winer, J.; Armanini, M.; Gillett, N.; Phillips, H. S.; Ferrara, N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. <i>  Nature </i><b>1993</b>, <i>362</i>, 841−844.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=362&publication_year=1993&pages=844&author=K.+L.+Kim&author=B.+Li&author=J.+Winer&author=M.+Armanini&author=N.+Gillett&author=H.+S.+Phillips&author=N+Ferrara&title=Inhibition+of+vascular+endothelial+growth+factor-induced+angiogenesis+suppresses+tumor+growth+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00010_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DK.%2BL.%26atitle%3DInhibition%2520of%2520vascular%2520endothelial%2520growth%2520factor-induced%2520angiogenesis%2520suppresses%2520tumor%2520growth%2520in%2520vivo%26jtitle%3DNature%26date%3D1993%26volume%3D362%26spage%3D844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm011022eb00010_2"><span><span class="NLM_string-ref">(b) Presta, L. G.; Chen, H.; O'Connor, S. J.; Chisholm, V.; Meng, Y. G.; Ktummen, L.; Winkler, M.; Ferrara, N. Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders. <i>  Cancer Res. </i><b>1997</b>, <i>57</i>, 4593−4599.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1997&pages=4599&author=L.+G.+Presta&author=H.+Chen&author=S.+J.+O%27Connor&author=V.+Chisholm&author=Y.+G.+Meng&author=L.+Ktummen&author=M.+Winkler&author=N+Ferrara&title=Humanization+of+an+anti-vascular+endothelial+growth+factor+monoclonal+antibody+for+the+therapy+of+solid+tumors+and+other+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00010_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPresta%26aufirst%3DL.%2BG.%26atitle%3DHumanization%2520of%2520an%2520anti-vascular%2520endothelial%2520growth%2520factor%2520monoclonal%2520antibody%2520for%2520the%2520therapy%2520of%2520solid%2520tumors%2520and%2520other%2520disorders%26jtitle%3DCancer%2520Res.%26date%3D1997%26volume%3D57%26spage%3D4599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm011022eb00010_3"><span><span class="NLM_string-ref">(c) Borgstrom, P.; Hillan, K. J.; Sriramarao, P.; Ferrara, N. Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralizing antibody:  novel concepts of angiostatic therapy from intavital videomicroscopy. <i>  Cancer Res. </i><b>1996</b>, <i>56</i>, 4032−4039.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1996&pages=4039&author=P.+Borgstrom&author=K.+J.+Hillan&author=P.+Sriramarao&author=N+Ferrara&title=Complete+inhibition+of+angiogenesis+and+growth+of+microtumors+by+anti-vascular+endothelial+growth+factor+neutralizing+antibody%3A%E2%80%89+novel+concepts+of+angiostatic+therapy+from+intavital+videomicroscopy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00010_3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBorgstrom%26aufirst%3DP.%26atitle%3DComplete%2520inhibition%2520of%2520angiogenesis%2520and%2520growth%2520of%2520microtumors%2520by%2520anti-vascular%2520endothelial%2520growth%2520factor%2520neutralizing%2520antibody%253A%25E2%2580%2589%2520novel%2520concepts%2520of%2520angiostatic%2520therapy%2520from%2520intavital%2520videomicroscopy%26jtitle%3DCancer%2520Res.%26date%3D1996%26volume%3D56%26spage%3D4039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm011022eb00011"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm011022eb00011'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="jm011022eb00011_1"><span><span class="NLM_string-ref">(a) Witte, L.; Hickling, D. J.; Zhu, Z.; Pytowski, B.; Kotanides, H.; Rockwell, P.; Bohlen, P. Monoclonal antibodies targetting the VEGF receptor-2 (Flk-1/KDR) as an anti-angiogenic therapeutic strategy. <i>  Cancer </i><i>Metastasis Rev. </i><b>1998</b>, <i>17</i>, 155−161.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1998&pages=161&author=L.+Witte&author=D.+J.+Hickling&author=Z.+Zhu&author=B.+Pytowski&author=H.+Kotanides&author=P.+Rockwell&author=P+Bohlen&title=Monoclonal+antibodies+targetting+the+VEGF+receptor-2+%28Flk-1%2FKDR%29+as+an+anti-angiogenic+therapeutic+strategy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00011_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWitte%26aufirst%3DL.%26atitle%3DMonoclonal%2520antibodies%2520targetting%2520the%2520VEGF%2520receptor-2%2520%2528Flk-1%252FKDR%2529%2520as%2520an%2520anti-angiogenic%2520therapeutic%2520strategy%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D1998%26volume%3D17%26spage%3D161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm011022eb00011_2"><span><span class="NLM_string-ref">(b) Skobe, M.; Rockwell, P.; Goldstein, N.; Vosseler, S.; Fusening, N. E. Halting angiogenesis suppresses carcinoma cell invasion. <i>  Nat. Med.</i><b>1997</b>, <i>3</i>, 1222−1227.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1997&pages=1227&author=M.+Skobe&author=P.+Rockwell&author=N.+Goldstein&author=S.+Vosseler&author=N.+E+Fusening&title=Halting+angiogenesis+suppresses+carcinoma+cell+invasion"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00011_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSkobe%26aufirst%3DM.%26atitle%3DHalting%2520angiogenesis%2520suppresses%2520carcinoma%2520cell%2520invasion%26jtitle%3DNat.%2520Med.%26date%3D1997%26volume%3D3%26spage%3D1227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm011022eb00012"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm011022eb00012'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="jm011022eb00012_1"><span><span class="NLM_string-ref">Prewett, M.; Huber, J.; Li, Y.; Santiago, A.; O'Connor, W.; King, K.; Overholser, J.; Hooper, A.; Pytowski, B.; Witte, L.; Bohlen, P.; Hicklin, D. J. Antivascular Endothelial Growth Factor Receptor (Fetal Liver Kinase 1) Monoclonal Antibody Inhibits Tumor Angiogenesis and Growth of Severeal Mouse and Human Tumors. <i>  Cancer Res.</i><b>1999</b>, <i>59</i>, 5209−5218.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=5218&author=M.+Prewett&author=J.+Huber&author=Y.+Li&author=A.+Santiago&author=W.+O%27Connor&author=K.+King&author=J.+Overholser&author=A.+Hooper&author=B.+Pytowski&author=L.+Witte&author=P.+Bohlen&author=D.+J+Hicklin&title=Antivascular+Endothelial+Growth+Factor+Receptor+%28Fetal+Liver+Kinase+1%29+Monoclonal+Antibody+Inhibits+Tumor+Angiogenesis+and+Growth+of+Severeal+Mouse+and+Human+Tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00012_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPrewett%26aufirst%3DM.%26atitle%3DAntivascular%2520Endothelial%2520Growth%2520Factor%2520Receptor%2520%2528Fetal%2520Liver%2520Kinase%25201%2529%2520Monoclonal%2520Antibody%2520Inhibits%2520Tumor%2520Angiogenesis%2520and%2520Growth%2520of%2520Severeal%2520Mouse%2520and%2520Human%2520Tumors%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26spage%3D5218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm011022eb00013"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm011022eb00013'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="jm011022eb00013_1"><span><span class="NLM_string-ref">Bold, G.; Altmann, K.-H.; Frei, J.; Lang, M.; Manley, P. W.; Traxler, P.; Wietfeld, B.; Bruggen, J.; Buchdunger, E.; Cozens, R.; Ferrari, S.; Furet, P.; Hofmann, F.; Martiny-Baron, G.; Mestan, J.; Rosel, J.; Sills, M.; Stover, D.; Acemoglu, F.; Boss, E.; Emmenegger, R.; Lasser, L.; Masso, E.; Roth, R.; Schlachter, C.; Vetterli, W.; Wyss, D.; Wood, J. M. New Anilinophthalazines as Potent and Orally well Absorbed Inhibitors of the VEGF Receptor Tyrosine Kinases Useful as antagonists of Tumor-Driven Angiogenesis. <i>  J. Med. Chem</i>. <b>2000</b>, <i>43</i>, 2310−2323.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=2323&author=G.+Bold&author=K.-H.+Altmann&author=J.+Frei&author=M.+Lang&author=P.+W.+Manley&author=P.+Traxler&author=B.+Wietfeld&author=J.+Bruggen&author=E.+Buchdunger&author=R.+Cozens&author=S.+Ferrari&author=P.+Furet&author=F.+Hofmann&author=G.+Martiny-Baron&author=J.+Mestan&author=J.+Rosel&author=M.+Sills&author=D.+Stover&author=F.+Acemoglu&author=E.+Boss&author=R.+Emmenegger&author=L.+Lasser&author=E.+Masso&author=R.+Roth&author=C.+Schlachter&author=W.+Vetterli&author=D.+Wyss&author=J.+M+Wood&title=New+Anilinophthalazines+as+Potent+and+Orally+well+Absorbed+Inhibitors+of+the+VEGF+Receptor+Tyrosine+Kinases+Useful+as+antagonists+of+Tumor-Driven+Angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00013_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBold%26aufirst%3DG.%26atitle%3DNew%2520Anilinophthalazines%2520as%2520Potent%2520and%2520Orally%2520well%2520Absorbed%2520Inhibitors%2520of%2520the%2520VEGF%2520Receptor%2520Tyrosine%2520Kinases%2520Useful%2520as%2520antagonists%2520of%2520Tumor-Driven%2520Angiogenesis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D2323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm011022eb00014"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm011022eb00014'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="jm011022eb00014_1"><span><span class="NLM_string-ref">Wood, J. M.; Bold, G.; Buchdunger, E.; Cozens, R.; Ferrari, S.; Frei, J.; Hofmann, F.; Mestan, J.; Mett, H.; O'Reilly, T.; Persohn, E.; Rosel, J.; Schnell, C.; Stover, D.; Theuer, A.; Towbin, H.; Wenger, F.; Woods-Cook, K.; Menrad, A.; Siemeister, G.; Schirner, M.; Thierauch, K.-H.; Schneider, M. R.; Drevs, J.; Martiny-Baron, G.; Totzke, F.; Marmé, D. <i>  Cancer Res.</i><b>2000</b>, <i>60</i>, 2178−2189.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Wood%2C+J.+M.%3B+Bold%2C+G.%3B+Buchdunger%2C+E.%3B+Cozens%2C+R.%3B+Ferrari%2C+S.%3B+Frei%2C+J.%3B+Hofmann%2C+F.%3B+Mestan%2C+J.%3B+Mett%2C+H.%3B+O%27Reilly%2C+T.%3B+Persohn%2C+E.%3B+Rosel%2C+J.%3B+Schnell%2C+C.%3B+Stover%2C+D.%3B+Theuer%2C+A.%3B+Towbin%2C+H.%3B+Wenger%2C+F.%3B+Woods-Cook%2C+K.%3B+Menrad%2C+A.%3B+Siemeister%2C+G.%3B+Schirner%2C+M.%3B+Thierauch%2C+K.-H.%3B+Schneider%2C+M.+R.%3B+Drevs%2C+J.%3B+Martiny-Baron%2C+G.%3B+Totzke%2C+F.%3B+Marm%C3%A9%2C+D.+Cancer+Res.+2000%2C+60%2C+2178%E2%88%922189.+Wood%2C+J.+M.%3B+Bold%2C+G.%3B+Buchdunger%2C+E.%3B+Cozens%2C+R.%3B+Ferrari%2C+S.%3B+Frei%2C+J.%3B+Hofmann%2C+F.%3B+Mestan%2C+J.%3B+Mett%2C+H.%3B+O%27Reilly%2C+T.%3B+Persohn%2C+E.%3B+Rosel%2C+J.%3B+Schnell%2C+C.%3B+Stover%2C+D.%3B+Theuer%2C+A.%3B+Towbin%2C+H.%3B+Wenger%2C+F.%3B+Woods-Cook%2C+K.%3B+Menrad%2C+A.%3B+Siemeister%2C+G.%3B+Schirner%2C+M.%3B+Thierauch%2C+K.-H.%3B+Schneider%2C+M.+R.%3B+Drevs%2C+J.%3B+Martiny-Baron%2C+G.%3B+Totzke%2C+F.%3B+Marm%C3%A9%2C+D.+Cancer+Res.2000%2C+60%2C+2178%E2%88%922189."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00014_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DJ.%2BM.%26jtitle%3DCancer%2520Res.%26date%3D2000%26volume%3D60%26spage%3D2189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm011022eb00015"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm011022eb00015'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="jm011022eb00015_1"><span><span class="NLM_string-ref">Sun, L.; Tran, N.; Liang, C.; Tang, F.; Rice, A.; Schreck, R.; Waltz, K.; Shawver, L. K.; McMahon, G.; Tang, C. Design, synthesis and evaluation of substituted 3-[(3- or 4-carboxyethylpyrrol-2-yl)methylidenyl]indolin-2-ones as inhibitors of VEGF, FGF, and PDGF receptor tyrosine kinases. <i>  J. Med. Chem.</i><b>1999</b>, <i>42</i>, 5120−5130.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=5130&author=L.+Sun&author=N.+Tran&author=C.+Liang&author=F.+Tang&author=A.+Rice&author=R.+Schreck&author=K.+Waltz&author=L.+K.+Shawver&author=G.+McMahon&author=C+Tang&title=Design%2C+synthesis+and+evaluation+of+substituted+3-%5B%283-+or+4-carboxyethylpyrrol-2-yl%29methylidenyl%5Dindolin-2-ones+as+inhibitors+of+VEGF%2C+FGF%2C+and+PDGF+receptor+tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00015_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DL.%26atitle%3DDesign%252C%2520synthesis%2520and%2520evaluation%2520of%2520substituted%25203-%255B%25283-%2520or%25204-carboxyethylpyrrol-2-yl%2529methylidenyl%255Dindolin-2-ones%2520as%2520inhibitors%2520of%2520VEGF%252C%2520FGF%252C%2520and%2520PDGF%2520receptor%2520tyrosine%2520kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D5130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm011022eb00016"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm011022eb00016'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="jm011022eb00016_1"><span><span class="NLM_string-ref">Laird, A. D.; Vajkoczy, P.; Shawver, L. K.; Thurnher, A.; Liang, C.; Mohammadi, M.; Schlessinger, J.; Ullrich, A.; Hubbard, S. R.; Blake, R. A.; Fong, T. A. T.; Strawn, L. M.; Sun, L.; Tang, C.; Hawtin, R.; Tang, F.; Shenoy, N.; Hirth, K. P.; McMahon, G.; Cherrington, J. M. SU6668 Is a Potent Antiangiogenic and Antitumour Agent That Induces Regression of Established Tumors. <i>  Cancer Res.</i><b>2000</b>, <i>60</i>, 4152−4160.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Laird%2C+A.+D.%3B+Vajkoczy%2C+P.%3B+Shawver%2C+L.+K.%3B+Thurnher%2C+A.%3B+Liang%2C+C.%3B+Mohammadi%2C+M.%3B+Schlessinger%2C+J.%3B+Ullrich%2C+A.%3B+Hubbard%2C+S.+R.%3B+Blake%2C+R.+A.%3B+Fong%2C+T.+A.+T.%3B+Strawn%2C+L.+M.%3B+Sun%2C+L.%3B+Tang%2C+C.%3B+Hawtin%2C+R.%3B+Tang%2C+F.%3B+Shenoy%2C+N.%3B+Hirth%2C+K.+P.%3B+McMahon%2C+G.%3B+Cherrington%2C+J.+M.+SU6668+Is+a+Potent+Antiangiogenic+and+Antitumour+Agent+That+Induces+Regression+of+Established+Tumors.+Cancer+Res.+2000%2C+60%2C+4152%E2%88%924160.+Laird%2C+A.+D.%3B+Vajkoczy%2C+P.%3B+Shawver%2C+L.+K.%3B+Thurnher%2C+A.%3B+Liang%2C+C.%3B+Mohammadi%2C+M.%3B+Schlessinger%2C+J.%3B+Ullrich%2C+A.%3B+Hubbard%2C+S.+R.%3B+Blake%2C+R.+A.%3B+Fong%2C+T.+A.+T.%3B+Strawn%2C+L.+M.%3B+Sun%2C+L.%3B+Tang%2C+C.%3B+Hawtin%2C+R.%3B+Tang%2C+F.%3B+Shenoy%2C+N.%3B+Hirth%2C+K.+P.%3B+McMahon%2C+G.%3B+Cherrington%2C+J.+M.+SU6668+Is+a+Potent+Antiangiogenic+and+Antitumour+Agent+That+Induces+Regression+of+Established+Tumors.+Cancer+Res.2000%2C+60%2C+4152%E2%88%924160."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00016_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLaird%26aufirst%3DA.%2BD.%26jtitle%3DCancer%2520Res.%26date%3D2000%26volume%3D60%26spage%3D4160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm011022eb00017"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm011022eb00017'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="jm011022eb00017_1"><span><span class="NLM_string-ref">Basser, R.; Hurwitz, H.; Barge, A.; Davis, I.; DeBoer, R.; Holden, S. N.; McArthur, G.; McKinley, M.; Nairn, K.; Persky, M.; Rischin, D.; Rosenthal, M.; Swaisland, H.; Eckhardt, S. G. Phase  1312  I Pharmacokinetic and Biological Study of the Angiogenesis Inhibitor, ZD6474, in Patients with solid tumors. Proceedings of the 37th Annual Meeting of the American Society of Clinical Oncology, San Francisco, May 2001; 21. Abstr. 396, 100a.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&conference=Proceedings+of+the+37th+Annual+Meeting+of+the+American+Society+of+Clinical+Oncology&author=R.+Basser&author=H.+Hurwitz&author=A.+Barge&author=I.+Davis&author=R.+DeBoer&author=S.+N.+Holden&author=G.+McArthur&author=M.+McKinley&author=K.+Nairn&author=M.+Persky&author=D.+Rischin&author=M.+Rosenthal&author=H.+Swaisland&author=S.+G.+Eckhardt&author=I+Phase&author=+Pharmacokinetic&title=Study+of+the+Angiogenesis+Inhibitor%2C+ZD6474%2C+in+Patients+with+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00017_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dproceeding%26sid%3Dliteratum%253Aachs%26aulast%3DBasser%26aufirst%3DR.%26atitle%3DStudy%2520of%2520the%2520Angiogenesis%2520Inhibitor%252C%2520ZD6474%252C%2520in%2520Patients%2520with%2520solid%2520tumors%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm011022eb00018"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm011022eb00018'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="jm011022eb00018_1"><span><span class="NLM_string-ref">Hennequin, L. F.; Thomas, A. P.; Johnstone, C.; Stokes, E. S. E.; Plé, P.; Lohmann, J.-J. M.; Ogilvie, D. J.; Dukes, M.; Wedge, S. R.; Curwen, J. O.; Kendrew, J.; Lambert-van-der-Brempt, C. Design and Structure−Activity Relationship of a New Class of Potent VEGF Receptor Tyrosine Kinase Inhibitors. <i>  J. Med. Chem.</i><b>1999</b>, <i>42</i>, 5369−5389.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=5389&author=L.+F.+Hennequin&author=A.+P.+Thomas&author=C.+Johnstone&author=E.+S.+E.+Stokes&author=P.+Pl%C3%A9&author=J.-J.+M.+Lohmann&author=D.+J.+Ogilvie&author=M.+Dukes&author=S.+R.+Wedge&author=J.+O.+Curwen&author=J.+Kendrew&author=+Lambert&title=Design+and+Structure%E2%88%92Activity+Relationship+of+a+New+Class+of+Potent+VEGF+Receptor+Tyrosine+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00018_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHennequin%26aufirst%3DL.%2BF.%26atitle%3DDesign%2520and%2520Structure%25E2%2588%2592Activity%2520Relationship%2520of%2520a%2520New%2520Class%2520of%2520Potent%2520VEGF%2520Receptor%2520Tyrosine%2520Kinase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D5389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm011022eb00019"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm011022eb00019'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="jm011022eb00019_1"><span><span class="NLM_string-ref">Wedge, S. R.; Ogilvie, D. J.; Dukes, M.; Kendrew, J.; Curwen, J. O.; Hennequin, L. F.; Thomas, A. P.; Stokes, E. S. E.; Curry, B.; Richmond, G. H.; Wadsworth, P. F. <i>  Cancer Res. </i><b>2000</b>, <i>60</i>, 970−975.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Wedge%2C+S.+R.%3B+Ogilvie%2C+D.+J.%3B+Dukes%2C+M.%3B+Kendrew%2C+J.%3B+Curwen%2C+J.+O.%3B+Hennequin%2C+L.+F.%3B+Thomas%2C+A.+P.%3B+Stokes%2C+E.+S.+E.%3B+Curry%2C+B.%3B+Richmond%2C+G.+H.%3B+Wadsworth%2C+P.+F.+Cancer+Res.+2000%2C+60%2C+970%E2%88%92975.+Wedge%2C+S.+R.%3B+Ogilvie%2C+D.+J.%3B+Dukes%2C+M.%3B+Kendrew%2C+J.%3B+Curwen%2C+J.+O.%3B+Hennequin%2C+L.+F.%3B+Thomas%2C+A.+P.%3B+Stokes%2C+E.+S.+E.%3B+Curry%2C+B.%3B+Richmond%2C+G.+H.%3B+Wadsworth%2C+P.+F.+Cancer+Res.+2000%2C+60%2C+970%E2%88%92975."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00019_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWedge%26aufirst%3DS.%2BR.%26jtitle%3DCancer%2520Res.%26date%3D2000%26volume%3D60%26spage%3D975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm011022eb00020"><div class="reference"><div class="NLM_citation" id="jm011022eb00020_1"><span><span class="NLM_string-ref">Villalobos, A.; Blake, J. F.; Biggers, C. K.; Butler, T. W.; Chapin, D. S.; Chen, Y. L.; Ives, J. L.; Jones, S. B.; Liston, D. R.; Nagel, A. A.; Nason, D. M.; Nielsen, J. A.; Shalaby, I. A.; White, W. F. Novel Benzisoxazole Derivatives as Potent and selective Inhibitors of Acetylcholinesterase. <i>  J. </i><i>Med. Chem</i>. <b>1994</b>, <i>37</i>, 2721−2734.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=2734&author=A.+Villalobos&author=J.+F.+Blake&author=C.+K.+Biggers&author=T.+W.+Butler&author=D.+S.+Chapin&author=Y.+L.+Chen&author=J.+L.+Ives&author=S.+B.+Jones&author=D.+R.+Liston&author=A.+A.+Nagel&author=D.+M.+Nason&author=J.+A.+Nielsen&author=I.+A.+Shalaby&author=W.+F+White&title=Novel+Benzisoxazole+Derivatives+as+Potent+and+selective+Inhibitors+of+Acetylcholinesterase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00020_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DNovel%2520Benzisoxazole%2520Derivatives%2520as%2520Potent%2520and%2520selective%2520Inhibitors%2520of%2520Acetylcholinesterase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D2734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm011022eb00021"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm011022eb00021'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="jm011022eb00021_1"><span><span class="NLM_string-ref">Clark, R. D.; Eglen, R.; Jahangir, A.; Miller, A. B.; Gardner, J. O. Preparation of 1-(4-aminophenyl)-ω-amino-1-alkanones as 5-HT4 receptor ligands. <i>  WO 9427965 A1 19941208.</i> CA 123:143641.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1208&publication_year=1994&pages=143641&author=R.+D.+Clark&author=R.+Eglen&author=A.+Jahangir&author=A.+B.+Miller&author=J.+O+Gardner&title=Preparation+of+1-%284-aminophenyl%29-%CF%89-amino-1-alkanones+as+5-HT4+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00021_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DR.%2BD.%26atitle%3DPreparation%2520of%25201-%25284-aminophenyl%2529-%25CF%2589-amino-1-alkanones%2520as%25205-HT4%2520receptor%2520ligands%26jtitle%3DWO%25209427965%2520A1%26date%3D1994%26volume%3D1208%26spage%3D143641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm011022eb00022"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm011022eb00022'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="jm011022eb00022_1"><span><span class="NLM_string-ref">Campbell, S. F.; Roberts, D. A.; Stubbs, J. K. Quinazoline cardiac stimulants. <i>  EP 94766 A2 19831123.</i> CA 100:121105.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1123&publication_year=1983&pages=121105&author=S.+F.+Campbell&author=D.+A.+Roberts&author=J.+K+Stubbs&title=Quinazoline+cardiac+stimulants"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00022_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCampbell%26aufirst%3DS.%2BF.%26atitle%3DQuinazoline%2520cardiac%2520stimulants%26jtitle%3DEP%252094766%2520A2%26date%3D1983%26volume%3D1123%26spage%3D121105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm011022eb00023"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm011022eb00023'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="jm011022eb00023_1"><span><span class="NLM_string-ref">Hennequin, L. F.; Thomas, A. P.; Johnstone, C.; Stokes, E. S. E.; Plé, P.; Wedge, S. R.; Ogilvie, D. J.; Kendrew, J.; Curwen, J. O.; Dukes, M. ZD6474: Design, synthesis and structure activity relationship of a novel, orally active VEGF receptor tyrosine kinase inhibitor. Poster No. 3152, 92nd AACR meeting, New Orleans, 2001.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&conference=92nd+AACR+meeting&author=L.+F.+Hennequin&author=A.+P.+Thomas&author=C.+Johnstone&author=E.+S.+E.+Stokes&author=P.+Pl%C3%A9&author=S.+R.+Wedge&author=D.+J.+Ogilvie&author=J.+Kendrew&author=J.+O.+Curwen&author=M.+Dukes&title=Design%2C+synthesis+and+structure+activity+relationship+of+a+novel%2C+orally+active+VEGF+receptor+tyrosine+kinase+inhibitor.+Poster+No.+3152"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00023_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dproceeding%26sid%3Dliteratum%253Aachs%26aulast%3DHennequin%26aufirst%3DL.%2BF.%26atitle%3DDesign%252C%2520synthesis%2520and%2520structure%2520activity%2520relationship%2520of%2520a%2520novel%252C%2520orally%2520active%2520VEGF%2520receptor%2520tyrosine%2520kinase%2520inhibitor.%2520Poster%2520No.%25203152%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm011022eb00024"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm011022eb00024'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="jm011022eb00024_1"><span><span class="NLM_string-ref">Hennequin, L. F.; Stokes, E. S. E.; McKerrecher, D.; Plé P.; Ogilvie, D. J.; Dukes, M.; Wedge, S. R.; Kendrew, J. Structure Activity Relationship and In Vivo Efficacy of Indole-ether Quinazolines, a Novel Series of Orally Active Inhibitors of VEGF Receptor Tyrosine Kinase Activity (Flt-1 and KDR). Poster No. 3133, 92nd AACR meeting, New Orleans, 2001.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&conference=92nd+AACR+meeting&author=L.+F.+Hennequin&author=E.+S.+E.+Stokes&author=D.+McKerrecher&author=P.+Pl%C3%A9&author=D.+J.+Ogilvie&author=M.+Dukes&author=S.+R.+Wedge&author=J.+Kendrew&title=Structure+Activity+Relationship+and+In+Vivo+Efficacy+of+Indole-ether+Quinazolines%2C+a+Novel+Series+of+Orally+Active+Inhibitors+of+VEGF+Receptor+Tyrosine+Kinase+Activity+%28Flt-1+and+KDR%29.+Poster+No.+3133"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00024_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dproceeding%26sid%3Dliteratum%253Aachs%26aulast%3DHennequin%26aufirst%3DL.%2BF.%26atitle%3DStructure%2520Activity%2520Relationship%2520and%2520In%2520Vivo%2520Efficacy%2520of%2520Indole-ether%2520Quinazolines%252C%2520a%2520Novel%2520Series%2520of%2520Orally%2520Active%2520Inhibitors%2520of%2520VEGF%2520Receptor%2520Tyrosine%2520Kinase%2520Activity%2520%2528Flt-1%2520and%2520KDR%2529.%2520Poster%2520No.%25203133%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm011022eb00025"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm011022eb00025'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="jm011022eb00025_1"><span><span class="NLM_string-ref">(a) Lohmann, J.-J. M.; Hennequin, L. F. A.; Thomas, A. P. Preparation and antiangiogenic and/or vascular permeability reducing effect of quinazoline derivatives. <i>  WO 9722596 A1 970626</i>. CA 127:135808.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=%28a%29+Lohmann%2C+J.-J.+M.%3B+Hennequin%2C+L.+F.+A.%3B+Thomas%2C+A.+P.+Preparation+and+antiangiogenic+and%2For+vascular+permeability+reducing+effect+of+quinazoline+derivatives.+WO+9722596+A1+970626.+CA+127%3A135808.+%28a%29+Lohmann%2C+J.-J.+M.%3B+Hennequin%2C+L.+F.+A.%3B+Thomas%2C+A.+P.+Preparation+and+antiangiogenic+and%2For+vascular+permeability+reducing+effect+of+quinazoline+derivatives.+WO+9722596+A1+970626.+CA+127%3A135808."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00025_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dfootnote%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm011022eb00025_2"><span><span class="NLM_string-ref">(b) Thomas, A. P.; Hennequin, L. F. A.; Plé, P. A. Quinoline derivatives inhibiting the effect of growth factors such as VEGF. <i>  WO 9813350 A1 </i><i>980402. </i>CA 128:270546.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=%28b%29+Thomas%2C+A.+P.%3B+Hennequin%2C+L.+F.+A.%3B+Pl%C3%A9%2C+P.+A.+Quinoline+derivatives+inhibiting+the+effect+of+growth+factors+such+as+VEGF.+WO+9813350+A1+980402.+CA+128%3A270546.+%28b%29+Thomas%2C+A.+P.%3B+Hennequin%2C+L.+F.+A.%3B+Pl%C3%A9%2C+P.+A.+Quinoline+derivatives+inhibiting+the+effect+of+growth+factors+such+as+VEGF.+WO+9813350+A1+980402.+CA+128%3A270546."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00025_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dfootnote%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm011022eb00025_3"><span><span class="NLM_string-ref">(c) Thomas, A. P.; Hennequin, L. F. A.; Johnstone, C.; Stokes, E. S. E.; Lohmann, J.-J. M.; Clayton, E. Preparation of quinazoline derivatives and pharmaceuticals compositions containing them. <i>  WO 9813354 A1 980402.</i> CA 128:257441.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=%28c%29+Thomas%2C+A.+P.%3B+Hennequin%2C+L.+F.+A.%3B+Johnstone%2C+C.%3B+Stokes%2C+E.+S.+E.%3B+Lohmann%2C+J.-J.+M.%3B+Clayton%2C+E.+Preparation+of+quinazoline+derivatives+and+pharmaceuticals+compositions+containing+them.+WO+9813354+A1+980402.+CA+128%3A257441.+%28c%29+Thomas%2C+A.+P.%3B+Hennequin%2C+L.+F.+A.%3B+Johnstone%2C+C.%3B+Stokes%2C+E.+S.+E.%3B+Lohmann%2C+J.-J.+M.%3B+Clayton%2C+E.+Preparation+of+quinazoline+derivatives+and+pharmaceuticals+compositions+containing+them.+WO+9813354+A1+980402.+CA+128%3A257441."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00025_3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dfootnote%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm011022eb00025_4"><span><span class="NLM_string-ref">(d) Thomas, A. P.; Hennequin, L. F. A. Preparation of anilinocinnolines and related compounds as inhibitors of angiogenesis and vascular permeability. <i>  WO </i><i>9734876 A1 970925</i>. CA 127:307392.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=%28d%29+Thomas%2C+A.+P.%3B+Hennequin%2C+L.+F.+A.+Preparation+of+anilinocinnolines+and+related+compounds+as+inhibitors+of+angiogenesis+and+vascular+permeability.+WO+9734876+A1+970925.+CA+127%3A307392.+%28d%29+Thomas%2C+A.+P.%3B+Hennequin%2C+L.+F.+A.+Preparation+of+anilinocinnolines+and+related+compounds+as+inhibitors+of+angiogenesis+and+vascular+permeability.+WO+9734876+A1+970925.+CA+127%3A307392."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00025_4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dfootnote%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm011022eb00025_5"><span><span class="NLM_string-ref">(e) Thomas, A. P.; Hennequin, L. F. A.; Johnstone, C. Preparation of 4-anilinoquinazolines for use in the treatment of disease states associated with antiangiogenesis and/or increased vascular permeability. <i>  WO 9732856 A1 970912</i>. CA 127:278209.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=%28e%29+Thomas%2C+A.+P.%3B+Hennequin%2C+L.+F.+A.%3B+Johnstone%2C+C.+Preparation+of+4-anilinoquinazolines+for+use+in+the+treatment+of+disease+states+associated+with+antiangiogenesis+and%2For+increased+vascular+permeability.+WO+9732856+A1+970912.+CA+127%3A278209.+%28e%29+Thomas%2C+A.+P.%3B+Hennequin%2C+L.+F.+A.%3B+Johnstone%2C+C.+Preparation+of+4-anilinoquinazolines+for+use+in+the+treatment+of+disease+states+associated+with+antiangiogenesis+and%2For+increased+vascular+permeability.+WO+9732856+A1+970912.+CA+127%3A278209."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00025_5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dfootnote%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm011022eb00025_6"><span><span class="NLM_string-ref">(f) Thomas, A. P.; Johnstone, C.; Hennequin, L. F. A. Preparation of quinazolines as VEGF inhibitors. <i>  WO 9730035 A1 970821</i>. CA 127:262698.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=%28f%29+Thomas%2C+A.+P.%3B+Johnstone%2C+C.%3B+Hennequin%2C+L.+F.+A.+Preparation+of+quinazolines+as+VEGF+inhibitors.+WO+9730035+A1+970821.+CA+127%3A262698.+%28f%29+Thomas%2C+A.+P.%3B+Johnstone%2C+C.%3B+Hennequin%2C+L.+F.+A.+Preparation+of+quinazolines+as+VEGF+inhibitors.+WO+9730035+A1+970821.+CA+127%3A262698."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00025_6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dfootnote%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm011022eb00025_7"><span><span class="NLM_string-ref">(f) Hennequin, L. F.; Stokes, E. S. E.; Thomas, A. P. Preparation of 4-anilino-7-piperidinyloxyquinazolines as vascular endothelial growth factor inhibitors. <i>  WO 0132651 A1 20010510. </i>CA 134:353317.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=0510&publication_year=2001&pages=353317&author=L.+F.+Hennequin&author=E.+S.+E.+Stokes&author=A.+P+Thomas&title=Preparation+of+4-anilino-7-piperidinyloxyquinazolines+as+vascular+endothelial+growth+factor+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00025_7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHennequin%26aufirst%3DL.%2BF.%26atitle%3DPreparation%2520of%25204-anilino-7-piperidinyloxyquinazolines%2520as%2520vascular%2520endothelial%2520growth%2520factor%2520inhibitors%26jtitle%3DWO%25200132651%2520A1%26date%3D2001%26volume%3D0510%26spage%3D353317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm011022eb00026"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm011022eb00026'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="jm011022eb00026_1"><span><span class="NLM_string-ref">Wedge, S. R.; Ogilvie, D. J.; Dukes, M.; Kendrew, J.; Curwen, J. O.; Hennequin, L. F.; Stokes, E. S. E.; Curry, B.; Wadsworth, P. F.; Richmond, G. H. P. Pharmacological efficacy of ZD6474, a VEGF receptor tyrosine kinase inhibitor, in rat. Poster No. 3126, 92nd AACR meeting, New Orleans, 2001.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&conference=92nd+AACR+meeting&author=S.+R.+Wedge&author=D.+J.+Ogilvie&author=M.+Dukes&author=J.+Kendrew&author=J.+O.+Curwen&author=L.+F.+Hennequin&author=E.+S.+E.+Stokes&author=B.+Curry&author=P.+F.+Wadsworth&author=G.+H.+P.+Richmond&title=Pharmacological+efficacy+of+ZD6474%2C+a+VEGF+receptor+tyrosine+kinase+inhibitor%2C+in+rat.+Poster+No.+3126"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00026_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dproceeding%26sid%3Dliteratum%253Aachs%26aulast%3DWedge%26aufirst%3DS.%2BR.%26atitle%3DPharmacological%2520efficacy%2520of%2520ZD6474%252C%2520a%2520VEGF%2520receptor%2520tyrosine%2520kinase%2520inhibitor%252C%2520in%2520rat.%2520Poster%2520No.%25203126%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm011022eb00027"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm011022eb00027'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="jm011022eb00027_1"><span><span class="NLM_string-ref">Salvador, R. L.; Simon, D. A Study of the Mannich Reaction with Propargyl Alcohol. <i>  Can. J. Chem.</i><b>1966</b>, <i>44</i>, 2570−2575.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1966&pages=2575&author=R.+L.+Salvador&author=D+Simon&title=A+Study+of+the+Mannich+Reaction+with+Propargyl+Alcohol"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00027_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSalvador%26aufirst%3DR.%2BL.%26atitle%3DA%2520Study%2520of%2520the%2520Mannich%2520Reaction%2520with%2520Propargyl%2520Alcohol%26jtitle%3DCan.%2520J.%2520Chem.%26date%3D1966%26volume%3D44%26spage%3D2575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'jm011022eb00001':['jm011022eb00001_1'],'jm011022eb00002':['jm011022eb00002_1'],'jm011022eb00003':['jm011022eb00003_1'],'jm011022eb00004':['jm011022eb00004_1'],'jm011022eb00005':['jm011022eb00005_1'],'jm011022eb00006':['jm011022eb00006_1'],'jm011022eb00007':['jm011022eb00007_1'],'jm011022eb00008':['jm011022eb00008_1'],'jm011022eb00009':['jm011022eb00009_1'],'jm011022eb00010':['jm011022eb00010_1','jm011022eb00010_2','jm011022eb00010_3'],'jm011022eb00011':['jm011022eb00011_1','jm011022eb00011_2'],'jm011022eb00012':['jm011022eb00012_1'],'jm011022eb00013':['jm011022eb00013_1'],'jm011022eb00014':['jm011022eb00014_1'],'jm011022eb00015':['jm011022eb00015_1'],'jm011022eb00016':['jm011022eb00016_1'],'jm011022eb00017':['jm011022eb00017_1'],'jm011022eb00018':['jm011022eb00018_1'],'jm011022eb00019':['jm011022eb00019_1'],'jm011022eb00020':['jm011022eb00020_1'],'jm011022eb00021':['jm011022eb00021_1'],'jm011022eb00022':['jm011022eb00022_1'],'jm011022eb00023':['jm011022eb00023_1'],'jm011022eb00024':['jm011022eb00024_1'],'jm011022eb00025':['jm011022eb00025_1','jm011022eb00025_2','jm011022eb00025_3','jm011022eb00025_4','jm011022eb00025_5','jm011022eb00025_6','jm011022eb00025_7'],'jm011022eb00026':['jm011022eb00026_1'],'jm011022eb00027':['jm011022eb00027_1']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 217 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nathalie  Lagarde</span>, <span class="hlFld-ContribAuthor ">Jean-François  Zagury</span>, and <span class="hlFld-ContribAuthor ">Matthieu  Montes</span>  . </span><span class="cited-content_cbyCitation_article-title">Benchmarking Data Sets for the Evaluation of Virtual Ligand Screening Methods: Review and Perspectives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2015,</strong> <em>55 </em>
                                    (7)
                                     , 1297-1307. <a href="https://doi.org/10.1021/acs.jcim.5b00090" title="DOI URL">https://doi.org/10.1021/acs.jcim.5b00090</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.5b00090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.5b00090%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DBenchmarking%252BData%252BSets%252Bfor%252Bthe%252BEvaluation%252Bof%252BVirtual%252BLigand%252BScreening%252BMethods%25253A%252BReview%252Band%252BPerspectives%26aulast%3DLagarde%26aufirst%3DNathalie%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D17022015%26date%3D18062015%26date%3D27072015%26date%3D03062015%26volume%3D55%26issue%3D7%26spage%3D1297%26epage%3D1307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiang  Wang</span>, <span class="hlFld-ContribAuthor ">María  Sánchez-Roselló</span>, <span class="hlFld-ContribAuthor ">José Luis  Aceña</span>, <span class="hlFld-ContribAuthor ">Carlos  del Pozo</span>, <span class="hlFld-ContribAuthor ">Alexander E.  Sorochinsky</span>, <span class="hlFld-ContribAuthor ">Santos  Fustero</span>, <span class="hlFld-ContribAuthor ">Vadim A.  Soloshonok</span>, and <span class="hlFld-ContribAuthor ">Hong  Liu</span>  . </span><span class="cited-content_cbyCitation_article-title">Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011). </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2014,</strong> <em>114 </em>
                                    (4)
                                     , 2432-2506. <a href="https://doi.org/10.1021/cr4002879" title="DOI URL">https://doi.org/10.1021/cr4002879</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cr4002879&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcr4002879%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DFluorine%252Bin%252BPharmaceutical%252BIndustry%25253A%252BFluorine-Containing%252BDrugs%252BIntroduced%252Bto%252Bthe%252BMarket%252Bin%252Bthe%252BLast%252BDecade%252B%2525282001%2525E2%252580%2525932011%252529%26aulast%3DWang%26aufirst%3DJiang%26date%3D2014%26date%3D2013%26date%3D2013%26date%3D27052013%26date%3D03122013%26date%3D26022014%26volume%3D114%26issue%3D4%26spage%3D2432%26epage%3D2506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jean-Christophe  Harmange</span>, <span class="hlFld-ContribAuthor ">Matthew M.  Weiss</span>, <span class="hlFld-ContribAuthor ">Julie  Germain</span>, <span class="hlFld-ContribAuthor ">Anthony J.  Polverino</span>, <span class="hlFld-ContribAuthor ">George  Borg</span>, <span class="hlFld-ContribAuthor ">James  Bready</span>, <span class="hlFld-ContribAuthor ">Danlin  Chen</span>, <span class="hlFld-ContribAuthor ">Deborah  Choquette</span>, <span class="hlFld-ContribAuthor ">Angela  Coxon</span>, <span class="hlFld-ContribAuthor ">Tom  DeMelfi</span>, <span class="hlFld-ContribAuthor ">Lucian  DiPietro</span>, <span class="hlFld-ContribAuthor ">Nicholas  Doerr</span>, <span class="hlFld-ContribAuthor ">Juan  Estrada</span>, <span class="hlFld-ContribAuthor ">Julie  Flynn</span>, <span class="hlFld-ContribAuthor ">Russell F.  Graceffa</span>, <span class="hlFld-ContribAuthor ">Shawn P.  Harriman</span>, <span class="hlFld-ContribAuthor ">Stephen  Kaufman</span>, <span class="hlFld-ContribAuthor ">Daniel S.  La</span>, <span class="hlFld-ContribAuthor ">Alexander  Long</span>, <span class="hlFld-ContribAuthor ">Matthew W.  Martin</span>, <span class="hlFld-ContribAuthor ">Sesha  Neervannan</span>, <span class="hlFld-ContribAuthor ">Vinod F.  Patel</span>, <span class="hlFld-ContribAuthor ">Michele  Potashman</span>, <span class="hlFld-ContribAuthor ">Kelly  Regal</span>, <span class="hlFld-ContribAuthor ">Phillip M.  Roveto</span>, <span class="hlFld-ContribAuthor ">Michael L.  Schrag</span>, <span class="hlFld-ContribAuthor ">Charlie  Starnes</span>, <span class="hlFld-ContribAuthor ">Andrew  Tasker</span>, <span class="hlFld-ContribAuthor ">Yohannes  Teffera</span>, <span class="hlFld-ContribAuthor ">Ling  Wang</span>, <span class="hlFld-ContribAuthor ">Ryan D.  White</span>, <span class="hlFld-ContribAuthor ">Douglas A.  Whittington</span> and <span class="hlFld-ContribAuthor ">Roger  Zanon</span>. </span><span class="cited-content_cbyCitation_article-title">Naphthamides as Novel and Potent Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors: Design, Synthesis, and Evaluation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2008,</strong> <em>51 </em>
                                    (6)
                                     , 1649-1667. <a href="https://doi.org/10.1021/jm701097z" title="DOI URL">https://doi.org/10.1021/jm701097z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm701097z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm701097z%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNaphthamides%252Bas%252BNovel%252Band%252BPotent%252BVascular%252BEndothelial%252BGrowth%252BFactor%252BReceptor%252BTyrosine%252BKinase%252BInhibitors%25253A%252BDesign%25252C%252BSynthesis%25252C%252Band%252BEvaluation%26aulast%3DHarmange%26aufirst%3DJean-Christophe%26date%3D2008%26date%3D2008%26date%3D2007%26date%3D27%252003%25202008%26date%3D07%252003%25202008%26date%3D04%252009%25202007%26volume%3D51%26issue%3D6%26spage%3D1649%26epage%3D1667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew M.  Weiss</span>, <span class="hlFld-ContribAuthor ">Jean-Christophe  Harmange</span>, <span class="hlFld-ContribAuthor ">Anthony J.  Polverino</span>, <span class="hlFld-ContribAuthor ">David  Bauer</span>, <span class="hlFld-ContribAuthor ">Loren  Berry</span>, <span class="hlFld-ContribAuthor ">Virginia  Berry</span>, <span class="hlFld-ContribAuthor ">George  Borg</span>, <span class="hlFld-ContribAuthor ">James  Bready</span>, <span class="hlFld-ContribAuthor ">Danlin  Chen</span>, <span class="hlFld-ContribAuthor ">Deborah  Choquette</span>, <span class="hlFld-ContribAuthor ">Angela  Coxon</span>, <span class="hlFld-ContribAuthor ">Tom  DeMelfi</span>, <span class="hlFld-ContribAuthor ">Nicholas  Doerr</span>, <span class="hlFld-ContribAuthor ">Juan  Estrada</span>, <span class="hlFld-ContribAuthor ">Julie  Flynn</span>, <span class="hlFld-ContribAuthor ">Russell F.  Graceffa</span>, <span class="hlFld-ContribAuthor ">Shawn P.  Harriman</span>, <span class="hlFld-ContribAuthor ">Stephen  Kaufman</span>, <span class="hlFld-ContribAuthor ">Daniel S.  La</span>, <span class="hlFld-ContribAuthor ">Alexander  Long</span>, <span class="hlFld-ContribAuthor ">Sesha  Neervannan</span>, <span class="hlFld-ContribAuthor ">Vinod F.  Patel</span>, <span class="hlFld-ContribAuthor ">Michele  Potashman</span>, <span class="hlFld-ContribAuthor ">Kelly  Regal</span>, <span class="hlFld-ContribAuthor ">Phillip M.  Roveto</span>, <span class="hlFld-ContribAuthor ">Michael L.  Schrag</span>, <span class="hlFld-ContribAuthor ">Charlie  Starnes</span>, <span class="hlFld-ContribAuthor ">Andrew  Tasker</span>, <span class="hlFld-ContribAuthor ">Yohannes  Teffera</span>, <span class="hlFld-ContribAuthor ">Douglas A.  Whittington</span> and <span class="hlFld-ContribAuthor ">Roger  Zanon</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of a Series of Naphthamides as Potent, Orally Active Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2008,</strong> <em>51 </em>
                                    (6)
                                     , 1668-1680. <a href="https://doi.org/10.1021/jm701098w" title="DOI URL">https://doi.org/10.1021/jm701098w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm701098w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm701098w%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DEvaluation%252Bof%252Ba%252BSeries%252Bof%252BNaphthamides%252Bas%252BPotent%25252C%252BOrally%252BActive%252BVascular%252BEndothelial%252BGrowth%252BFactor%252BReceptor-2%252BTyrosine%252BKinase%252BInhibitors%26aulast%3DWeiss%26aufirst%3DMatthew%2BM.%26date%3D2008%26date%3D2008%26date%3D2007%26date%3D27%252003%25202008%26date%3D07%252003%25202008%26date%3D04%252009%25202007%26volume%3D51%26issue%3D6%26spage%3D1668%26epage%3D1680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel S.  La</span>, <span class="hlFld-ContribAuthor ">Julie  Belzile</span>, <span class="hlFld-ContribAuthor ">James V.  Bready</span>, <span class="hlFld-ContribAuthor ">Angela  Coxon</span>, <span class="hlFld-ContribAuthor ">Thomas  DeMelfi</span>, <span class="hlFld-ContribAuthor ">Nicholas  Doerr</span>, <span class="hlFld-ContribAuthor ">Juan  Estrada</span>, <span class="hlFld-ContribAuthor ">Julie C.  Flynn</span>, <span class="hlFld-ContribAuthor ">Shaun R.  Flynn</span>, <span class="hlFld-ContribAuthor ">Russell F.  Graceffa</span>, <span class="hlFld-ContribAuthor ">Shawn P.  Harriman</span>, <span class="hlFld-ContribAuthor ">Jay F.  Larrow</span>, <span class="hlFld-ContribAuthor ">Alexander M.  Long</span>, <span class="hlFld-ContribAuthor ">Matthew W.  Martin</span>, <span class="hlFld-ContribAuthor ">Michael J.  Morrison</span>, <span class="hlFld-ContribAuthor ">Vinod F.  Patel</span>, <span class="hlFld-ContribAuthor ">Philip M.  Roveto</span>, <span class="hlFld-ContribAuthor ">Ling  Wang</span>, <span class="hlFld-ContribAuthor ">Matthew M.  Weiss</span>, <span class="hlFld-ContribAuthor ">Douglas A.  Whittington</span>, <span class="hlFld-ContribAuthor ">Yohannes  Teffera</span>, <span class="hlFld-ContribAuthor ">Zhiyang  Zhao</span>, <span class="hlFld-ContribAuthor ">Anthony J.  Polverino</span> and <span class="hlFld-ContribAuthor ">Jean-Christophe  Harmange</span>. </span><span class="cited-content_cbyCitation_article-title">Novel 2,3-Dihydro-1,4-Benzoxazines as Potent and Orally Bioavailable Inhibitors of Tumor-Driven Angiogenesis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2008,</strong> <em>51 </em>
                                    (6)
                                     , 1695-1705. <a href="https://doi.org/10.1021/jm701129j" title="DOI URL">https://doi.org/10.1021/jm701129j</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm701129j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm701129j%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252B2%25252C3-Dihydro-1%25252C4-Benzoxazines%252Bas%252BPotent%252Band%252BOrally%252BBioavailable%252BInhibitors%252Bof%252BTumor-Driven%252BAngiogenesis%26aulast%3DLa%26aufirst%3DDaniel%2BS.%26date%3D2008%26date%3D2008%26date%3D2007%26date%3D27%252003%25202008%26date%3D27%252002%25202008%26date%3D11%252009%25202007%26volume%3D51%26issue%3D6%26spage%3D1695%26epage%3D1705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Konstantine A.  Kislyi,,   Alexander V.  Samet,,   Yuri A.  Strelenko, and,   <span class="NLM_string-name hlFld-ContribAuthor">Victor V.  Semenov</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic Utilization of Polynitroaromatic Compounds. 6. Remarkable Regioselectivity in Nucleophilic Displacement of Aromatic Nitro Groups with Amines. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2008,</strong> <em>73 </em>
                                    (6)
                                     , 2285-2291. <a href="https://doi.org/10.1021/jo702532x" title="DOI URL">https://doi.org/10.1021/jo702532x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo702532x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo702532x%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthetic%252BUtilization%252Bof%252BPolynitroaromatic%252BCompounds.%252B6.%252BRemarkable%252BRegioselectivity%252Bin%252BNucleophilic%252BDisplacement%252Bof%252BAromatic%252BNitro%252BGroups%252Bwith%252BAmines%26aulast%3DKislyi%26aufirst%3DKonstantine%2BA.%26date%3D2008%26date%3D2008%26date%3D2007%26date%3D26%252011%25202007%2520Received%2520November%252026%252C%25202007%26volume%3D73%26issue%3D6%26spage%3D2285%26epage%3D2291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jillian Hattaway  Luttman</span>, <span class="hlFld-ContribAuthor ">Ashley  Colemon</span>, <span class="hlFld-ContribAuthor ">Benjamin  Mayro</span>, <span class="hlFld-ContribAuthor ">Ann Marie  Pendergast</span>. </span><span class="cited-content_cbyCitation_article-title">Role of the ABL tyrosine kinases in the epithelial–mesenchymal transition and the metastatic cascade. </span><span class="cited-content_cbyCitation_journal-name">Cell Communication and Signaling</span><span> <strong>2021,</strong> <em>19 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12964-021-00739-6" title="DOI URL">https://doi.org/10.1186/s12964-021-00739-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12964-021-00739-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12964-021-00739-6%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Communication%2520and%2520Signaling%26atitle%3DRole%252Bof%252Bthe%252BABL%252Btyrosine%252Bkinases%252Bin%252Bthe%252Bepithelial%2525E2%252580%252593mesenchymal%252Btransition%252Band%252Bthe%252Bmetastatic%252Bcascade%26aulast%3DLuttman%26aufirst%3DJillian%2BHattaway%26date%3D2021%26date%3D2021%26volume%3D19%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Shi</span>. </span><span class="cited-content_cbyCitation_article-title">Angiogenesis Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-66. <a href="https://doi.org/10.1002/0471266949.bmc271" title="DOI URL">https://doi.org/10.1002/0471266949.bmc271</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc271&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc271%26sid%3Dliteratum%253Aachs%26atitle%3DAngiogenesis%252BInhibitors%26aulast%3DShi%26aufirst%3DLei%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D66%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mingfeng  Yu</span>, <span class="hlFld-ContribAuthor ">Solomon  Tadesse</span>, <span class="hlFld-ContribAuthor ">Shudong  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">US FDA‐Approved Small‐Molecule Kinase Inhibitors for Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-65. <a href="https://doi.org/10.1002/0471266949.bmc214.pub2" title="DOI URL">https://doi.org/10.1002/0471266949.bmc214.pub2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc214.pub2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc214.pub2%26sid%3Dliteratum%253Aachs%26atitle%3DUS%252BFDA%2525E2%252580%252590Approved%252BSmall%2525E2%252580%252590Molecule%252BKinase%252BInhibitors%252Bfor%252BCancer%252BTherapy%26aulast%3DYu%26aufirst%3DMingfeng%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D65%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vakhid А.  Mamedov</span>, <span class="hlFld-ContribAuthor ">Nataliya А.  Zhukova</span>, <span class="hlFld-ContribAuthor ">Milyausha S.  Kadyrova</span>. </span><span class="cited-content_cbyCitation_article-title">The Dimroth Rearrangement in the Synthesis of Condensed Pyrimidines – Structural Analogs of Antiviral Compounds. </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2021,</strong> <em>57 </em>
                                    (4)
                                     , 342-368. <a href="https://doi.org/10.1007/s10593-021-02913-7" title="DOI URL">https://doi.org/10.1007/s10593-021-02913-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-021-02913-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-021-02913-7%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3DThe%252BDimroth%252BRearrangement%252Bin%252Bthe%252BSynthesis%252Bof%252BCondensed%252BPyrimidines%252B%2525E2%252580%252593%252BStructural%252BAnalogs%252Bof%252BAntiviral%252BCompounds%26aulast%3DMamedov%26aufirst%3DVakhid%2B%25D0%2590.%26date%3D2021%26date%3D2021%26volume%3D57%26issue%3D4%26spage%3D342%26epage%3D368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuai  Wang</span>, <span class="hlFld-ContribAuthor ">Xiao-Han  Yuan</span>, <span class="hlFld-ContribAuthor ">Sai-Qi  Wang</span>, <span class="hlFld-ContribAuthor ">Wen  Zhao</span>, <span class="hlFld-ContribAuthor ">Xiao-Bing  Chen</span>, <span class="hlFld-ContribAuthor ">Bin  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">FDA-approved pyrimidine-fused bicyclic heterocycles for cancer therapy: Synthesis and clinical application. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>214 </em>, 113218. <a href="https://doi.org/10.1016/j.ejmech.2021.113218" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113218</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113218%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFDA-approved%252Bpyrimidine-fused%252Bbicyclic%252Bheterocycles%252Bfor%252Bcancer%252Btherapy%25253A%252BSynthesis%252Band%252Bclinical%252Bapplication%26aulast%3DWang%26aufirst%3DShuai%26date%3D2021%26volume%3D214%26spage%3D113218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fatemeh  Azmian Moghadam</span>, <span class="hlFld-ContribAuthor ">Mehdi  Evazalipour</span>, <span class="hlFld-ContribAuthor ">Hassan  Kefayati</span>, <span class="hlFld-ContribAuthor ">Saeed  Ghasemi</span>. </span><span class="cited-content_cbyCitation_article-title">6,7-Disubstituted-4-anilinoquinazoline: Design, Synthesis and Anticancer Activity as a Novel Series of Potent Anticancer Agents. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutical Sciences</span><span> <strong>2020,</strong> <em>27 </em>
                                    (2)
                                     , 209-218. <a href="https://doi.org/10.34172/PS.2020.72" title="DOI URL">https://doi.org/10.34172/PS.2020.72</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.34172/PS.2020.72&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.34172%2FPS.2020.72%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutical%2520Sciences%26atitle%3D6%25252C7-Disubstituted-4-anilinoquinazoline%25253A%252BDesign%25252C%252BSynthesis%252Band%252BAnticancer%252BActivity%252Bas%252Ba%252BNovel%252BSeries%252Bof%252BPotent%252BAnticancer%252BAgents%26aulast%3DAzmian%2BMoghadam%26aufirst%3DFatemeh%26date%3D2020%26date%3D2020%26volume%3D27%26issue%3D2%26spage%3D209%26epage%3D218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Teresa  Żołek</span>, <span class="hlFld-ContribAuthor ">Aleksandra  Trzeciak</span>, <span class="hlFld-ContribAuthor ">Dorota  Maciejewska</span>. </span><span class="cited-content_cbyCitation_article-title">Theoretical evaluation of EGFR kinase inhibition and toxicity of di-indol-3-yl disulphides with anti-cancer potency. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2020,</strong> <em>13 </em>, 1-13. <a href="https://doi.org/10.1080/07391102.2020.1815576" title="DOI URL">https://doi.org/10.1080/07391102.2020.1815576</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2020.1815576&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2020.1815576%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DTheoretical%252Bevaluation%252Bof%252BEGFR%252Bkinase%252Binhibition%252Band%252Btoxicity%252Bof%252Bdi-indol-3-yl%252Bdisulphides%252Bwith%252Banti-cancer%252Bpotency%26aulast%3D%25C5%25BBo%25C5%2582ek%26aufirst%3DTeresa%26date%3D2020%26date%3D2020%26volume%3D13%26spage%3D1%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">Pharmacokinetics (
              ADME
              ). </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 133-224. <a href="https://doi.org/10.1002/9781119607311.ch3" title="DOI URL">https://doi.org/10.1002/9781119607311.ch3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781119607311.ch3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781119607311.ch3%26sid%3Dliteratum%253Aachs%26atitle%3DPharmacokinetics%252B%252528%252BADME%252B%252529%26date%3D2020%26date%3D2020%26spage%3D133%26epage%3D224%26pub%3DWiley%26atitle%3DMedicinal%252BChemistry%252Bfor%252BPractitioners%26aulast%3DLi%26aufirst%3DJie%2BJack%26date%3D2020%26date%3D2020%26volume%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roberto  Ria</span>, <span class="hlFld-ContribAuthor ">Assunta  Melaccio</span>, <span class="hlFld-ContribAuthor ">Vito  Racanelli</span>, <span class="hlFld-ContribAuthor ">Angelo  Vacca</span>. </span><span class="cited-content_cbyCitation_article-title">Anti-VEGF Drugs in the Treatment of Multiple Myeloma Patients. </span><span class="cited-content_cbyCitation_journal-name">Journal of Clinical Medicine</span><span> <strong>2020,</strong> <em>9 </em>
                                    (6)
                                     , 1765. <a href="https://doi.org/10.3390/jcm9061765" title="DOI URL">https://doi.org/10.3390/jcm9061765</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/jcm9061765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fjcm9061765%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Clinical%2520Medicine%26atitle%3DAnti-VEGF%252BDrugs%252Bin%252Bthe%252BTreatment%252Bof%252BMultiple%252BMyeloma%252BPatients%26aulast%3DRia%26aufirst%3DRoberto%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D6%26spage%3D1765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Radek  Indra</span>, <span class="hlFld-ContribAuthor ">Petr  Pompach</span>, <span class="hlFld-ContribAuthor ">Katarína  Vavrová</span>, <span class="hlFld-ContribAuthor ">Kateřina  Jáklová</span>, <span class="hlFld-ContribAuthor ">Zbyněk  Heger</span>, <span class="hlFld-ContribAuthor ">Vojtěch  Adam</span>, <span class="hlFld-ContribAuthor ">Tomáš  Eckschlager</span>, <span class="hlFld-ContribAuthor ">Kateřina  Kopečková</span>, <span class="hlFld-ContribAuthor ">Volker Manfred  Arlt</span>, <span class="hlFld-ContribAuthor ">Marie  Stiborová</span>. </span><span class="cited-content_cbyCitation_article-title">Cytochrome P450 and flavin-containing monooxygenase enzymes are responsible for differential oxidation of the anti-thyroid-cancer drug vandetanib by human and rat hepatic microsomal systems. </span><span class="cited-content_cbyCitation_journal-name">Environmental Toxicology and Pharmacology</span><span> <strong>2020,</strong> <em>74 </em>, 103310. <a href="https://doi.org/10.1016/j.etap.2019.103310" title="DOI URL">https://doi.org/10.1016/j.etap.2019.103310</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.etap.2019.103310&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.etap.2019.103310%26sid%3Dliteratum%253Aachs%26jtitle%3DEnvironmental%2520Toxicology%2520and%2520Pharmacology%26atitle%3DCytochrome%252BP450%252Band%252Bflavin-containing%252Bmonooxygenase%252Benzymes%252Bare%252Bresponsible%252Bfor%252Bdifferential%252Boxidation%252Bof%252Bthe%252Banti-thyroid-cancer%252Bdrug%252Bvandetanib%252Bby%252Bhuman%252Band%252Brat%252Bhepatic%252Bmicrosomal%252Bsystems%26aulast%3DIndra%26aufirst%3DRadek%26date%3D2020%26volume%3D74%26spage%3D103310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoming  Ma</span>, <span class="hlFld-ContribAuthor ">Xiaofeng  Zhang</span>, <span class="hlFld-ContribAuthor ">John Mark  Awad</span>, <span class="hlFld-ContribAuthor ">Guoshu  Xie</span>, <span class="hlFld-ContribAuthor ">Weiqi  Qiu</span>, <span class="hlFld-ContribAuthor ">Rachel E.  Muriph</span>, <span class="hlFld-ContribAuthor ">Wei  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Sequential decarboxylative [3+2] cycloaddition and Staudinger/aza-Wittig reactions for diastereoselective synthesis of tetrahydro-pyrroloquinazolines and tetrahedro-pyrrolobenzodiazepines. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2020,</strong> <em>61 </em>
                                    (2)
                                     , 151392. <a href="https://doi.org/10.1016/j.tetlet.2019.151392" title="DOI URL">https://doi.org/10.1016/j.tetlet.2019.151392</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2019.151392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2019.151392%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DSequential%252Bdecarboxylative%252B%25255B3%25252B2%25255D%252Bcycloaddition%252Band%252BStaudinger%25252Faza-Wittig%252Breactions%252Bfor%252Bdiastereoselective%252Bsynthesis%252Bof%252Btetrahydro-pyrroloquinazolines%252Band%252Btetrahedro-pyrrolobenzodiazepines%26aulast%3DMa%26aufirst%3DXiaoming%26date%3D2020%26volume%3D61%26issue%3D2%26spage%3D151392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Huiqiang  Wei</span>, <span class="hlFld-ContribAuthor ">Yuqing  Duan</span>, <span class="hlFld-ContribAuthor ">Wenfeng  Gou</span>, <span class="hlFld-ContribAuthor ">Jie  Cui</span>, <span class="hlFld-ContribAuthor ">Hongxin  Ning</span>, <span class="hlFld-ContribAuthor ">Deguan  Li</span>, <span class="hlFld-ContribAuthor ">Yong  Qin</span>, <span class="hlFld-ContribAuthor ">Qiang  Liu</span>, <span class="hlFld-ContribAuthor ">Yiliang  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel 4-anilinoquinazoline derivatives as hypoxia-selective EGFR and VEGFR-2 dual inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>181 </em>, 111552. <a href="https://doi.org/10.1016/j.ejmech.2019.07.055" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.07.055</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.07.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.07.055%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252B4-anilinoquinazoline%252Bderivatives%252Bas%252Bhypoxia-selective%252BEGFR%252Band%252BVEGFR-2%252Bdual%252Binhibitors%26aulast%3DWei%26aufirst%3DHuiqiang%26date%3D2019%26volume%3D181%26spage%3D111552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mossenta</span>, <span class="hlFld-ContribAuthor ">Busato</span>, <span class="hlFld-ContribAuthor ">Baboci</span>, <span class="hlFld-ContribAuthor ">Cintio</span>, <span class="hlFld-ContribAuthor ">Toffoli</span>, <span class="hlFld-ContribAuthor ">Bo</span>. </span><span class="cited-content_cbyCitation_article-title">New Insight into Therapies Targeting Angiogenesis in Hepatocellular Carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2019,</strong> <em>11 </em>
                                    (8)
                                     , 1086. <a href="https://doi.org/10.3390/cancers11081086" title="DOI URL">https://doi.org/10.3390/cancers11081086</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers11081086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers11081086%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DNew%252BInsight%252Binto%252BTherapies%252BTargeting%252BAngiogenesis%252Bin%252BHepatocellular%252BCarcinoma%26aulast%3DMossenta%26date%3D2019%26date%3D2019%26volume%3D11%26issue%3D8%26spage%3D1086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Radek  Indra</span>, <span class="hlFld-ContribAuthor ">Petr  Pompach</span>, <span class="hlFld-ContribAuthor ">Václav  Martínek</span>, <span class="hlFld-ContribAuthor ">Paulína  Takácsová</span>, <span class="hlFld-ContribAuthor ">Katarína  Vavrová</span>, <span class="hlFld-ContribAuthor ">Zbyněk  Heger</span>, <span class="hlFld-ContribAuthor ">Vojtěch  Adam</span>, <span class="hlFld-ContribAuthor ">Tomáš  Eckschlager</span>, <span class="hlFld-ContribAuthor ">Kateřina  Kopečková</span>, <span class="hlFld-ContribAuthor ">Volker Manfred  Arlt</span>, <span class="hlFld-ContribAuthor ">Marie  Stiborová</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of Human Enzymes Oxidizing the Anti-Thyroid-Cancer Drug Vandetanib and Explanation of the High Efficiency of Cytochrome P450 3A4 in its Oxidation. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2019,</strong> <em>20 </em>
                                    (14)
                                     , 3392. <a href="https://doi.org/10.3390/ijms20143392" title="DOI URL">https://doi.org/10.3390/ijms20143392</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms20143392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms20143392%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DIdentification%252Bof%252BHuman%252BEnzymes%252BOxidizing%252Bthe%252BAnti-Thyroid-Cancer%252BDrug%252BVandetanib%252Band%252BExplanation%252Bof%252Bthe%252BHigh%252BEfficiency%252Bof%252BCytochrome%252BP450%252B3A4%252Bin%252Bits%252BOxidation%26aulast%3DIndra%26aufirst%3DRadek%26date%3D2019%26date%3D2019%26volume%3D20%26issue%3D14%26spage%3D3392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Khalil  Miloudi</span>, <span class="hlFld-ContribAuthor ">Malika  Oubaha</span>, <span class="hlFld-ContribAuthor ">Catherine  Ménard</span>, <span class="hlFld-ContribAuthor ">Agnieszka  Dejda</span>, <span class="hlFld-ContribAuthor ">Vera  Guber</span>, <span class="hlFld-ContribAuthor ">Gael  Cagnone</span>, <span class="hlFld-ContribAuthor ">Ariel M.  Wilson</span>, <span class="hlFld-ContribAuthor ">Nicolas  Tétreault</span>, <span class="hlFld-ContribAuthor ">Gaëlle  Mawambo</span>, <span class="hlFld-ContribAuthor ">Francois  Binet</span>, <span class="hlFld-ContribAuthor ">Rony  Chidiac</span>, <span class="hlFld-ContribAuthor ">Chantal  Delisle</span>, <span class="hlFld-ContribAuthor ">Manuel  Buscarlet</span>, <span class="hlFld-ContribAuthor ">Agustin  Cerani</span>, <span class="hlFld-ContribAuthor ">Sergio  Crespo-Garcia</span>, <span class="hlFld-ContribAuthor ">Katie  Bentley</span>, <span class="hlFld-ContribAuthor ">Flavio  Rezende</span>, <span class="hlFld-ContribAuthor ">Jean-Sebastien  Joyal</span>, <span class="hlFld-ContribAuthor ">Frédérick A.  Mallette</span>, <span class="hlFld-ContribAuthor ">Jean-Philippe  Gratton</span>, <span class="hlFld-ContribAuthor ">Bruno  Larrivée</span>, <span class="hlFld-ContribAuthor ">Przemyslaw  Sapieha</span>. </span><span class="cited-content_cbyCitation_article-title">NOTCH1 signaling induces pathological vascular permeability in diabetic retinopathy. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2019,</strong> <em>116 </em>
                                    (10)
                                     , 4538-4547. <a href="https://doi.org/10.1073/pnas.1814711116" title="DOI URL">https://doi.org/10.1073/pnas.1814711116</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.1814711116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.1814711116%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DNOTCH1%252Bsignaling%252Binduces%252Bpathological%252Bvascular%252Bpermeability%252Bin%252Bdiabetic%252Bretinopathy%26aulast%3DMiloudi%26aufirst%3DKhalil%26date%3D2019%26date%3D2019%26volume%3D116%26issue%3D10%26spage%3D4538%26epage%3D4547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">T.  Tegnebratt</span>, <span class="hlFld-ContribAuthor ">L.  Lu</span>, <span class="hlFld-ContribAuthor ">S.  Eksborg</span>, <span class="hlFld-ContribAuthor ">A.  Chireh</span>, <span class="hlFld-ContribAuthor ">P.  Damberg</span>, <span class="hlFld-ContribAuthor ">S.  Nikkhou-Aski</span>, <span class="hlFld-ContribAuthor ">T.  Foukakis</span>, <span class="hlFld-ContribAuthor ">H.  Rundqvist</span>, <span class="hlFld-ContribAuthor ">S.  Holmin</span>, <span class="hlFld-ContribAuthor ">R. V.  Kuiper</span>, <span class="hlFld-ContribAuthor ">E.  Samen</span>. </span><span class="cited-content_cbyCitation_article-title">Treatment response assessment with (R)-[11CPAQ PET in the MMTV-PyMT mouse model of breast cancer. </span><span class="cited-content_cbyCitation_journal-name">EJNMMI Research</span><span> <strong>2018,</strong> <em>8 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13550-018-0380-x" title="DOI URL">https://doi.org/10.1186/s13550-018-0380-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13550-018-0380-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13550-018-0380-x%26sid%3Dliteratum%253Aachs%26jtitle%3DEJNMMI%2520Research%26atitle%3DTreatment%252Bresponse%252Bassessment%252Bwith%252B%252528R%252529-%25255B11CPAQ%252BPET%252Bin%252Bthe%252BMMTV-PyMT%252Bmouse%252Bmodel%252Bof%252Bbreast%252Bcancer%26aulast%3DTegnebratt%26aufirst%3DT.%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hyang-Ae  Lee</span>, <span class="hlFld-ContribAuthor ">Sung-Ae  Hyun</span>, <span class="hlFld-ContribAuthor ">Byungjin  Byun</span>, <span class="hlFld-ContribAuthor ">Jong-Hak  Chae</span>, <span class="hlFld-ContribAuthor ">Ki-Suk  Kim</span>, . </span><span class="cited-content_cbyCitation_article-title">Electrophysiological mechanisms of vandetanib-induced cardiotoxicity: Comparison of action potentials in rabbit Purkinje fibers and pluripotent stem cell-derived cardiomyocytes. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2018,</strong> <em>13 </em>
                                    (4)
                                     , e0195577. <a href="https://doi.org/10.1371/journal.pone.0195577" title="DOI URL">https://doi.org/10.1371/journal.pone.0195577</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0195577&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0195577%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DElectrophysiological%252Bmechanisms%252Bof%252Bvandetanib-induced%252Bcardiotoxicity%25253A%252BComparison%252Bof%252Baction%252Bpotentials%252Bin%252Brabbit%252BPurkinje%252Bfibers%252Band%252Bpluripotent%252Bstem%252Bcell-derived%252Bcardiomyocytes%26aulast%3DLee%26aufirst%3DHyang-Ae%26date%3D2018%26date%3D2018%26volume%3D13%26issue%3D4%26spage%3De0195577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu-Jen  Chiu</span>, <span class="hlFld-ContribAuthor ">Mann-Jen  Hour</span>, <span class="hlFld-ContribAuthor ">Yi-An  Jin</span>, <span class="hlFld-ContribAuthor ">Chi-Cheng  Lu</span>, <span class="hlFld-ContribAuthor ">Fuu-Jen  Tsai</span>, <span class="hlFld-ContribAuthor ">Tai-Lin  Chen</span>, <span class="hlFld-ContribAuthor ">Hsu  Ma</span>, <span class="hlFld-ContribAuthor ">Yu-Ning  Juan</span>, <span class="hlFld-ContribAuthor ">Jai-Sing  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Disruption of IGF‑1R signaling by a novel quinazoline derivative, HMJ‑30, inhibits invasiveness and reverses epithelial-mesenchymal transition in osteosarcoma U‑2 OS cells. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Oncology</span><span> <strong>2018,</strong> <em> </em><a href="https://doi.org/10.3892/ijo.2018.4325" title="DOI URL">https://doi.org/10.3892/ijo.2018.4325</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3892/ijo.2018.4325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3892%2Fijo.2018.4325%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Oncology%26atitle%3DDisruption%252Bof%252BIGF%2525E2%252580%2525911R%252Bsignaling%252Bby%252Ba%252Bnovel%252Bquinazoline%252Bderivative%25252C%252BHMJ%2525E2%252580%25259130%25252C%252Binhibits%252Binvasiveness%252Band%252Breverses%252Bepithelial-mesenchymal%252Btransition%252Bin%252Bosteosarcoma%252BU%2525E2%252580%2525912%252BOS%252Bcells%26aulast%3DChiu%26aufirst%3DYu-Jen%26date%3D2018%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ira L.  Kraft</span>, <span class="hlFld-ContribAuthor ">Srivandana  Akshintala</span>, <span class="hlFld-ContribAuthor ">Yuelin  Zhu</span>, <span class="hlFld-ContribAuthor ">Haiyan  Lei</span>, <span class="hlFld-ContribAuthor ">Claudia  Derse-Anthony</span>, <span class="hlFld-ContribAuthor ">Eva  Dombi</span>, <span class="hlFld-ContribAuthor ">Seth M.  Steinberg</span>, <span class="hlFld-ContribAuthor ">Maya  Lodish</span>, <span class="hlFld-ContribAuthor ">Steven G.  Waguespack</span>, <span class="hlFld-ContribAuthor ">Oxana  Kapustina</span>, <span class="hlFld-ContribAuthor ">Elizabeth  Fox</span>, <span class="hlFld-ContribAuthor ">Frank M.  Balis</span>, <span class="hlFld-ContribAuthor ">Maria J.  Merino</span>, <span class="hlFld-ContribAuthor ">Paul S.  Meltzer</span>, <span class="hlFld-ContribAuthor ">John W.  Glod</span>, <span class="hlFld-ContribAuthor ">Jack F.  Shern</span>, <span class="hlFld-ContribAuthor ">Brigitte C.  Widemann</span>. </span><span class="cited-content_cbyCitation_article-title">Outcomes of Children and Adolescents with Advanced Hereditary Medullary Thyroid Carcinoma Treated with Vandetanib. </span><span class="cited-content_cbyCitation_journal-name">Clinical Cancer Research</span><span> <strong>2018,</strong> <em>24 </em>
                                    (4)
                                     , 753-765. <a href="https://doi.org/10.1158/1078-0432.CCR-17-2101" title="DOI URL">https://doi.org/10.1158/1078-0432.CCR-17-2101</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1078-0432.CCR-17-2101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1078-0432.CCR-17-2101%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Cancer%2520Research%26atitle%3DOutcomes%252Bof%252BChildren%252Band%252BAdolescents%252Bwith%252BAdvanced%252BHereditary%252BMedullary%252BThyroid%252BCarcinoma%252BTreated%252Bwith%252BVandetanib%26aulast%3DKraft%26aufirst%3DIra%2BL.%26date%3D2018%26date%3D2017%26volume%3D24%26issue%3D4%26spage%3D753%26epage%3D765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luca  Costantino</span>, <span class="hlFld-ContribAuthor ">Daniela  Barlocco</span>. </span><span class="cited-content_cbyCitation_article-title">Designing Approaches to Multitarget Drugs. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 161-205. <a href="https://doi.org/10.1002/9783527674381.ch7" title="DOI URL">https://doi.org/10.1002/9783527674381.ch7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527674381.ch7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527674381.ch7%26sid%3Dliteratum%253Aachs%26atitle%3DDesigning%252BApproaches%252Bto%252BMultitarget%252BDrugs%26aulast%3DCostantino%26aufirst%3DLuca%26date%3D2017%26date%3D2017%26spage%3D161%26epage%3D205%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DDrug%252BSelectivity%26aulast%3DHandler%26aufirst%3DNorbert%26date%3D2017%26volume%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Masashi  Nagao</span>, <span class="hlFld-ContribAuthor ">John L.  Hamilton</span>, <span class="hlFld-ContribAuthor ">Ranjan  Kc</span>, <span class="hlFld-ContribAuthor ">Agnes D.  Berendsen</span>, <span class="hlFld-ContribAuthor ">Xuchen  Duan</span>, <span class="hlFld-ContribAuthor ">Chan Wook  Cheong</span>, <span class="hlFld-ContribAuthor ">Xin  Li</span>, <span class="hlFld-ContribAuthor ">Hee-Jeong  Im</span>, <span class="hlFld-ContribAuthor ">Bjorn R.  Olsen</span>. </span><span class="cited-content_cbyCitation_article-title">Vascular Endothelial Growth Factor in Cartilage Development and Osteoarthritis. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2017,</strong> <em>7 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-017-13417-w" title="DOI URL">https://doi.org/10.1038/s41598-017-13417-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-017-13417-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-017-13417-w%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DVascular%252BEndothelial%252BGrowth%252BFactor%252Bin%252BCartilage%252BDevelopment%252Band%252BOsteoarthritis%26aulast%3DNagao%26aufirst%3DMasashi%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tina  Cascone</span>, <span class="hlFld-ContribAuthor ">Li  Xu</span>, <span class="hlFld-ContribAuthor ">Heather Y.  Lin</span>, <span class="hlFld-ContribAuthor ">Wenbin  Liu</span>, <span class="hlFld-ContribAuthor ">Hai T.  Tran</span>, <span class="hlFld-ContribAuthor ">Yuan  Liu</span>, <span class="hlFld-ContribAuthor ">Kathryn  Howells</span>, <span class="hlFld-ContribAuthor ">Vincent  Haddad</span>, <span class="hlFld-ContribAuthor ">Emer  Hanrahan</span>, <span class="hlFld-ContribAuthor ">Monique B.  Nilsson</span>, <span class="hlFld-ContribAuthor ">Maria A.  Cortez</span>, <span class="hlFld-ContribAuthor ">Uma  Giri</span>, <span class="hlFld-ContribAuthor ">Humam  Kadara</span>, <span class="hlFld-ContribAuthor ">Babita  Saigal</span>, <span class="hlFld-ContribAuthor ">Yun-Yong  Park</span>, <span class="hlFld-ContribAuthor ">Weiyi  Peng</span>, <span class="hlFld-ContribAuthor ">Ju-Seog  Lee</span>, <span class="hlFld-ContribAuthor ">Anderson J.  Ryan</span>, <span class="hlFld-ContribAuthor ">Juliane M.  Jüergensmeier</span>, <span class="hlFld-ContribAuthor ">Roy S.  Herbst</span>, <span class="hlFld-ContribAuthor ">Jing  Wang</span>, <span class="hlFld-ContribAuthor ">Robert R.  Langley</span>, <span class="hlFld-ContribAuthor ">Ignacio I.  Wistuba</span>, <span class="hlFld-ContribAuthor ">Jack J.  Lee</span>, <span class="hlFld-ContribAuthor ">John V.  Heymach</span>. </span><span class="cited-content_cbyCitation_article-title">The HGF/c-MET Pathway Is a Driver and Biomarker of VEGFR-inhibitor Resistance and Vascular Remodeling in Non–Small Cell Lung Cancer. </span><span class="cited-content_cbyCitation_journal-name">Clinical Cancer Research</span><span> <strong>2017,</strong> <em>23 </em>
                                    (18)
                                     , 5489-5501. <a href="https://doi.org/10.1158/1078-0432.CCR-16-3216" title="DOI URL">https://doi.org/10.1158/1078-0432.CCR-16-3216</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1078-0432.CCR-16-3216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1078-0432.CCR-16-3216%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Cancer%2520Research%26atitle%3DThe%252BHGF%25252Fc-MET%252BPathway%252BIs%252Ba%252BDriver%252Band%252BBiomarker%252Bof%252BVEGFR-inhibitor%252BResistance%252Band%252BVascular%252BRemodeling%252Bin%252BNon%2525E2%252580%252593Small%252BCell%252BLung%252BCancer%26aulast%3DCascone%26aufirst%3DTina%26date%3D2017%26date%3D2017%26volume%3D23%26issue%3D18%26spage%3D5489%26epage%3D5501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Atulkumar A.  Kamble</span>, <span class="hlFld-ContribAuthor ">Ravindra R.  Kamble</span>, <span class="hlFld-ContribAuthor ">Lakkanna S.  Chougala</span>, <span class="hlFld-ContribAuthor ">Jagadish S.  Kadadevarmath</span>, <span class="hlFld-ContribAuthor ">Shivaraj R.  Maidur</span>, <span class="hlFld-ContribAuthor ">Parutagouda S.  Patil</span>, <span class="hlFld-ContribAuthor ">Mahadev N.  Kumbar</span>, <span class="hlFld-ContribAuthor ">Sheetal B.  Marganakop</span>. </span><span class="cited-content_cbyCitation_article-title">Photophysical, Electrochemical Studies of Novel Pyrazol-4-yl-2,3-dihydroquinazolin-4(1
              H
              )-ones and Their Anticancer Activity. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2017,</strong> <em>2 </em>
                                    (23)
                                     , 6882-6890. <a href="https://doi.org/10.1002/slct.201700498" title="DOI URL">https://doi.org/10.1002/slct.201700498</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201700498&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201700498%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DPhotophysical%25252C%252BElectrochemical%252BStudies%252Bof%252BNovel%252BPyrazol-4-yl-2%25252C3-dihydroquinazolin-4%2525281%252BH%252B%252529-ones%252Band%252BTheir%252BAnticancer%252BActivity%26aulast%3DKamble%26aufirst%3DAtulkumar%2BA.%26date%3D2017%26date%3D2017%26volume%3D2%26issue%3D23%26spage%3D6882%26epage%3D6890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Riyo  Morimoto‐Kamata</span>, <span class="hlFld-ContribAuthor ">Satoru  Yui</span>. </span><span class="cited-content_cbyCitation_article-title">Insulin‐like growth factor‐1 signaling is responsible for cathepsin G‐induced aggregation of breast cancer
              MCF
              ‐7 cells. </span><span class="cited-content_cbyCitation_journal-name">Cancer Science</span><span> <strong>2017,</strong> <em>108 </em>
                                    (8)
                                     , 1574-1583. <a href="https://doi.org/10.1111/cas.13286" title="DOI URL">https://doi.org/10.1111/cas.13286</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cas.13286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcas.13286%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Science%26atitle%3DInsulin%2525E2%252580%252590like%252Bgrowth%252Bfactor%2525E2%252580%2525901%252Bsignaling%252Bis%252Bresponsible%252Bfor%252Bcathepsin%252BG%2525E2%252580%252590induced%252Baggregation%252Bof%252Bbreast%252Bcancer%252BMCF%252B%2525E2%252580%2525907%252Bcells%26aulast%3DMorimoto%25E2%2580%2590Kamata%26aufirst%3DRiyo%26date%3D2017%26date%3D2017%26volume%3D108%26issue%3D8%26spage%3D1574%26epage%3D1583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Axel  Kleemann</span>. </span><span class="cited-content_cbyCitation_article-title">Antineoplastic and Immunomodulating Agents (L). </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 1-56. <a href="https://doi.org/10.1002/14356007.a05_001.pub3" title="DOI URL">https://doi.org/10.1002/14356007.a05_001.pub3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/14356007.a05_001.pub3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F14356007.a05_001.pub3%26sid%3Dliteratum%253Aachs%26atitle%3DAntineoplastic%252Band%252BImmunomodulating%252BAgents%252B%252528L%252529%26aulast%3DKleemann%26aufirst%3DAxel%26date%3D2017%26date%3D2017%26spage%3D1%26epage%3D56%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DUllmann%252527s%252BEncyclopedia%252Bof%252BIndustrial%252BChemistry%26date%3D2000%26date%3D2000%26volume%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kayleigh L.  Brocklesby</span>, <span class="hlFld-ContribAuthor ">Jennifer S.  Waby</span>, <span class="hlFld-ContribAuthor ">Chris  Cawthorne</span>, <span class="hlFld-ContribAuthor ">Graham  Smith</span>. </span><span class="cited-content_cbyCitation_article-title">An alternative synthesis of Vandetanib (Caprelsa™) via a microwave accelerated Dimroth rearrangement. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2017,</strong> <em>58 </em>
                                    (15)
                                     , 1467-1469. <a href="https://doi.org/10.1016/j.tetlet.2017.02.082" title="DOI URL">https://doi.org/10.1016/j.tetlet.2017.02.082</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2017.02.082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2017.02.082%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DAn%252Balternative%252Bsynthesis%252Bof%252BVandetanib%252B%252528Caprelsa%2525E2%252584%2525A2%252529%252Bvia%252Ba%252Bmicrowave%252Baccelerated%252BDimroth%252Brearrangement%26aulast%3DBrocklesby%26aufirst%3DKayleigh%2BL.%26date%3D2017%26volume%3D58%26issue%3D15%26spage%3D1467%26epage%3D1469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hai-Qi  Zhang</span>, <span class="hlFld-ContribAuthor ">Fei-Hu  Gong</span>, <span class="hlFld-ContribAuthor ">Ji-Qing  Ye</span>, <span class="hlFld-ContribAuthor ">Chi  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiao-Hong  Yue</span>, <span class="hlFld-ContribAuthor ">Chuan-Gui  Li</span>, <span class="hlFld-ContribAuthor ">Yun-Gen  Xu</span>, <span class="hlFld-ContribAuthor ">Li-Ping  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Design and discovery of 4-anilinoquinazoline-urea derivatives as dual TK inhibitors of EGFR and VEGFR-2. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>125 </em>, 245-254. <a href="https://doi.org/10.1016/j.ejmech.2016.09.039" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.09.039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.09.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.09.039%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bdiscovery%252Bof%252B4-anilinoquinazoline-urea%252Bderivatives%252Bas%252Bdual%252BTK%252Binhibitors%252Bof%252BEGFR%252Band%252BVEGFR-2%26aulast%3DZhang%26aufirst%3DHai-Qi%26date%3D2017%26volume%3D125%26spage%3D245%26epage%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kovuru  Gopalaiah</span>, <span class="hlFld-ContribAuthor ">Anupama  Saini</span>, <span class="hlFld-ContribAuthor ">Alka  Devi</span>. </span><span class="cited-content_cbyCitation_article-title">Iron-catalyzed cascade reaction of 2-aminobenzyl alcohols with benzylamines: synthesis of quinazolines by trapping of ammonia. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2017,</strong> <em>15 </em>
                                    (27)
                                     , 5781-5789. <a href="https://doi.org/10.1039/C7OB01159H" title="DOI URL">https://doi.org/10.1039/C7OB01159H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7OB01159H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7OB01159H%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DIron-catalyzed%252Bcascade%252Breaction%252Bof%252B2-aminobenzyl%252Balcohols%252Bwith%252Bbenzylamines%25253A%252Bsynthesis%252Bof%252Bquinazolines%252Bby%252Btrapping%252Bof%252Bammonia%26aulast%3DGopalaiah%26aufirst%3DKovuru%26date%3D2017%26date%3D2017%26volume%3D15%26issue%3D27%26spage%3D5781%26epage%3D5789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adel S.  El-Azab</span>, <span class="hlFld-ContribAuthor ">Alaa A.-M.  Abdel-Aziz</span>, <span class="hlFld-ContribAuthor ">Hazem A.  Ghabbour</span>, <span class="hlFld-ContribAuthor ">Manal A.  Al-Gendy</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis,
              in vitro
              antitumour activity, and molecular docking study of novel 2-substituted mercapto-3-(3,4,5-trimethoxybenzyl)-4(3H)-quinazolinone analogues. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2017,</strong> <em>32 </em>
                                    (1)
                                     , 1229-1239. <a href="https://doi.org/10.1080/14756366.2017.1368504" title="DOI URL">https://doi.org/10.1080/14756366.2017.1368504</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2017.1368504&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2017.1368504%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%25252C%252Bin%252Bvitro%252Bantitumour%252Bactivity%25252C%252Band%252Bmolecular%252Bdocking%252Bstudy%252Bof%252Bnovel%252B2-substituted%252Bmercapto-3-%2525283%25252C4%25252C5-trimethoxybenzyl%252529-4%2525283H%252529-quinazolinone%252Banalogues%26aulast%3DEl-Azab%26aufirst%3DAdel%2BS.%26date%3D2017%26date%3D2017%26volume%3D32%26issue%3D1%26spage%3D1229%26epage%3D1239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sébastien  Soriano</span>, <span class="hlFld-ContribAuthor ">Margarita  Escudero-Casao</span>, <span class="hlFld-ContribAuthor ">M. Isabel  Matheu</span>, <span class="hlFld-ContribAuthor ">Yolanda  Díaz</span>, <span class="hlFld-ContribAuthor ">Sergio  Castillón</span>. </span><span class="cited-content_cbyCitation_article-title">Substrate-Regiocontrolled Synthesis of Enantioenriched Allylic Amines by Palladium-Catalysed Asymmetric Allylic Amination: Formal Synthesis of Fagomine. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2016,</strong> <em>358 </em>
                                    (24)
                                     , 4057-4066. <a href="https://doi.org/10.1002/adsc.201600583" title="DOI URL">https://doi.org/10.1002/adsc.201600583</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201600583&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201600583%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DSubstrate-Regiocontrolled%252BSynthesis%252Bof%252BEnantioenriched%252BAllylic%252BAmines%252Bby%252BPalladium-Catalysed%252BAsymmetric%252BAllylic%252BAmination%25253A%252BFormal%252BSynthesis%252Bof%252BFagomine%26aulast%3DSoriano%26aufirst%3DS%25C3%25A9bastien%26date%3D2016%26date%3D2016%26volume%3D358%26issue%3D24%26spage%3D4057%26epage%3D4066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Huiqiang  Wei</span>, <span class="hlFld-ContribAuthor ">Deguan  Li</span>, <span class="hlFld-ContribAuthor ">Xiangbo  Yang</span>, <span class="hlFld-ContribAuthor ">Haihua  Shang</span>, <span class="hlFld-ContribAuthor ">Saijun  Fan</span>, <span class="hlFld-ContribAuthor ">Yiliang  Li</span>, <span class="hlFld-ContribAuthor ">Dan  Song</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of Vandetanib Derivatives Containing Nitroimidazole Groups as Tyrosine Kinase Inhibitors in Normoxia and Hypoxia. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2016,</strong> <em>21 </em>
                                    (12)
                                     , 1693. <a href="https://doi.org/10.3390/molecules21121693" title="DOI URL">https://doi.org/10.3390/molecules21121693</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules21121693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules21121693%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BVandetanib%252BDerivatives%252BContaining%252BNitroimidazole%252BGroups%252Bas%252BTyrosine%252BKinase%252BInhibitors%252Bin%252BNormoxia%252Band%252BHypoxia%26aulast%3DWei%26aufirst%3DHuiqiang%26date%3D2016%26date%3D2016%26volume%3D21%26issue%3D12%26spage%3D1693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lu  Yang</span>, <span class="hlFld-ContribAuthor ">Shadi  Moghaddas</span>, <span class="hlFld-ContribAuthor ">Homa  Dezvareh</span>, <span class="hlFld-ContribAuthor ">Louiza  Belkacemi</span>, <span class="hlFld-ContribAuthor ">Steven J.  Bark</span>, <span class="hlFld-ContribAuthor ">Rathindra N.  Bose</span>, <span class="hlFld-ContribAuthor ">Loi H.  Do</span>. </span><span class="cited-content_cbyCitation_article-title">Insights into the anti-angiogenic properties of phosphaplatins. </span><span class="cited-content_cbyCitation_journal-name">Journal of Inorganic Biochemistry</span><span> <strong>2016,</strong> <em>164 </em>, 5-16. <a href="https://doi.org/10.1016/j.jinorgbio.2016.07.020" title="DOI URL">https://doi.org/10.1016/j.jinorgbio.2016.07.020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jinorgbio.2016.07.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jinorgbio.2016.07.020%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Inorganic%2520Biochemistry%26atitle%3DInsights%252Binto%252Bthe%252Banti-angiogenic%252Bproperties%252Bof%252Bphosphaplatins%26aulast%3DYang%26aufirst%3DLu%26date%3D2016%26volume%3D164%26spage%3D5%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Poupak  Fallahi</span>, <span class="hlFld-ContribAuthor ">Silvia Martina  Ferrari</span>, <span class="hlFld-ContribAuthor ">Enke  Baldini</span>, <span class="hlFld-ContribAuthor ">Marco  Biricotti</span>, <span class="hlFld-ContribAuthor ">Salvatore  Ulisse</span>, <span class="hlFld-ContribAuthor ">Gabriele  Materazzi</span>, <span class="hlFld-ContribAuthor ">Paolo  Miccoli</span>, <span class="hlFld-ContribAuthor ">Alessandro  Antonelli</span>. </span><span class="cited-content_cbyCitation_article-title">The safety and efficacy of vandetanib in the treatment of progressive medullary thyroid cancer. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Anticancer Therapy</span><span> <strong>2016,</strong> <em>16 </em>
                                    (11)
                                     , 1109-1118. <a href="https://doi.org/10.1080/14737140.2016.1238764" title="DOI URL">https://doi.org/10.1080/14737140.2016.1238764</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14737140.2016.1238764&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14737140.2016.1238764%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Anticancer%2520Therapy%26atitle%3DThe%252Bsafety%252Band%252Befficacy%252Bof%252Bvandetanib%252Bin%252Bthe%252Btreatment%252Bof%252Bprogressive%252Bmedullary%252Bthyroid%252Bcancer%26aulast%3DFallahi%26aufirst%3DPoupak%26date%3D2016%26date%3D2016%26volume%3D16%26issue%3D11%26spage%3D1109%26epage%3D1118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alaa A.-M.  Abdel-Aziz</span>, <span class="hlFld-ContribAuthor ">Laila A.  Abou-Zeid</span>, <span class="hlFld-ContribAuthor ">Kamal Eldin H.  ElTahir</span>, <span class="hlFld-ContribAuthor ">Menshawy A.  Mohamed</span>, <span class="hlFld-ContribAuthor ">Mohamed A.  Abu El-Enin</span>, <span class="hlFld-ContribAuthor ">Adel S.  El-Azab</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis of 2,3-disubstitued 4(3H)-quinazolinone derivatives as anti-inflammatory and analgesic agents: COX-1/2 inhibitory activities and molecular docking studies. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (16)
                                     , 3818-3828. <a href="https://doi.org/10.1016/j.bmc.2016.06.026" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.06.026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.06.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.06.026%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Bof%252B2%25252C3-disubstitued%252B4%2525283H%252529-quinazolinone%252Bderivatives%252Bas%252Banti-inflammatory%252Band%252Banalgesic%252Bagents%25253A%252BCOX-1%25252F2%252Binhibitory%252Bactivities%252Band%252Bmolecular%252Bdocking%252Bstudies%26aulast%3DAbdel-Aziz%26aufirst%3DAlaa%2BA.-M.%26date%3D2016%26volume%3D24%26issue%3D16%26spage%3D3818%26epage%3D3828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jingya  Zhang</span>, <span class="hlFld-ContribAuthor ">Linna  Zhang</span>, <span class="hlFld-ContribAuthor ">Yuanyou  Wang</span>, <span class="hlFld-ContribAuthor ">Guisen  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Development of anti-angiogenic tyrosine kinases inhibitors: molecular structures and binding modes. </span><span class="cited-content_cbyCitation_journal-name">Cancer Chemotherapy and Pharmacology</span><span> <strong>2016,</strong> <em>77 </em>
                                    (5)
                                     , 905-926. <a href="https://doi.org/10.1007/s00280-016-2961-6" title="DOI URL">https://doi.org/10.1007/s00280-016-2961-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00280-016-2961-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00280-016-2961-6%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Chemotherapy%2520and%2520Pharmacology%26atitle%3DDevelopment%252Bof%252Banti-angiogenic%252Btyrosine%252Bkinases%252Binhibitors%25253A%252Bmolecular%252Bstructures%252Band%252Bbinding%252Bmodes%26aulast%3DZhang%26aufirst%3DJingya%26date%3D2016%26date%3D2016%26volume%3D77%26issue%3D5%26spage%3D905%26epage%3D926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicola  Maurea</span>, <span class="hlFld-ContribAuthor ">Carmela  Coppola</span>, <span class="hlFld-ContribAuthor ">Giovanna  Piscopo</span>, <span class="hlFld-ContribAuthor ">Francesca  Galletta</span>, <span class="hlFld-ContribAuthor ">Gennaro  Riccio</span>, <span class="hlFld-ContribAuthor ">Emanuela  Esposito</span>, <span class="hlFld-ContribAuthor ">Claudia  De Lorenzo</span>, <span class="hlFld-ContribAuthor ">Michelino  De Laurentiis</span>, <span class="hlFld-ContribAuthor ">Paolo  Spallarossa</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Mercuro</span>. </span><span class="cited-content_cbyCitation_article-title">Pathophysiology of cardiotoxicity from target therapy and angiogenesis inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cardiovascular Medicine</span><span> <strong>2016,</strong> <em>17 </em>, e19-e26. <a href="https://doi.org/10.2459/JCM.0000000000000377" title="DOI URL">https://doi.org/10.2459/JCM.0000000000000377</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2459/JCM.0000000000000377&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2459%2FJCM.0000000000000377%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cardiovascular%2520Medicine%26atitle%3DPathophysiology%252Bof%252Bcardiotoxicity%252Bfrom%252Btarget%252Btherapy%252Band%252Bangiogenesis%252Binhibitors%26aulast%3DMaurea%26aufirst%3DNicola%26date%3D2016%26volume%3D17%26spage%3De19%26epage%3De26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elizabeth R.  Kessler</span>, <span class="hlFld-ContribAuthor ">S. Gail  Eckhardt</span>, <span class="hlFld-ContribAuthor ">Todd M.  Pitts</span>, <span class="hlFld-ContribAuthor ">Erica L.  Bradshaw-Pierce</span>, <span class="hlFld-ContribAuthor ">Cindy L.  O’byrant</span>, <span class="hlFld-ContribAuthor ">Wells A.  Messersmith</span>, <span class="hlFld-ContribAuthor ">Sujatha  Nallapreddy</span>, <span class="hlFld-ContribAuthor ">Colin  Weekes</span>, <span class="hlFld-ContribAuthor ">Jennifer  Spratlin</span>, <span class="hlFld-ContribAuthor ">Christopher H.  Lieu</span>, <span class="hlFld-ContribAuthor ">Madeleine A.  Kane</span>, <span class="hlFld-ContribAuthor ">Sarah  Eppers</span>, <span class="hlFld-ContribAuthor ">Elizabeth  Freas</span>, <span class="hlFld-ContribAuthor ">Stephen  Leong</span>. </span><span class="cited-content_cbyCitation_article-title">Phase I trial of vandetanib in combination with gemcitabine and capecitabine in patients with advanced solid tumors with an expanded cohort in pancreatic and biliary cancers. </span><span class="cited-content_cbyCitation_journal-name">Investigational New Drugs</span><span> <strong>2016,</strong> <em>34 </em>
                                    (2)
                                     , 176-183. <a href="https://doi.org/10.1007/s10637-015-0316-5" title="DOI URL">https://doi.org/10.1007/s10637-015-0316-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10637-015-0316-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10637-015-0316-5%26sid%3Dliteratum%253Aachs%26jtitle%3DInvestigational%2520New%2520Drugs%26atitle%3DPhase%252BI%252Btrial%252Bof%252Bvandetanib%252Bin%252Bcombination%252Bwith%252Bgemcitabine%252Band%252Bcapecitabine%252Bin%252Bpatients%252Bwith%252Badvanced%252Bsolid%252Btumors%252Bwith%252Ban%252Bexpanded%252Bcohort%252Bin%252Bpancreatic%252Band%252Bbiliary%252Bcancers%26aulast%3DKessler%26aufirst%3DElizabeth%2BR.%26date%3D2016%26date%3D2015%26volume%3D34%26issue%3D2%26spage%3D176%26epage%3D183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Menshawy A.  Mohamed</span>, <span class="hlFld-ContribAuthor ">Rezk R.  Ayyad</span>, <span class="hlFld-ContribAuthor ">Taghreed Z.  Shawer</span>, <span class="hlFld-ContribAuthor ">Alaa A.-M.  Abdel-Aziz</span>, <span class="hlFld-ContribAuthor ">Adel S.  El-Azab</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and antitumor evaluation of trimethoxyanilides based on 4(3H)-quinazolinone scaffolds. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>112 </em>, 106-113. <a href="https://doi.org/10.1016/j.ejmech.2016.02.002" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.02.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.02.002%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bantitumor%252Bevaluation%252Bof%252Btrimethoxyanilides%252Bbased%252Bon%252B4%2525283H%252529-quinazolinone%252Bscaffolds%26aulast%3DMohamed%26aufirst%3DMenshawy%2BA.%26date%3D2016%26volume%3D112%26spage%3D106%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hai-Qi  Zhang</span>, <span class="hlFld-ContribAuthor ">Fei-Hu  Gong</span>, <span class="hlFld-ContribAuthor ">Chuan-Gui  Li</span>, <span class="hlFld-ContribAuthor ">Chi  Zhang</span>, <span class="hlFld-ContribAuthor ">Yan-Jie  Wang</span>, <span class="hlFld-ContribAuthor ">Yun-Gen  Xu</span>, <span class="hlFld-ContribAuthor ">Li-Ping  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Design and discovery of 4-anilinoquinazoline-acylamino derivatives as EGFR and VEGFR-2 dual TK inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>109 </em>, 371-379. <a href="https://doi.org/10.1016/j.ejmech.2015.12.032" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.12.032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.12.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.12.032%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bdiscovery%252Bof%252B4-anilinoquinazoline-acylamino%252Bderivatives%252Bas%252BEGFR%252Band%252BVEGFR-2%252Bdual%252BTK%252Binhibitors%26aulast%3DZhang%26aufirst%3DHai-Qi%26date%3D2016%26volume%3D109%26spage%3D371%26epage%3D379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kyu-Won  Kim</span>, <span class="hlFld-ContribAuthor ">Jae Kyung  Roh</span>, <span class="hlFld-ContribAuthor ">Hee-Jun  Wee</span>, <span class="hlFld-ContribAuthor ">Chan  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Targeted Anticancer Drugs. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 175-238. <a href="https://doi.org/10.1007/978-94-024-0844-7_9" title="DOI URL">https://doi.org/10.1007/978-94-024-0844-7_9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-94-024-0844-7_9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-94-024-0844-7_9%26sid%3Dliteratum%253Aachs%26atitle%3DMolecular%252BTargeted%252BAnticancer%252BDrugs%26aulast%3DKim%26aufirst%3DKyu-Won%26date%3D2016%26date%3D2016%26spage%3D175%26epage%3D238%26pub%3DSpringer%2520Netherlands%26atitle%3DCancer%252BDrug%252BDiscovery%26aulast%3DKim%26aufirst%3DKyu-Won%26date%3D2016%26volume%3D309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sahar M.  Abou-Seri</span>, <span class="hlFld-ContribAuthor ">Wagdy M.  Eldehna</span>, <span class="hlFld-ContribAuthor ">Mamdouh M.  Ali</span>, <span class="hlFld-ContribAuthor ">Dalal A.  Abou El Ella</span>. </span><span class="cited-content_cbyCitation_article-title">1-Piperazinylphthalazines as potential VEGFR-2 inhibitors and anticancer agents: Synthesis and in vitro biological evaluation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>107 </em>, 165-179. <a href="https://doi.org/10.1016/j.ejmech.2015.10.053" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.10.053</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.10.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.10.053%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3D1-Piperazinylphthalazines%252Bas%252Bpotential%252BVEGFR-2%252Binhibitors%252Band%252Banticancer%252Bagents%25253A%252BSynthesis%252Band%252Bin%2525C2%2525A0vitro%252Bbiological%252Bevaluation%26aulast%3DAbou-Seri%26aufirst%3DSahar%2BM.%26date%3D2016%26volume%3D107%26spage%3D165%26epage%3D179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mostafa Mohammed  Ghorab</span>, <span class="hlFld-ContribAuthor ">Mansour Sulaiman  Alsaid</span>, <span class="hlFld-ContribAuthor ">Yassin Mohammed  Nissan</span>, <span class="hlFld-ContribAuthor ">Abdelkader Elbadawy  Ashour</span>, <span class="hlFld-ContribAuthor ">Abdullah Abdulalrahman  Al-Mishari</span>, <span class="hlFld-ContribAuthor ">Ashok  Kumar</span>, <span class="hlFld-ContribAuthor ">Sheikh Fayaz  Ahmed</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Sulfonamide Derivatives Carrying a Biologically Active 3,4-Dimethoxyphenyl Moiety as VEGFR-2 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">CHEMICAL & PHARMACEUTICAL BULLETIN</span><span> <strong>2016,</strong> <em>64 </em>
                                    (12)
                                     , 1747-1754. <a href="https://doi.org/10.1248/cpb.c16-00614" title="DOI URL">https://doi.org/10.1248/cpb.c16-00614</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1248/cpb.c16-00614&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1248%2Fcpb.c16-00614%26sid%3Dliteratum%253Aachs%26jtitle%3DCHEMICAL%2520%2526%2520PHARMACEUTICAL%2520BULLETIN%26atitle%3DNovel%252BSulfonamide%252BDerivatives%252BCarrying%252Ba%252BBiologically%252BActive%252B3%25252C4-Dimethoxyphenyl%252BMoiety%252Bas%252BVEGFR-2%252BInhibitors%26aulast%3DGhorab%26aufirst%3DMostafa%2BMohammed%26date%3D2016%26volume%3D64%26issue%3D12%26spage%3D1747%26epage%3D1754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Margaréta  Vojtičková</span>, <span class="hlFld-ContribAuthor ">Juraj  Dobiaš</span>, <span class="hlFld-ContribAuthor ">Gilles  Hanquet</span>, <span class="hlFld-ContribAuthor ">Gabriela  Addová</span>, <span class="hlFld-ContribAuthor ">Rengul  Cetin-Atalay</span>, <span class="hlFld-ContribAuthor ">Deniz Cansen  Yildirim</span>, <span class="hlFld-ContribAuthor ">Andrej  Boháč</span>. </span><span class="cited-content_cbyCitation_article-title">Ynamide Click chemistry in development of triazole VEGFR2 TK modulators. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>103 </em>, 105-122. <a href="https://doi.org/10.1016/j.ejmech.2015.08.012" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.08.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.08.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.08.012%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DYnamide%252BClick%252Bchemistry%252Bin%252Bdevelopment%252Bof%252Btriazole%252BVEGFR2%252BTK%252Bmodulators%26aulast%3DVojti%25C4%258Dkov%25C3%25A1%26aufirst%3DMargar%25C3%25A9ta%26date%3D2015%26volume%3D103%26spage%3D105%26epage%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiani  Liu</span>, <span class="hlFld-ContribAuthor ">Jiangxue  Wu</span>, <span class="hlFld-ContribAuthor ">Ling  Zhou</span>, <span class="hlFld-ContribAuthor ">Changchuan  Pan</span>, <span class="hlFld-ContribAuthor ">Yi  Zhou</span>, <span class="hlFld-ContribAuthor ">Wuying  Du</span>, <span class="hlFld-ContribAuthor ">Jie-min  Chen</span>, <span class="hlFld-ContribAuthor ">Xiaofeng  Zhu</span>, <span class="hlFld-ContribAuthor ">Jingnan  Shen</span>, <span class="hlFld-ContribAuthor ">Shuai  Chen</span>, <span class="hlFld-ContribAuthor ">Ran-yi  Liu</span>, <span class="hlFld-ContribAuthor ">Wenlin  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">ZD6474, a new treatment strategy for human osteosarcoma, and its potential synergistic effect with celecoxib. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2015,</strong> <em>6 </em>
                                    (25)
                                     , 21341-21352. <a href="https://doi.org/10.18632/oncotarget.4179" title="DOI URL">https://doi.org/10.18632/oncotarget.4179</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.4179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.4179%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DZD6474%25252C%252Ba%252Bnew%252Btreatment%252Bstrategy%252Bfor%252Bhuman%252Bosteosarcoma%25252C%252Band%252Bits%252Bpotential%252Bsynergistic%252Beffect%252Bwith%252Bcelecoxib%26aulast%3DLiu%26aufirst%3DJiani%26date%3D2015%26date%3D2015%26volume%3D6%26issue%3D25%26spage%3D21341%26epage%3D21352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong  Zhang</span>, <span class="hlFld-ContribAuthor ">Kai  Zhang</span>, <span class="hlFld-ContribAuthor ">Meng  Zhao</span>, <span class="hlFld-ContribAuthor ">Lixia  Zhang</span>, <span class="hlFld-ContribAuthor ">Mingze  Qin</span>, <span class="hlFld-ContribAuthor ">Shuchun  Guo</span>, <span class="hlFld-ContribAuthor ">Yanfang  Zhao</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a novel class anti-proliferative agents and potential inhibitors of EGFR tyrosine kinases based on 4-anilinotetrahydropyrido[4,3-d]pyrimidine scaffold: Design, synthesis and biological evaluations. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (15)
                                     , 4591-4607. <a href="https://doi.org/10.1016/j.bmc.2015.05.059" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.05.059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.05.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.05.059%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252Bnovel%252Bclass%252Banti-proliferative%252Bagents%252Band%252Bpotential%252Binhibitors%252Bof%252BEGFR%252Btyrosine%252Bkinases%252Bbased%252Bon%252B4-anilinotetrahydropyrido%25255B4%25252C3-d%25255Dpyrimidine%252Bscaffold%25253A%252BDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluations%26aulast%3DZhang%26aufirst%3DYong%26date%3D2015%26volume%3D23%26issue%3D15%26spage%3D4591%26epage%3D4607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexander W  Hird</span>, <span class="hlFld-ContribAuthor ">Brian M  Aquila</span>, <span class="hlFld-ContribAuthor ">Edward J  Hennessy</span>, <span class="hlFld-ContribAuthor ">Melissa M  Vasbinder</span>, <span class="hlFld-ContribAuthor ">Bin  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Small molecule inhibitor of apoptosis proteins antagonists: a patent review. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2015,</strong> <em>25 </em>
                                    (7)
                                     , 755-774. <a href="https://doi.org/10.1517/13543776.2015.1041922" title="DOI URL">https://doi.org/10.1517/13543776.2015.1041922</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2015.1041922&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2015.1041922%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DSmall%252Bmolecule%252Binhibitor%252Bof%252Bapoptosis%252Bproteins%252Bantagonists%25253A%252Ba%252Bpatent%252Breview%26aulast%3DHird%26aufirst%3DAlexander%2BW%26date%3D2015%26date%3D2015%26volume%3D25%26issue%3D7%26spage%3D755%26epage%3D774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marwa F.  Ahmed</span>, <span class="hlFld-ContribAuthor ">Amany  Belal</span>, <span class="hlFld-ContribAuthor ">Mahmoud  Youns</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, molecular modeling and anti-breast cancer activity of novel quinazolin-4-one derivatives linked to thiazolidinone, oxadiazole or pyrazole moieties. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2015,</strong> <em>24 </em>
                                    (7)
                                     , 2993-3007. <a href="https://doi.org/10.1007/s00044-015-1357-1" title="DOI URL">https://doi.org/10.1007/s00044-015-1357-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-015-1357-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-015-1357-1%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Bmolecular%252Bmodeling%252Band%252Banti-breast%252Bcancer%252Bactivity%252Bof%252Bnovel%252Bquinazolin-4-one%252Bderivatives%252Blinked%252Bto%252Bthiazolidinone%25252C%252Boxadiazole%252Bor%252Bpyrazole%252Bmoieties%26aulast%3DAhmed%26aufirst%3DMarwa%2BF.%26date%3D2015%26date%3D2015%26volume%3D24%26issue%3D7%26spage%3D2993%26epage%3D3007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xin  Zhai</span>, <span class="hlFld-ContribAuthor ">Limei  Wang</span>, <span class="hlFld-ContribAuthor ">Jiyue  Shi</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel tricyclic 5H-Pyridazino[4,5-b]indoles as potent antitumor agents: Design, synthesis and biological evaluation. </span><span class="cited-content_cbyCitation_journal-name">Chemical Research in Chinese Universities</span><span> <strong>2015,</strong> <em>31 </em>
                                    (3)
                                     , 372-380. <a href="https://doi.org/10.1007/s40242-015-4435-5" title="DOI URL">https://doi.org/10.1007/s40242-015-4435-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40242-015-4435-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40242-015-4435-5%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Research%2520in%2520Chinese%2520Universities%26atitle%3DDiscovery%252Bof%252Bnovel%252Btricyclic%252B5H-Pyridazino%25255B4%25252C5-b%25255Dindoles%252Bas%252Bpotent%252Bantitumor%252Bagents%25253A%252BDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%26aulast%3DZhai%26aufirst%3DXin%26date%3D2015%26date%3D2015%26volume%3D31%26issue%3D3%26spage%3D372%26epage%3D380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert  Roskoski</span>. </span><span class="cited-content_cbyCitation_article-title">Src protein-tyrosine kinase structure, mechanism, and small molecule inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2015,</strong> <em>94 </em>, 9-25. <a href="https://doi.org/10.1016/j.phrs.2015.01.003" title="DOI URL">https://doi.org/10.1016/j.phrs.2015.01.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2015.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2015.01.003%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DSrc%252Bprotein-tyrosine%252Bkinase%252Bstructure%25252C%252Bmechanism%25252C%252Band%252Bsmall%252Bmolecule%252Binhibitors%26aulast%3DRoskoski%26aufirst%3DRobert%26date%3D2015%26volume%3D94%26spage%3D9%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ali M.  Youssef</span>, <span class="hlFld-ContribAuthor ">Ahmed K.  EL-Ziaty</span>, <span class="hlFld-ContribAuthor ">Wael S. I.  Abou-Elmagd</span>, <span class="hlFld-ContribAuthor ">Sayed K.  Ramadan</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Synthesis of Some Imidazolyl-, Benzoxazinyl-, and Quinazolinyl-2,4-dioxothiazolidine Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2015,</strong> <em>52 </em>
                                    (1)
                                     , 278-283. <a href="https://doi.org/10.1002/jhet.1943" title="DOI URL">https://doi.org/10.1002/jhet.1943</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.1943&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.1943%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DNovel%252BSynthesis%252Bof%252BSome%252BImidazolyl-%25252C%252BBenzoxazinyl-%25252C%252Band%252BQuinazolinyl-2%25252C4-dioxothiazolidine%252BDerivatives%26aulast%3DYoussef%26aufirst%3DAli%2BM.%26date%3D2015%26date%3D2014%26volume%3D52%26issue%3D1%26spage%3D278%26epage%3D283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carmen  Avendaño</span>, <span class="hlFld-ContribAuthor ">J. Carlos  Menéndez</span>. </span><span class="cited-content_cbyCitation_article-title">Drugs That Inhibit Signaling Pathways for Tumor Cell Growth and Proliferation. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 391-491. <a href="https://doi.org/10.1016/B978-0-444-62649-3.00010-7" title="DOI URL">https://doi.org/10.1016/B978-0-444-62649-3.00010-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-444-62649-3.00010-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-444-62649-3.00010-7%26sid%3Dliteratum%253Aachs%26atitle%3DDrugs%252BThat%252BInhibit%252BSignaling%252BPathways%252Bfor%252BTumor%252BCell%252BGrowth%252Band%252BProliferation%26aulast%3DAvenda%25C3%25B1o%26aufirst%3DCarmen%26date%3D2015%26spage%3D391%26epage%3D491%26pub%3DElsevier%26atitle%3DMedicinal%252BChemistry%252Bof%252BAnticancer%252BDrugs%26date%3D2015%26volume%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amritpal  Singh</span>, <span class="hlFld-ContribAuthor ">Neetu  Goel</span>. </span><span class="cited-content_cbyCitation_article-title">Regioselective nucleophilic aromatic substitution reactions of 5,7-dinitroquinazoline-4-one and 5,7-dinitroquinazoline-4-thione with methylamine: a mechanistic consideration. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2015,</strong> <em>39 </em>
                                    (6)
                                     , 4351-4358. <a href="https://doi.org/10.1039/C5NJ00291E" title="DOI URL">https://doi.org/10.1039/C5NJ00291E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5NJ00291E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5NJ00291E%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DRegioselective%252Bnucleophilic%252Baromatic%252Bsubstitution%252Breactions%252Bof%252B5%25252C7-dinitroquinazoline-4-one%252Band%252B5%25252C7-dinitroquinazoline-4-thione%252Bwith%252Bmethylamine%25253A%252Ba%252Bmechanistic%252Bconsideration%26aulast%3DSingh%26aufirst%3DAmritpal%26date%3D2015%26date%3D2015%26volume%3D39%26issue%3D6%26spage%3D4351%26epage%3D4358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephanie L.  Barnes</span>, <span class="hlFld-ContribAuthor ">C. Chad  Quarles</span>, <span class="hlFld-ContribAuthor ">Thomas E.  Yankeelov</span>, . </span><span class="cited-content_cbyCitation_article-title">Modeling the Effect of Intra-Voxel Diffusion of Contrast Agent on the Quantitative Analysis of Dynamic Contrast Enhanced Magnetic Resonance Imaging. </span><span class="cited-content_cbyCitation_journal-name">PLoS ONE</span><span> <strong>2014,</strong> <em>9 </em>
                                    (10)
                                     , e108726. <a href="https://doi.org/10.1371/journal.pone.0108726" title="DOI URL">https://doi.org/10.1371/journal.pone.0108726</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0108726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0108726%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520ONE%26atitle%3DModeling%252Bthe%252BEffect%252Bof%252BIntra-Voxel%252BDiffusion%252Bof%252BContrast%252BAgent%252Bon%252Bthe%252BQuantitative%252BAnalysis%252Bof%252BDynamic%252BContrast%252BEnhanced%252BMagnetic%252BResonance%252BImaging%26aulast%3DBarnes%26aufirst%3DStephanie%2BL.%26date%3D2014%26date%3D2014%26volume%3D9%26issue%3D10%26spage%3De108726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mai I.  Shahin</span>, <span class="hlFld-ContribAuthor ">Dalal A.  Abou El Ella</span>, <span class="hlFld-ContribAuthor ">Nasser S.M.  Ismail</span>, <span class="hlFld-ContribAuthor ">Khaled A.M.  Abouzid</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of type-II VEGFR-2 inhibitors based on quinoxaline scaffold. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2014,</strong> <em>56 </em>, 16-26. <a href="https://doi.org/10.1016/j.bioorg.2014.05.010" title="DOI URL">https://doi.org/10.1016/j.bioorg.2014.05.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2014.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2014.05.010%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Btype-II%252BVEGFR-2%252Binhibitors%252Bbased%252Bon%252Bquinoxaline%252Bscaffold%26aulast%3DShahin%26aufirst%3DMai%2BI.%26date%3D2014%26volume%3D56%26spage%3D16%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antonella  De Luca</span>, <span class="hlFld-ContribAuthor ">Amelia  D’Alessio</span>, <span class="hlFld-ContribAuthor ">Monica Rosaria  Maiello</span>, <span class="hlFld-ContribAuthor ">Marianna  Gallo</span>, <span class="hlFld-ContribAuthor ">Simona  Bevilacqua</span>, <span class="hlFld-ContribAuthor ">Daniela  Frezzetti</span>, <span class="hlFld-ContribAuthor ">Alessandro  Morabito</span>, <span class="hlFld-ContribAuthor ">Francesco  Perrone</span>, <span class="hlFld-ContribAuthor ">Nicola  Normanno</span>. </span><span class="cited-content_cbyCitation_article-title">Vandetanib as a potential treatment for breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2014,</strong> <em>23 </em>
                                    (9)
                                     , 1295-1303. <a href="https://doi.org/10.1517/13543784.2014.942034" title="DOI URL">https://doi.org/10.1517/13543784.2014.942034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543784.2014.942034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543784.2014.942034%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DVandetanib%252Bas%252Ba%252Bpotential%252Btreatment%252Bfor%252Bbreast%252Bcancer%26aulast%3DDe%2BLuca%26aufirst%3DAntonella%26date%3D2014%26date%3D2014%26volume%3D23%26issue%3D9%26spage%3D1295%26epage%3D1303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Feng  Li</span>, <span class="hlFld-ContribAuthor ">Sheng  Jiang</span>, <span class="hlFld-ContribAuthor ">Youli  Zu</span>, <span class="hlFld-ContribAuthor ">Daniel Y.  Lee</span>, <span class="hlFld-ContribAuthor ">Zheng  Li</span>. </span><span class="cited-content_cbyCitation_article-title">A Tyrosine Kinase Inhibitor–Based High-Affinity PET Radiopharmaceutical Targets Vascular Endothelial Growth Factor Receptor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Nuclear Medicine</span><span> <strong>2014,</strong> <em>55 </em>
                                    (9)
                                     , 1525-1531. <a href="https://doi.org/10.2967/jnumed.114.138925" title="DOI URL">https://doi.org/10.2967/jnumed.114.138925</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2967/jnumed.114.138925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2967%2Fjnumed.114.138925%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Nuclear%2520Medicine%26atitle%3DA%252BTyrosine%252BKinase%252BInhibitor%2525E2%252580%252593Based%252BHigh-Affinity%252BPET%252BRadiopharmaceutical%252BTargets%252BVascular%252BEndothelial%252BGrowth%252BFactor%252BReceptor%26aulast%3DLi%26aufirst%3DFeng%26date%3D2014%26date%3D2014%26volume%3D55%26issue%3D9%26spage%3D1525%26epage%3D1531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John G.  Moffat</span>, <span class="hlFld-ContribAuthor ">Joachim  Rudolph</span>, <span class="hlFld-ContribAuthor ">David  Bailey</span>. </span><span class="cited-content_cbyCitation_article-title">Phenotypic screening in cancer drug discovery — past, present and future. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Drug Discovery</span><span> <strong>2014,</strong> <em>13 </em>
                                    (8)
                                     , 588-602. <a href="https://doi.org/10.1038/nrd4366" title="DOI URL">https://doi.org/10.1038/nrd4366</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nrd4366&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnrd4366%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Drug%2520Discovery%26atitle%3DPhenotypic%252Bscreening%252Bin%252Bcancer%252Bdrug%252Bdiscovery%252B%2525E2%252580%252594%252Bpast%25252C%252Bpresent%252Band%252Bfuture%26aulast%3DMoffat%26aufirst%3DJohn%2BG.%26date%3D2014%26date%3D2014%26volume%3D13%26issue%3D8%26spage%3D588%26epage%3D602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rangadhar  Pradhan</span>, <span class="hlFld-ContribAuthor ">Shashi  Rajput</span>, <span class="hlFld-ContribAuthor ">Mahitosh  Mandal</span>, <span class="hlFld-ContribAuthor ">Analava  Mitra</span>, <span class="hlFld-ContribAuthor ">Soumen  Das</span>. </span><span class="cited-content_cbyCitation_article-title">Frequency dependent impedimetric cytotoxic evaluation of anticancer drug on breast cancer cell. </span><span class="cited-content_cbyCitation_journal-name">Biosensors and Bioelectronics</span><span> <strong>2014,</strong> <em>55 </em>, 44-50. <a href="https://doi.org/10.1016/j.bios.2013.11.060" title="DOI URL">https://doi.org/10.1016/j.bios.2013.11.060</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bios.2013.11.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bios.2013.11.060%26sid%3Dliteratum%253Aachs%26jtitle%3DBiosensors%2520and%2520Bioelectronics%26atitle%3DFrequency%252Bdependent%252Bimpedimetric%252Bcytotoxic%252Bevaluation%252Bof%252Banticancer%252Bdrug%252Bon%252Bbreast%252Bcancer%252Bcell%26aulast%3DPradhan%26aufirst%3DRangadhar%26date%3D2014%26volume%3D55%26spage%3D44%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rangadhar  Pradhan</span>, <span class="hlFld-ContribAuthor ">Mahitosh  Mandal</span>, <span class="hlFld-ContribAuthor ">Analava  Mitra</span>, <span class="hlFld-ContribAuthor ">Soumen  Das</span>. </span><span class="cited-content_cbyCitation_article-title">Assessing Cytotoxic Effect of ZD6474 on MDA-MB-468 Cells Using Cell-Based Sensor. </span><span class="cited-content_cbyCitation_journal-name">IEEE Sensors Journal</span><span> <strong>2014,</strong> <em>14 </em>
                                    (5)
                                     , 1476-1481. <a href="https://doi.org/10.1109/JSEN.2013.2296717" title="DOI URL">https://doi.org/10.1109/JSEN.2013.2296717</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1109/JSEN.2013.2296717&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1109%2FJSEN.2013.2296717%26sid%3Dliteratum%253Aachs%26jtitle%3DIEEE%2520Sensors%2520Journal%26atitle%3DAssessing%252BCytotoxic%252BEffect%252Bof%252BZD6474%252Bon%252BMDA-MB-468%252BCells%252BUsing%252BCell-Based%252BSensor%26aulast%3DPradhan%26aufirst%3DRangadhar%26date%3D2014%26volume%3D14%26issue%3D5%26spage%3D1476%26epage%3D1481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fuming  Xu</span>, <span class="hlFld-ContribAuthor ">Hao  Xu</span>, <span class="hlFld-ContribAuthor ">Xuejian  Wang</span>, <span class="hlFld-ContribAuthor ">Lei  Zhang</span>, <span class="hlFld-ContribAuthor ">Qingli  Wen</span>, <span class="hlFld-ContribAuthor ">Yingjie  Zhang</span>, <span class="hlFld-ContribAuthor ">Wenfang  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of N-(3-((7H-purin-6-yl)thio)-4-hydroxynaphthalen-1-yl)-sulfonamide derivatives as novel protein kinase and angiogenesis inhibitors for the treatment of cancer: Synthesis and biological evaluation. Part III. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2014,</strong> <em>22 </em>
                                    (4)
                                     , 1487-1495. <a href="https://doi.org/10.1016/j.bmc.2013.11.052" title="DOI URL">https://doi.org/10.1016/j.bmc.2013.11.052</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2013.11.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2013.11.052%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BN-%2525283-%252528%2525287H-purin-6-yl%252529thio%252529-4-hydroxynaphthalen-1-yl%252529-sulfonamide%252Bderivatives%252Bas%252Bnovel%252Bprotein%252Bkinase%252Band%252Bangiogenesis%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252Bcancer%25253A%252BSynthesis%252Band%252Bbiological%252Bevaluation.%252BPart%252BIII%26aulast%3DXu%26aufirst%3DFuming%26date%3D2014%26volume%3D22%26issue%3D4%26spage%3D1487%26epage%3D1495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Axel  Kleemann</span>. </span><span class="cited-content_cbyCitation_article-title">Protein Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 1-26. <a href="https://doi.org/10.1002/14356007.r22_r01" title="DOI URL">https://doi.org/10.1002/14356007.r22_r01</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/14356007.r22_r01&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F14356007.r22_r01%26sid%3Dliteratum%253Aachs%26atitle%3DProtein%252BKinase%252BInhibitors%26aulast%3DKleemann%26aufirst%3DAxel%26date%3D2014%26date%3D2014%26spage%3D1%26epage%3D26%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DUllmann%252527s%252BEncyclopedia%252Bof%252BIndustrial%252BChemistry%26date%3D2000%26date%3D2000%26volume%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qi  Wang</span>, <span class="hlFld-ContribAuthor ">Julie A.  Zorn</span>, <span class="hlFld-ContribAuthor ">John  Kuriyan</span>. </span><span class="cited-content_cbyCitation_article-title">A Structural Atlas of Kinases Inhibited by Clinically Approved Drugs. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 23-67. <a href="https://doi.org/10.1016/B978-0-12-397918-6.00002-1" title="DOI URL">https://doi.org/10.1016/B978-0-12-397918-6.00002-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-397918-6.00002-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-397918-6.00002-1%26sid%3Dliteratum%253Aachs%26atitle%3DA%252BStructural%252BAtlas%252Bof%252BKinases%252BInhibited%252Bby%252BClinically%252BApproved%252BDrugs%26aulast%3DWang%26aufirst%3DQi%26date%3D2014%26spage%3D23%26epage%3D67%26pub%3DElsevier%26atitle%3DProtein%252BKinase%252BInhibitors%252Bin%252BResearch%252Band%252BMedicine%26date%3D2014%26volume%3D548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.  Mortlock</span>, <span class="hlFld-ContribAuthor ">K.  Foote</span>, <span class="hlFld-ContribAuthor ">J.  Kettle</span>, <span class="hlFld-ContribAuthor ">B.  Aquila</span>. </span><span class="cited-content_cbyCitation_article-title">Kinase Inhibitors in Cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,<a href="https://doi.org/10.1016/B978-0-12-409547-2.11033-9" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.11033-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.11033-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.11033-9%26sid%3Dliteratum%253Aachs%26atitle%3DKinase%252BInhibitors%252Bin%252BCancer%26aulast%3DMortlock%26aufirst%3DA.%26date%3D2014%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2014%26volume%3D409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Erik  Samén</span>, <span class="hlFld-ContribAuthor ">Li  Lu</span>, <span class="hlFld-ContribAuthor ">Jan  Mulder</span>, <span class="hlFld-ContribAuthor ">Jan-Olov  Thorell</span>, <span class="hlFld-ContribAuthor ">Peter  Damberg</span>, <span class="hlFld-ContribAuthor ">Tetyana  Tegnebratt</span>, <span class="hlFld-ContribAuthor ">Lars  Holmgren</span>, <span class="hlFld-ContribAuthor ">Helene  Rundqvist</span>, <span class="hlFld-ContribAuthor ">Sharon  Stone-Elander</span>. </span><span class="cited-content_cbyCitation_article-title">Visualization of angiogenesis during cancer development in the polyoma middle T breast cancer model: molecular imaging with (R)-[11C]PAQ. </span><span class="cited-content_cbyCitation_journal-name">EJNMMI Research</span><span> <strong>2014,</strong> <em>4 </em>
                                    (1)
                                     , 17. <a href="https://doi.org/10.1186/2191-219X-4-17" title="DOI URL">https://doi.org/10.1186/2191-219X-4-17</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/2191-219X-4-17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2F2191-219X-4-17%26sid%3Dliteratum%253Aachs%26jtitle%3DEJNMMI%2520Research%26atitle%3DVisualization%252Bof%252Bangiogenesis%252Bduring%252Bcancer%252Bdevelopment%252Bin%252Bthe%252Bpolyoma%252Bmiddle%252BT%252Bbreast%252Bcancer%252Bmodel%25253A%252Bmolecular%252Bimaging%252Bwith%252B%252528R%252529-%25255B11C%25255DPAQ%26aulast%3DSam%25C3%25A9n%26aufirst%3DErik%26date%3D2014%26volume%3D4%26issue%3D1%26spage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">He Ping  Yan</span>, <span class="hlFld-ContribAuthor ">Gui Ping  Ouyang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Characterization of 7 - (3 - (substituted-phenoxy) propoxy) Quinazoline Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Advanced Materials Research</span><span> <strong>2013,</strong> <em>781-784 </em>, 1003-1006. <a href="https://doi.org/10.4028/www.scientific.net/AMR.781-784.1003" title="DOI URL">https://doi.org/10.4028/www.scientific.net/AMR.781-784.1003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4028/www.scientific.net/AMR.781-784.1003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4028%2Fwww.scientific.net%2FAMR.781-784.1003%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Materials%2520Research%26atitle%3DSynthesis%252Band%252BCharacterization%252Bof%252B7%252B-%252B%2525283%252B-%252B%252528substituted-phenoxy%252529%252Bpropoxy%252529%252BQuinazoline%252BDerivatives%26aulast%3DYan%26aufirst%3DHe%2BPing%26date%3D2013%26date%3D2013%26volume%3D781-784%26spage%3D1003%26epage%3D1006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marwa F.  Ahmed</span>, <span class="hlFld-ContribAuthor ">Mahmoud  Youns</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Evaluation of a Novel Series of 6,8-Dibromo-4(3
              H
              )quinazolinone Derivatives as Anticancer Agents. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2013,</strong> <em>346 </em>
                                    (8)
                                     , 610-617. <a href="https://doi.org/10.1002/ardp.201300158" title="DOI URL">https://doi.org/10.1002/ardp.201300158</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201300158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201300158%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252Ba%252BNovel%252BSeries%252Bof%252B6%25252C8-Dibromo-4%2525283%252BH%252B%252529quinazolinone%252BDerivatives%252Bas%252BAnticancer%252BAgents%26aulast%3DAhmed%26aufirst%3DMarwa%2BF.%26date%3D2013%26date%3D2013%26volume%3D346%26issue%3D8%26spage%3D610%26epage%3D617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ibrahim A.  Al-Suwaidan</span>, <span class="hlFld-ContribAuthor ">Amer M.  Alanazi</span>, <span class="hlFld-ContribAuthor ">Alaa A.-M.  Abdel-Aziz</span>, <span class="hlFld-ContribAuthor ">Menshawy A.  Mohamed</span>, <span class="hlFld-ContribAuthor ">Adel S.  El-Azab</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of 2-mercapto-3-phenethylquinazoline bearing anilide fragments as potential antitumor agents: Molecular docking study. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (13)
                                     , 3935-3941. <a href="https://doi.org/10.1016/j.bmcl.2013.04.056" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.04.056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.04.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.04.056%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B2-mercapto-3-phenethylquinazoline%252Bbearing%252Banilide%252Bfragments%252Bas%252Bpotential%252Bantitumor%252Bagents%25253A%252BMolecular%252Bdocking%252Bstudy%26aulast%3DAl-Suwaidan%26aufirst%3DIbrahim%2BA.%26date%3D2013%26volume%3D23%26issue%3D13%26spage%3D3935%26epage%3D3941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fuming  Xu</span>, <span class="hlFld-ContribAuthor ">Yuping  Jia</span>, <span class="hlFld-ContribAuthor ">Qingli  Wen</span>, <span class="hlFld-ContribAuthor ">Xuejian  Wang</span>, <span class="hlFld-ContribAuthor ">Lei  Zhang</span>, <span class="hlFld-ContribAuthor ">Yingjie  Zhang</span>, <span class="hlFld-ContribAuthor ">Kanghui  Yang</span>, <span class="hlFld-ContribAuthor ">Wenfang  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of N-(4-hydroxy-3-mercaptonaphthalen-1-yl)amides as inhibitors of angiogenesis and tumor growth. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>64 </em>, 377-388. <a href="https://doi.org/10.1016/j.ejmech.2013.03.043" title="DOI URL">https://doi.org/10.1016/j.ejmech.2013.03.043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2013.03.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2013.03.043%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252BN-%2525284-hydroxy-3-mercaptonaphthalen-1-yl%252529amides%252Bas%252Binhibitors%252Bof%252Bangiogenesis%252Band%252Btumor%252Bgrowth%26aulast%3DXu%26aufirst%3DFuming%26date%3D2013%26volume%3D64%26spage%3D377%26epage%3D388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">GiangThy N.  Ton</span>, <span class="hlFld-ContribAuthor ">Megan E.  Banaszynski</span>, <span class="hlFld-ContribAuthor ">Jill M.  Kolesar</span>. </span><span class="cited-content_cbyCitation_article-title">Vandetanib: A novel targeted therapy for the treatment of metastatic or locally advanced medullary thyroid cancer. </span><span class="cited-content_cbyCitation_journal-name">American Journal of Health-System Pharmacy</span><span> <strong>2013,</strong> <em>70 </em>
                                    (10)
                                     , 849-855. <a href="https://doi.org/10.2146/ajhp120253" title="DOI URL">https://doi.org/10.2146/ajhp120253</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2146/ajhp120253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2146%2Fajhp120253%26sid%3Dliteratum%253Aachs%26jtitle%3DAmerican%2520Journal%2520of%2520Health-System%2520Pharmacy%26atitle%3DVandetanib%25253A%252BA%252Bnovel%252Btargeted%252Btherapy%252Bfor%252Bthe%252Btreatment%252Bof%252Bmetastatic%252Bor%252Blocally%252Badvanced%252Bmedullary%252Bthyroid%252Bcancer%26aulast%3DTon%26aufirst%3DGiangThy%2BN.%26date%3D2013%26volume%3D70%26issue%3D10%26spage%3D849%26epage%3D855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daisy H.  Fleita</span>, <span class="hlFld-ContribAuthor ">Rafat M.  Mohareb</span>, <span class="hlFld-ContribAuthor ">Ola K.  Sakka</span>. </span><span class="cited-content_cbyCitation_article-title">Antitumor and antileishmanial evaluation of novel heterocycles derived from quinazoline scaffold: a molecular modeling approach. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2013,</strong> <em>22 </em>
                                    (5)
                                     , 2207-2221. <a href="https://doi.org/10.1007/s00044-012-0213-9" title="DOI URL">https://doi.org/10.1007/s00044-012-0213-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-012-0213-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-012-0213-9%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DAntitumor%252Band%252Bantileishmanial%252Bevaluation%252Bof%252Bnovel%252Bheterocycles%252Bderived%252Bfrom%252Bquinazoline%252Bscaffold%25253A%252Ba%252Bmolecular%252Bmodeling%252Bapproach%26aulast%3DFleita%26aufirst%3DDaisy%2BH.%26date%3D2013%26date%3D2012%26volume%3D22%26issue%3D5%26spage%3D2207%26epage%3D2221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ashraf Hassan Fekry Abd  El-Wahab</span>, <span class="hlFld-ContribAuthor ">Hany Mostafa  Mohamed</span>, <span class="hlFld-ContribAuthor ">Ahmed Mohamed  El-Agrody</span>, <span class="hlFld-ContribAuthor ">Mohamed Ahmed  El-Nassag</span>, <span class="hlFld-ContribAuthor ">Ahmed Hammam  Bedair</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, reactions and biological evaluation of benzyltriazolophthalazine derivatives. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Chemistry</span><span> <strong>2013,</strong> <em>4 </em>
                                    (1)
                                     , 10-19. <a href="https://doi.org/10.5155/eurjchem.4.1.10-19.707" title="DOI URL">https://doi.org/10.5155/eurjchem.4.1.10-19.707</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5155/eurjchem.4.1.10-19.707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5155%2Feurjchem.4.1.10-19.707%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Chemistry%26atitle%3DSynthesis%25252C%252Breactions%252Band%252Bbiological%252Bevaluation%252Bof%252Bbenzyltriazolophthalazine%252Bderivatives%26aulast%3DEl-Wahab%26aufirst%3DAshraf%2BHassan%2BFekry%2BAbd%26date%3D2013%26date%3D2013%26volume%3D4%26issue%3D1%26spage%3D10%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniele  Vergara</span>, <span class="hlFld-ContribAuthor ">Pasquale  Simeone</span>, <span class="hlFld-ContribAuthor ">Piero  del Boccio</span>, <span class="hlFld-ContribAuthor ">Claudia  Toto</span>, <span class="hlFld-ContribAuthor ">Damiana  Pieragostino</span>, <span class="hlFld-ContribAuthor ">Andrea  Tinelli</span>, <span class="hlFld-ContribAuthor ">Raffaele  Acierno</span>, <span class="hlFld-ContribAuthor ">Saverio  Alberti</span>, <span class="hlFld-ContribAuthor ">Michel  Salzet</span>, <span class="hlFld-ContribAuthor ">Gianluigi  Giannelli</span>, <span class="hlFld-ContribAuthor ">Paolo  Sacchetta</span>, <span class="hlFld-ContribAuthor ">Michele  Maffia</span>. </span><span class="cited-content_cbyCitation_article-title">Comparative proteome profiling of breast tumor cell lines by gel electrophoresis and mass spectrometry reveals an epithelial mesenchymal transition associated protein signature. </span><span class="cited-content_cbyCitation_journal-name">Mol. BioSyst.</span><span> <strong>2013,</strong> <em>9 </em>
                                    (6)
                                     , 1127-1138. <a href="https://doi.org/10.1039/C2MB25401H" title="DOI URL">https://doi.org/10.1039/C2MB25401H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C2MB25401H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC2MB25401H%26sid%3Dliteratum%253Aachs%26jtitle%3DMol.%2520BioSyst.%26atitle%3DComparative%252Bproteome%252Bprofiling%252Bof%252Bbreast%252Btumor%252Bcell%252Blines%252Bby%252Bgel%252Belectrophoresis%252Band%252Bmass%252Bspectrometry%252Breveals%252Ban%252Bepithelial%252Bmesenchymal%252Btransition%252Bassociated%252Bprotein%252Bsignature%26aulast%3DVergara%26aufirst%3DDaniele%26date%3D2013%26date%3D2013%26volume%3D9%26issue%3D6%26spage%3D1127%26epage%3D1138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benjamin J.  Deadman</span>, <span class="hlFld-ContribAuthor ">Mark D.  Hopkin</span>, <span class="hlFld-ContribAuthor ">Ian R.  Baxendale</span>, <span class="hlFld-ContribAuthor ">Steven V.  Ley</span>. </span><span class="cited-content_cbyCitation_article-title">The synthesis of Bcr-Abl inhibiting anticancer pharmaceutical agents imatinib, nilotinib and dasatinib. </span><span class="cited-content_cbyCitation_journal-name">Org. Biomol. Chem.</span><span> <strong>2013,</strong> <em>11 </em>
                                    (11)
                                     , 1766-1800. <a href="https://doi.org/10.1039/C2OB27003J" title="DOI URL">https://doi.org/10.1039/C2OB27003J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C2OB27003J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC2OB27003J%26sid%3Dliteratum%253Aachs%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26atitle%3DThe%252Bsynthesis%252Bof%252BBcr-Abl%252Binhibiting%252Banticancer%252Bpharmaceutical%252Bagents%252Bimatinib%25252C%252Bnilotinib%252Band%252Bdasatinib%26aulast%3DDeadman%26aufirst%3DBenjamin%2BJ.%26date%3D2013%26date%3D2013%26volume%3D11%26issue%3D11%26spage%3D1766%26epage%3D1800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew  Advani</span>, <span class="hlFld-ContribAuthor ">Kim A.  Connelly</span>, <span class="hlFld-ContribAuthor ">Suzanne L.  Advani</span>, <span class="hlFld-ContribAuthor ">Kerri  Thai</span>, <span class="hlFld-ContribAuthor ">Yuan  Zhang</span>, <span class="hlFld-ContribAuthor ">Darren J.  Kelly</span>, <span class="hlFld-ContribAuthor ">Richard E.  Gilbert</span>. </span><span class="cited-content_cbyCitation_article-title">Role of the eNOS-NO System in Regulating the Antiproteinuric Effects of VEGF Receptor 2 Inhibition in Diabetes. </span><span class="cited-content_cbyCitation_journal-name">BioMed Research International</span><span> <strong>2013,</strong> <em>2013 </em>, 1-8. <a href="https://doi.org/10.1155/2013/201475" title="DOI URL">https://doi.org/10.1155/2013/201475</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2013/201475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2013%2F201475%26sid%3Dliteratum%253Aachs%26jtitle%3DBioMed%2520Research%2520International%26atitle%3DRole%252Bof%252Bthe%252BeNOS-NO%252BSystem%252Bin%252BRegulating%252Bthe%252BAntiproteinuric%252BEffects%252Bof%252BVEGF%252BReceptor%252B2%252BInhibition%252Bin%252BDiabetes%26aulast%3DAdvani%26aufirst%3DAndrew%26date%3D2013%26volume%3D2013%26spage%3D1%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">He Ping  Yan</span>, <span class="hlFld-ContribAuthor ">Du Shu  Huang</span>, <span class="hlFld-ContribAuthor ">Ju Cheng  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Characterization of 4-(3′-Chlorophenylamino)-6-Methoxy Quinazoline Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Advanced Materials Research</span><span> <strong>2013,</strong> <em>634-638 </em>, 1215-1218. <a href="https://doi.org/10.4028/www.scientific.net/AMR.634-638.1215" title="DOI URL">https://doi.org/10.4028/www.scientific.net/AMR.634-638.1215</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4028/www.scientific.net/AMR.634-638.1215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4028%2Fwww.scientific.net%2FAMR.634-638.1215%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Materials%2520Research%26atitle%3DSynthesis%252Band%252BCharacterization%252Bof%252B4-%2525283%2525E2%252580%2525B2-Chlorophenylamino%252529-6-Methoxy%252BQuinazoline%252BDerivatives%26aulast%3DYan%26aufirst%3DHe%2BPing%26date%3D2013%26date%3D2013%26volume%3D634-638%26spage%3D1215%26epage%3D1218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lingyi  Huang</span>, <span class="hlFld-ContribAuthor ">Zhengui  Huang</span>, <span class="hlFld-ContribAuthor ">Zhiqiang  Bai</span>, <span class="hlFld-ContribAuthor ">Rui  Xie</span>, <span class="hlFld-ContribAuthor ">Liping  Sun</span>, <span class="hlFld-ContribAuthor ">Kejiang  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Development and strategies of VEGFR-2/KDR inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2012,</strong> <em>4 </em>
                                    (14)
                                     , 1839-1852. <a href="https://doi.org/10.4155/fmc.12.121" title="DOI URL">https://doi.org/10.4155/fmc.12.121</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.12.121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.12.121%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Band%252Bstrategies%252Bof%252BVEGFR-2%25252FKDR%252Binhibitors%26aulast%3DHuang%26aufirst%3DLingyi%26date%3D2012%26volume%3D4%26issue%3D14%26spage%3D1839%26epage%3D1852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jaya  Prabhakaran</span>, <span class="hlFld-ContribAuthor ">Victoria  Arango</span>, <span class="hlFld-ContribAuthor ">Vattoly J.  Majo</span>, <span class="hlFld-ContribAuthor ">Norman R.  Simpson</span>, <span class="hlFld-ContribAuthor ">Suham A.  Kassir</span>, <span class="hlFld-ContribAuthor ">Mark D.  Underwood</span>, <span class="hlFld-ContribAuthor ">Hanish  Polavarapu</span>, <span class="hlFld-ContribAuthor ">Jeffrey N.  Bruce</span>, <span class="hlFld-ContribAuthor ">Peter  Canoll</span>, <span class="hlFld-ContribAuthor ">J.  John Mann</span>, <span class="hlFld-ContribAuthor ">J.S.  Dileep Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and in vitro evaluation of [18F](R)-FEPAQ: A potential PET ligand for VEGFR2. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (15)
                                     , 5104-5107. <a href="https://doi.org/10.1016/j.bmcl.2012.05.099" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.05.099</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.05.099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.05.099%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bin%252Bvitro%252Bevaluation%252Bof%252B%25255B18F%25255D%252528R%252529-FEPAQ%25253A%252BA%252Bpotential%252BPET%252Bligand%252Bfor%252BVEGFR2%26aulast%3DPrabhakaran%26aufirst%3DJaya%26date%3D2012%26volume%3D22%26issue%3D15%26spage%3D5104%26epage%3D5107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dan Qing  Fang</span>, <span class="hlFld-ContribAuthor ">Wen Juan  Wu</span>, <span class="hlFld-ContribAuthor ">Rong  Zhang</span>, <span class="hlFld-ContribAuthor ">Guo Hua  Zeng</span>, <span class="hlFld-ContribAuthor ">Kang Cheng  Zheng</span>. </span><span class="cited-content_cbyCitation_article-title">Theoretical Studies of QSAR and Molecular Design on a Novel Series of Ethynyl-3-Quinolinecarbonitriles as Src Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2012,</strong> <em>80 </em>
                                    (1)
                                     , 134-147. <a href="https://doi.org/10.1111/j.1747-0285.2012.01385.x" title="DOI URL">https://doi.org/10.1111/j.1747-0285.2012.01385.x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/j.1747-0285.2012.01385.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fj.1747-0285.2012.01385.x%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DTheoretical%252BStudies%252Bof%252BQSAR%252Band%252BMolecular%252BDesign%252Bon%252Ba%252BNovel%252BSeries%252Bof%252BEthynyl-3-Quinolinecarbonitriles%252Bas%252BSrc%252BInhibitors%26aulast%3DFang%26aufirst%3DDan%2BQing%26date%3D2012%26date%3D2012%26volume%3D80%26issue%3D1%26spage%3D134%26epage%3D147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michiel  Smits</span>, <span class="hlFld-ContribAuthor ">Thomas  Wurdinger</span>, <span class="hlFld-ContribAuthor ">Bert  Hof</span>, <span class="hlFld-ContribAuthor ">Joost A. R.  Drexhage</span>, <span class="hlFld-ContribAuthor ">Dirk  Geerts</span>, <span class="hlFld-ContribAuthor ">Pieter  Wesseling</span>, <span class="hlFld-ContribAuthor ">David P.  Noske</span>, <span class="hlFld-ContribAuthor ">W. Peter  Vandertop</span>, <span class="hlFld-ContribAuthor ">Helga E.  Vries</span>, <span class="hlFld-ContribAuthor ">Arie  Reijerkerk</span>. </span><span class="cited-content_cbyCitation_article-title">Myc‐associated zinc finger protein (MAZ) is regulated by miR‐125b and mediates VEGF‐induced angiogenesis in glioblastoma. </span><span class="cited-content_cbyCitation_journal-name">The FASEB Journal</span><span> <strong>2012,</strong> <em>26 </em>
                                    (6)
                                     , 2639-2647. <a href="https://doi.org/10.1096/fj.11-202820" title="DOI URL">https://doi.org/10.1096/fj.11-202820</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1096/fj.11-202820&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1096%2Ffj.11-202820%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520FASEB%2520Journal%26atitle%3DMyc%2525E2%252580%252590associated%252Bzinc%252Bfinger%252Bprotein%252B%252528MAZ%252529%252Bis%252Bregulated%252Bby%252BmiR%2525E2%252580%252590125b%252Band%252Bmediates%252BVEGF%2525E2%252580%252590induced%252Bangiogenesis%252Bin%252Bglioblastoma%26aulast%3DSmits%26aufirst%3DMichiel%26date%3D2012%26date%3D2012%26volume%3D26%26issue%3D6%26spage%3D2639%26epage%3D2647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bruno  Gori</span>, <span class="hlFld-ContribAuthor ">Serena  Ricciardi</span>, <span class="hlFld-ContribAuthor ">Alberto  Fulvi</span>, <span class="hlFld-ContribAuthor ">Ester  Del Signore</span>, <span class="hlFld-ContribAuthor ">Filippo  de Marinis</span>. </span><span class="cited-content_cbyCitation_article-title">New oral multitargeted antiangiogenics in non-small-cell lung cancer treatment. </span><span class="cited-content_cbyCitation_journal-name">Future Oncology</span><span> <strong>2012,</strong> <em>8 </em>
                                    (5)
                                     , 559-573. <a href="https://doi.org/10.2217/fon.12.48" title="DOI URL">https://doi.org/10.2217/fon.12.48</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2217/fon.12.48&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2217%2Ffon.12.48%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Oncology%26atitle%3DNew%252Boral%252Bmultitargeted%252Bantiangiogenics%252Bin%252Bnon-small-cell%252Blung%252Bcancer%252Btreatment%26aulast%3DGori%26aufirst%3DBruno%26date%3D2012%26volume%3D8%26issue%3D5%26spage%3D559%26epage%3D573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Margaret E.  Macy</span>, <span class="hlFld-ContribAuthor ">Deborah  DeRyckere</span>, <span class="hlFld-ContribAuthor ">Lia  Gore</span>. </span><span class="cited-content_cbyCitation_article-title">Vandetanib mediates anti-leukemia activity by multiple mechanisms and interacts synergistically with DNA damaging agents. </span><span class="cited-content_cbyCitation_journal-name">Investigational New Drugs</span><span> <strong>2012,</strong> <em>30 </em>
                                    (2)
                                     , 468-479. <a href="https://doi.org/10.1007/s10637-010-9572-6" title="DOI URL">https://doi.org/10.1007/s10637-010-9572-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10637-010-9572-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10637-010-9572-6%26sid%3Dliteratum%253Aachs%26jtitle%3DInvestigational%2520New%2520Drugs%26atitle%3DVandetanib%252Bmediates%252Banti-leukemia%252Bactivity%252Bby%252Bmultiple%252Bmechanisms%252Band%252Binteracts%252Bsynergistically%252Bwith%252BDNA%252Bdamaging%252Bagents%26aulast%3DMacy%26aufirst%3DMargaret%2BE.%26date%3D2012%26date%3D2010%26volume%3D30%26issue%3D2%26spage%3D468%26epage%3D479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Orathai  Sawatdichaikul</span>, <span class="hlFld-ContribAuthor ">Supa  Hannongbua</span>, <span class="hlFld-ContribAuthor ">Chak  Sangma</span>, <span class="hlFld-ContribAuthor ">Peter  Wolschann</span>, <span class="hlFld-ContribAuthor ">Kiattawee  Choowongkomon</span>. </span><span class="cited-content_cbyCitation_article-title">In silico screening of epidermal growth factor receptor (EGFR) in the tyrosine kinase domain through a medicinal plant compound database. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Modeling</span><span> <strong>2012,</strong> <em>18 </em>
                                    (3)
                                     , 1241-1254. <a href="https://doi.org/10.1007/s00894-011-1135-z" title="DOI URL">https://doi.org/10.1007/s00894-011-1135-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00894-011-1135-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00894-011-1135-z%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Modeling%26atitle%3DIn%252Bsilico%252Bscreening%252Bof%252Bepidermal%252Bgrowth%252Bfactor%252Breceptor%252B%252528EGFR%252529%252Bin%252Bthe%252Btyrosine%252Bkinase%252Bdomain%252Bthrough%252Ba%252Bmedicinal%252Bplant%252Bcompound%252Bdatabase%26aulast%3DSawatdichaikul%26aufirst%3DOrathai%26date%3D2012%26date%3D2011%26volume%3D18%26issue%3D3%26spage%3D1241%26epage%3D1254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elise  Langenkamp</span>, <span class="hlFld-ContribAuthor ">Peter J.  Zwiers</span>, <span class="hlFld-ContribAuthor ">Henk E.  Moorlag</span>, <span class="hlFld-ContribAuthor ">William P.  Leenders</span>, <span class="hlFld-ContribAuthor ">Brad  St. Croix</span>, <span class="hlFld-ContribAuthor ">Grietje  Molema</span>. </span><span class="cited-content_cbyCitation_article-title">Vascular endothelial growth factor receptor 2 inhibition in-vivo affects tumor vasculature in a tumor type-dependent way and downregulates vascular endothelial growth factor receptor 2 protein without a prominent role for miR-296. </span><span class="cited-content_cbyCitation_journal-name">Anti-Cancer Drugs</span><span> <strong>2012,</strong> <em>23 </em>
                                    (2)
                                     , 161-172. <a href="https://doi.org/10.1097/CAD.0b013e32834dc279" title="DOI URL">https://doi.org/10.1097/CAD.0b013e32834dc279</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/CAD.0b013e32834dc279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FCAD.0b013e32834dc279%26sid%3Dliteratum%253Aachs%26jtitle%3DAnti-Cancer%2520Drugs%26atitle%3DVascular%252Bendothelial%252Bgrowth%252Bfactor%252Breceptor%252B2%252Binhibition%252Bin-vivo%252Baffects%252Btumor%252Bvasculature%252Bin%252Ba%252Btumor%252Btype-dependent%252Bway%252Band%252Bdownregulates%252Bvascular%252Bendothelial%252Bgrowth%252Bfactor%252Breceptor%252B2%252Bprotein%252Bwithout%252Ba%252Bprominent%252Brole%252Bfor%252BmiR-296%26aulast%3DLangenkamp%26aufirst%3DElise%26date%3D2012%26volume%3D23%26issue%3D2%26spage%3D161%26epage%3D172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joanne  Bronson</span>, <span class="hlFld-ContribAuthor ">Murali  Dhar</span>, <span class="hlFld-ContribAuthor ">William  Ewing</span>, <span class="hlFld-ContribAuthor ">Nils  Lonberg</span>. </span><span class="cited-content_cbyCitation_article-title">To Market, To Market—2011. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2012,</strong>,, 499-569. <a href="https://doi.org/10.1016/B978-0-12-396492-2.00031-X" title="DOI URL">https://doi.org/10.1016/B978-0-12-396492-2.00031-X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-396492-2.00031-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-396492-2.00031-X%26sid%3Dliteratum%253Aachs%26atitle%3DTo%252BMarket%25252C%252BTo%252BMarket%2525E2%252580%2525942011%26aulast%3DBronson%26aufirst%3DJoanne%26date%3D2012%26spage%3D499%26epage%3D569%26pub%3DElsevier%26atitle%3DAnnual%252BReports%252Bin%252BMedicinal%252BChemistry%252BVolume%252B47%26date%3D2012%26volume%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aleem  Gangjee</span>, <span class="hlFld-ContribAuthor ">Sonali  Kurup</span>, <span class="hlFld-ContribAuthor ">Michael A.  Ihnat</span>, <span class="hlFld-ContribAuthor ">Jessica E.  Thorpe</span>, <span class="hlFld-ContribAuthor ">Bryan  Disch</span>. </span><span class="cited-content_cbyCitation_article-title">N4-Aryl-6-substitutedphenylmethyl-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamines as receptor tyrosine kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2012,</strong> <em>20 </em>
                                    (2)
                                     , 910-914. <a href="https://doi.org/10.1016/j.bmc.2011.11.058" title="DOI URL">https://doi.org/10.1016/j.bmc.2011.11.058</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2011.11.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2011.11.058%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DN4-Aryl-6-substitutedphenylmethyl-7H-pyrrolo%25255B2%25252C3-d%25255Dpyrimidine-2%25252C4-diamines%252Bas%252Breceptor%252Btyrosine%252Bkinase%252Binhibitors%26aulast%3DGangjee%26aufirst%3DAleem%26date%3D2012%26volume%3D20%26issue%3D2%26spage%3D910%26epage%3D914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Syed Umar Farooq  Rizvi</span>, <span class="hlFld-ContribAuthor ">Hamid Latif  Siddiqui</span>, <span class="hlFld-ContribAuthor ">Muhammad  Nisar</span>, <span class="hlFld-ContribAuthor ">Nematullah  Khan</span>, <span class="hlFld-ContribAuthor ">Inamullah  Khan</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and molecular docking of quinolyl-thienyl chalcones as anti-angiogenic agents targeting VEGFR-2 tyrosine kinase. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (2)
                                     , 942-944. <a href="https://doi.org/10.1016/j.bmcl.2011.12.017" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.12.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.12.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.12.017%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Band%252Bmolecular%252Bdocking%252Bof%252Bquinolyl-thienyl%252Bchalcones%252Bas%252Banti-angiogenic%252Bagents%252Btargeting%252BVEGFR-2%252Btyrosine%252Bkinase%26aulast%3DRizvi%26aufirst%3DSyed%2BUmar%2BFarooq%26date%3D2012%26volume%3D22%26issue%3D2%26spage%3D942%26epage%3D944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul  Martin</span>, <span class="hlFld-ContribAuthor ">Stuart  Oliver</span>, <span class="hlFld-ContribAuthor ">Sarah-Jane  Kennedy</span>, <span class="hlFld-ContribAuthor ">Elizabeth  Partridge</span>, <span class="hlFld-ContribAuthor ">Michael  Hutchison</span>, <span class="hlFld-ContribAuthor ">David  Clarke</span>, <span class="hlFld-ContribAuthor ">Petrina  Giles</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacokinetics of Vandetanib: Three Phase I Studies in Healthy Subjects. </span><span class="cited-content_cbyCitation_journal-name">Clinical Therapeutics</span><span> <strong>2012,</strong> <em>34 </em>
                                    (1)
                                     , 221-237. <a href="https://doi.org/10.1016/j.clinthera.2011.11.011" title="DOI URL">https://doi.org/10.1016/j.clinthera.2011.11.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.clinthera.2011.11.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.clinthera.2011.11.011%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Therapeutics%26atitle%3DPharmacokinetics%252Bof%252BVandetanib%25253A%252BThree%252BPhase%252BI%252BStudies%252Bin%252BHealthy%252BSubjects%26aulast%3DMartin%26aufirst%3DPaul%26date%3D2012%26volume%3D34%26issue%3D1%26spage%3D221%26epage%3D237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joost CM  Uitdehaag</span>, <span class="hlFld-ContribAuthor ">Guido JR  Zaman</span>. </span><span class="cited-content_cbyCitation_article-title">A theoretical entropy score as a single value to express inhibitor selectivity. </span><span class="cited-content_cbyCitation_journal-name">BMC Bioinformatics</span><span> <strong>2011,</strong> <em>12 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/1471-2105-12-94" title="DOI URL">https://doi.org/10.1186/1471-2105-12-94</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/1471-2105-12-94&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2F1471-2105-12-94%26sid%3Dliteratum%253Aachs%26jtitle%3DBMC%2520Bioinformatics%26atitle%3DA%252Btheoretical%252Bentropy%252Bscore%252Bas%252Ba%252Bsingle%252Bvalue%252Bto%252Bexpress%252Binhibitor%252Bselectivity%26aulast%3DUitdehaag%26aufirst%3DJoost%2BCM%26date%3D2011%26date%3D2011%26volume%3D12%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zaher K.  Otrock</span>, <span class="hlFld-ContribAuthor ">Hassan A.  Hatoum</span>, <span class="hlFld-ContribAuthor ">Khaled M.  Musallam</span>, <span class="hlFld-ContribAuthor ">Ahmad H.  Awada</span>, <span class="hlFld-ContribAuthor ">Ali I.  Shamseddine</span>. </span><span class="cited-content_cbyCitation_article-title">Is VEGF a predictive biomarker to anti-angiogenic therapy?. </span><span class="cited-content_cbyCitation_journal-name">Critical Reviews in Oncology/Hematology</span><span> <strong>2011,</strong> <em>79 </em>
                                    (2)
                                     , 103-111. <a href="https://doi.org/10.1016/j.critrevonc.2010.07.008" title="DOI URL">https://doi.org/10.1016/j.critrevonc.2010.07.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.critrevonc.2010.07.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.critrevonc.2010.07.008%26sid%3Dliteratum%253Aachs%26jtitle%3DCritical%2520Reviews%2520in%2520Oncology%252FHematology%26atitle%3DIs%252BVEGF%252Ba%252Bpredictive%252Bbiomarker%252Bto%252Banti-angiogenic%252Btherapy%25253F%26aulast%3DOtrock%26aufirst%3DZaher%2BK.%26date%3D2011%26volume%3D79%26issue%3D2%26spage%3D103%26epage%3D111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Milan  Remko</span>, <span class="hlFld-ContribAuthor ">Andrej  Boháč</span>, <span class="hlFld-ContribAuthor ">Lucia  Kováčiková</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular structure, pKa, lipophilicity, solubility, absorption, polar surface area, and blood brain barrier penetration of some antiangiogenic agents. </span><span class="cited-content_cbyCitation_journal-name">Structural Chemistry</span><span> <strong>2011,</strong> <em>22 </em>
                                    (3)
                                     , 635-648. <a href="https://doi.org/10.1007/s11224-011-9741-z" title="DOI URL">https://doi.org/10.1007/s11224-011-9741-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11224-011-9741-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11224-011-9741-z%26sid%3Dliteratum%253Aachs%26jtitle%3DStructural%2520Chemistry%26atitle%3DMolecular%252Bstructure%25252C%252BpKa%25252C%252Blipophilicity%25252C%252Bsolubility%25252C%252Babsorption%25252C%252Bpolar%252Bsurface%252Barea%25252C%252Band%252Bblood%252Bbrain%252Bbarrier%252Bpenetration%252Bof%252Bsome%252Bantiangiogenic%252Bagents%26aulast%3DRemko%26aufirst%3DMilan%26date%3D2011%26date%3D2011%26volume%3D22%26issue%3D3%26spage%3D635%26epage%3D648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mingzhang  Gao</span>, <span class="hlFld-ContribAuthor ">Christian M.  Lola</span>, <span class="hlFld-ContribAuthor ">Min  Wang</span>, <span class="hlFld-ContribAuthor ">Kathy D.  Miller</span>, <span class="hlFld-ContribAuthor ">George W.  Sledge</span>, <span class="hlFld-ContribAuthor ">Qi-Huang  Zheng</span>. </span><span class="cited-content_cbyCitation_article-title">Radiosynthesis of [11C]Vandetanib and [11C]chloro-Vandetanib as new potential PET agents for imaging of VEGFR in cancer. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>21 </em>
                                    (11)
                                     , 3222-3226. <a href="https://doi.org/10.1016/j.bmcl.2011.04.049" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.04.049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.04.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.04.049%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DRadiosynthesis%252Bof%252B%25255B11C%25255DVandetanib%252Band%252B%25255B11C%25255Dchloro-Vandetanib%252Bas%252Bnew%252Bpotential%252BPET%252Bagents%252Bfor%252Bimaging%252Bof%252BVEGFR%252Bin%252Bcancer%26aulast%3DGao%26aufirst%3DMingzhang%26date%3D2011%26volume%3D21%26issue%3D11%26spage%3D3222%26epage%3D3226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Malleshappa N.  Noolvi</span>, <span class="hlFld-ContribAuthor ">Harun M.  Patel</span>, <span class="hlFld-ContribAuthor ">Varun  Bhardwaj</span>, <span class="hlFld-ContribAuthor ">Ankit  Chauhan</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and in vitro antitumor activity of substituted quinazoline and quinoxaline derivatives: Search for anticancer agent. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>46 </em>
                                    (6)
                                     , 2327-2346. <a href="https://doi.org/10.1016/j.ejmech.2011.03.015" title="DOI URL">https://doi.org/10.1016/j.ejmech.2011.03.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2011.03.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2011.03.015%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bin%252Bvitro%252Bantitumor%252Bactivity%252Bof%252Bsubstituted%252Bquinazoline%252Band%252Bquinoxaline%252Bderivatives%25253A%252BSearch%252Bfor%252Banticancer%252Bagent%26aulast%3DNoolvi%26aufirst%3DMalleshappa%2BN.%26date%3D2011%26volume%3D46%26issue%3D6%26spage%3D2327%26epage%3D2346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicola  Heron</span>. </span><span class="cited-content_cbyCitation_article-title">From Discovery to Clinic: Aurora Kinase Inhibitors as Novel Treatments for Cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2011,</strong>,, 195-228. <a href="https://doi.org/10.1002/9783527633470.ch7" title="DOI URL">https://doi.org/10.1002/9783527633470.ch7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527633470.ch7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527633470.ch7%26sid%3Dliteratum%253Aachs%26atitle%3DFrom%252BDiscovery%252Bto%252BClinic%25253A%252BAurora%252BKinase%252BInhibitors%252Bas%252BNovel%252BTreatments%252Bfor%252BCancer%26aulast%3DHeron%26aufirst%3DNicola%26date%3D2011%26date%3D2011%26spage%3D195%26epage%3D228%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DProtein%252BKinases%252Bas%252BDrug%252BTargets%26aulast%3DKlebl%26aufirst%3DBert%26date%3D2011%26volume%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul  Martin</span>, <span class="hlFld-ContribAuthor ">Stuart  Oliver</span>, <span class="hlFld-ContribAuthor ">Jane  Robertson</span>, <span class="hlFld-ContribAuthor ">Sarah-Jane  Kennedy</span>, <span class="hlFld-ContribAuthor ">Jessica  Read</span>, <span class="hlFld-ContribAuthor ">Thierry  Duvauchelle</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacokinetic Drug Interactions with Vandetanib during Coadministration with Rifampicin or Itraconazole. </span><span class="cited-content_cbyCitation_journal-name">Drugs in R & D</span><span> <strong>2011,</strong> <em>11 </em>
                                    (1)
                                     , 37-51. <a href="https://doi.org/10.1007/BF03259793" title="DOI URL">https://doi.org/10.1007/BF03259793</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/BF03259793&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2FBF03259793%26sid%3Dliteratum%253Aachs%26jtitle%3DDrugs%2520in%2520R%2520%2526%2520D%26atitle%3DPharmacokinetic%252BDrug%252BInteractions%252Bwith%252BVandetanib%252Bduring%252BCoadministration%252Bwith%252BRifampicin%252Bor%252BItraconazole%26aulast%3DMartin%26aufirst%3DPaul%26date%3D2011%26date%3D2012%26volume%3D11%26issue%3D1%26spage%3D37%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div><a href="#" data-source="/pb/widgets/cited-by?doi=10.1021%2Fjm011022e&amp;widgetId=9cf770f4-a9a2-46e0-bd29-3da15bcf4ae0&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2002.45.issue-6%3Barticle%3Aarticle%3A10.1021%2Fjm011022e%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text&amp;citedByCount=217&amp;pagesCount=3&amp;pageNumber=2" title="Load more citations" class="button_primary float-right cited-by__see-more mb-5"><i aria-hidden="”true”" class="icon-angle-double-down"></i><span>Load more citations</span></a></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-6/jm011022e/production/images/medium/jm011022en00001.gif" alt="" id="_i2" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-6/jm011022e/production/images/large/jm011022en00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm011022e&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm011022ef00001" data-index="1" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-6/jm011022e/production/images/medium/jm011022ef00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-6/jm011022e/production/images/large/jm011022ef00001.jpeg" id="rightTab-_i5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 1 </p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-6/jm011022e/production/images/large/jm011022ef00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm011022e&amp;id=jm011022ef00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm011022ef00002" data-index="2" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-6/jm011022e/production/images/medium/jm011022ef00002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-6/jm011022e/production/images/large/jm011022ef00002.jpeg" id="rightTab-_i7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 2   </p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-6/jm011022e/production/images/large/jm011022ef00002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm011022e&amp;id=jm011022ef00002"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm011022eh00001" data-index="3" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-6/jm011022e/production/images/medium/jm011022eh00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-6/jm011022e/production/images/large/jm011022eh00001.jpeg" id="rightTab-_i10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 1 <i><sup>a,b</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents:  (a) R<sup>1</sup>-Ar-NH<sub>2</sub>/<i>i</i>PrOH/HCl/reflux (procedure A or G) or R<sup>1</sup>-Ar-NH<sub>2</sub>/NaH/DMF (procedure H). <i><sup>b</sup></i><sup></sup> TFA (procedure L or J).</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-6/jm011022e/production/images/large/jm011022eh00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm011022e&amp;id=jm011022eh00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm011022eh00002" data-index="4" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-6/jm011022e/production/images/medium/jm011022eh00002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-6/jm011022e/production/images/large/jm011022eh00002.jpeg" id="rightTab-_i11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 2 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents:  (a) DMF/K<sub>2</sub>CO<sub>3</sub> (procedure M). (b) i. Ph<sub>3</sub>P/DEAD; ii. TFA (procedure I). (c) R<sup>2</sup>OH (see Table 1)/<i>n</i>-Bu<sub>3</sub>P/ADDP (procedure C) or Ph<sub>3</sub>P/DEAD (procedure E or F). (d) 1-(3-Chloropropyl)pyrrolidine/DMF/K<sub>2</sub>CO<sub>3</sub> (procedure D). (e) TFA (procedure J or L). </p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-6/jm011022e/production/images/large/jm011022eh00002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm011022e&amp;id=jm011022eh00002"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm011022eh00003" data-index="5" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-6/jm011022e/production/images/medium/jm011022eh00003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-6/jm011022e/production/images/large/jm011022eh00003.jpeg" id="rightTab-_i12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 3 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents:  (a) <b>54</b>:  Ph<sub>3</sub>P/CH<sub>2</sub>Cl<sub>2</sub>/DEAD. (b) <b>55</b>:  K<sub>2</sub>CO<sub>3</sub>/DMF. (c) TFA. (d) MeOH/THF/HCHO/NaBH<sub>3</sub>CN. (e) HCHO/NaB(OAc)<sub>3</sub>/AcOH. (f) MeOH/NH<sub>3</sub>. (g) SOCl<sub>2</sub>/DMF. (h) R<sup>1</sup>-Ar-NH<sub>2</sub>/<i>i</i>PrOH/HCl (procedure A or G). (i) NaH/DMF (procedure H).</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-6/jm011022e/production/images/large/jm011022eh00003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm011022e&amp;id=jm011022eh00003"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm011022eh00004" data-index="6" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-6/jm011022e/production/images/medium/jm011022eh00004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-6/jm011022e/production/images/large/jm011022eh00004.jpeg" id="rightTab-_i15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 4 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> HCOOH, HCHO, reflux (procedure K).</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-6/jm011022e/production/images/large/jm011022eh00004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm011022e&amp;id=jm011022eh00004"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm011022eh00005" data-index="7" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-6/jm011022e/production/images/medium/jm011022eh00005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-6/jm011022e/production/images/large/jm011022eh00005.jpeg" id="rightTab-_i18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 5 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents:  (a) Cl-(CH<sub>2</sub>)<sub>3</sub>-Br/K<sub>2</sub>CO<sub>3</sub>/DMF. (b) <i>N</i>-Methylpiperazine/100 °C (procedure B).</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2002/jmcmar.2002.45.issue-6/jm011022e/production/images/large/jm011022eh00005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm011022e&amp;id=jm011022eh00005"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"></div><p class="rightTab-references-count">
            This article references 27 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-jm011022eb00001"><div class="reference"><strong class="refLabel"><a href="#jm011022eb00001" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-jm011022eb00001_1"><span><span class="NLM_string-ref">Fan, T. P. D.; Jaggar, R.; Bicknell, R. Controlling the vasculature:  angiogenesis, anti-angiogenesis, and vascular targetting of gene therapy. <i>  Trends Pharmacol. Sci.</i><b>1995</b>, <i>16</i>, 57−66.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1995&pages=66&author=T.+P.+D.+Fan&author=R.+Jaggar&author=R+Bicknell&title=Controlling+the+vasculature%3A%E2%80%89+angiogenesis%2C+anti-angiogenesis%2C+and+vascular+targetting+of+gene+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00001_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DT.%2BP.%2BD.%26atitle%3DControlling%2520the%2520vasculature%253A%25E2%2580%2589%2520angiogenesis%252C%2520anti-angiogenesis%252C%2520and%2520vascular%2520targetting%2520of%2520gene%2520therapy%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1995%26volume%3D16%26spage%3D66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm011022eb00002"><div class="reference"><strong class="refLabel"><a href="#jm011022eb00002" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-jm011022eb00002_1"><span><span class="NLM_string-ref">Folkman, J. Angiogenesis in cancer, vascular, rheumtoid and other disease. <i>  Nat. Med.</i><b>1995</b>, <i>1</i>, 27−31.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1995&pages=31&author=J+Folkman&title=Angiogenesis+in+cancer%2C+vascular%2C+rheumtoid+and+other+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00002_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFolkman%26aufirst%3DJ%26atitle%3DAngiogenesis%2520in%2520cancer%252C%2520vascular%252C%2520rheumtoid%2520and%2520other%2520disease%26jtitle%3DNat.%2520Med.%26date%3D1995%26volume%3D1%26spage%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm011022eb00003"><div class="reference"><strong class="refLabel"><a href="#jm011022eb00003" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-jm011022eb00003_1"><span><span class="NLM_string-ref">Jakeman, L. B.; Armanini, M.; Phillips, H. S.; Ferrara, N. Developmental expression of binding sites and messenger ribonucleic acid for vascular endothelial growth factor suggests a role for this protein in vasculogenesis and angiogenesis. <i>  Endocrinology</i><b>1993</b>, <i>133</i>, 848−859.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=1993&pages=859&author=L.+B.+Jakeman&author=M.+Armanini&author=H.+S.+Phillips&author=N+Ferrara&title=Developmental+expression+of+binding+sites+and+messenger+ribonucleic+acid+for+vascular+endothelial+growth+factor+suggests+a+role+for+this+protein+in+vasculogenesis+and+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00003_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJakeman%26aufirst%3DL.%2BB.%26atitle%3DDevelopmental%2520expression%2520of%2520binding%2520sites%2520and%2520messenger%2520ribonucleic%2520acid%2520for%2520vascular%2520endothelial%2520growth%2520factor%2520suggests%2520a%2520role%2520for%2520this%2520protein%2520in%2520vasculogenesis%2520and%2520angiogenesis%26jtitle%3DEndocrinology%26date%3D1993%26volume%3D133%26spage%3D859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm011022eb00004"><div class="reference"><strong class="refLabel"><a href="#jm011022eb00004" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-jm011022eb00004_1"><span><span class="NLM_string-ref">Connolly, D. T.; Olander, J. V.; Heuvelman, D.; Nelson, R.; Monsell, R.; Siegel, N.; Haymore, B. L.; Leimgruber, R.; Feder, J. Human vascular permeability factor. Isolation from U937 cells. <i>  J. Biol. Chem</i>. <b>1989</b>, <i>264</i>, 20017−20024.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=264&publication_year=1989&pages=20024&author=D.+T.+Connolly&author=J.+V.+Olander&author=D.+Heuvelman&author=R.+Nelson&author=R.+Monsell&author=N.+Siegel&author=B.+L.+Haymore&author=R.+Leimgruber&author=J+Feder&title=Human+vascular+permeability+factor.+Isolation+from+U937+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00004_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DConnolly%26aufirst%3DD.%2BT.%26atitle%3DHuman%2520vascular%2520permeability%2520factor.%2520Isolation%2520from%2520U937%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1989%26volume%3D264%26spage%3D20024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm011022eb00005"><div class="reference"><strong class="refLabel"><a href="#jm011022eb00005" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-jm011022eb00005_1"><span><span class="NLM_string-ref">Plowman, G. D.; Ullrich, A.; Shawver, L. K. Receptor tyrosine kinases as targets for drug intervention. <i>  Drug News Perspect.</i><b>1994</b>, <i>7</i>, 334−339.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1994&pages=339&author=G.+D.+Plowman&author=A.+Ullrich&author=L.+K+Shawver&title=Receptor+tyrosine+kinases+as+targets+for+drug+intervention"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00005_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPlowman%26aufirst%3DG.%2BD.%26atitle%3DReceptor%2520tyrosine%2520kinases%2520as%2520targets%2520for%2520drug%2520intervention%26jtitle%3DDrug%2520News%2520Perspect.%26date%3D1994%26volume%3D7%26spage%3D339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm011022eb00006"><div class="reference"><strong class="refLabel"><a href="#jm011022eb00006" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-jm011022eb00006_1"><span><span class="NLM_string-ref">Straw, L. M.; Shawver, L. K. Tyrosine kinases in disease: overview of kinase inhibitors as therapeutic agents and current drugs in clinical trials. <i>  Exp. Opin. Invest. Drugs </i><b>1998</b>, <i>7</i>, 553−573.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1998&pages=573&author=L.+M.+Straw&author=L.+K+Shawver&title=Tyrosine+kinases+in+disease%3A+overview+of+kinase+inhibitors+as+therapeutic+agents+and+current+drugs+in+clinical+trials"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00006_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStraw%26aufirst%3DL.%2BM.%26atitle%3DTyrosine%2520kinases%2520in%2520disease%253A%2520overview%2520of%2520kinase%2520inhibitors%2520as%2520therapeutic%2520agents%2520and%2520current%2520drugs%2520in%2520clinical%2520trials%26jtitle%3DExp.%2520Opin.%2520Invest.%2520Drugs%26date%3D1998%26volume%3D7%26spage%3D573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm011022eb00007"><div class="reference"><strong class="refLabel"><a href="#jm011022eb00007" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-jm011022eb00007_1"><span><span class="NLM_string-ref">Shawver, L. K.; Lipson, K. E.; Fong, T. A. T.; McMahon, G.; Plowman, G. D.; Strawn, L. M. Receptor tyrosine kinases as targets for inhibition of angiogenesis. <i>  Drug Discov. Today</i><b>1997</b>, <i>2</i>, 50−63.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1997&pages=63&author=L.+K.+Shawver&author=K.+E.+Lipson&author=T.+A.+T.+Fong&author=G.+McMahon&author=G.+D.+Plowman&author=L.+M+Strawn&title=Receptor+tyrosine+kinases+as+targets+for+inhibition+of+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00007_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShawver%26aufirst%3DL.%2BK.%26atitle%3DReceptor%2520tyrosine%2520kinases%2520as%2520targets%2520for%2520inhibition%2520of%2520angiogenesis%26jtitle%3DDrug%2520Discov.%2520Today%26date%3D1997%26volume%3D2%26spage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm011022eb00008"><div class="reference"><strong class="refLabel"><a href="#jm011022eb00008" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-jm011022eb00008_1"><span><span class="NLM_string-ref">De Vries, C.; Escobedo, J. A.; Ueno, H.; Houck, K.; Ferrara, N.; Williams, L. T. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. <i>  Science</i><b>1992</b>, <i>255</i>, 989−991.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=255&publication_year=1992&pages=991&author=C.+De+Vries&author=J.+A.+Escobedo&author=H.+Ueno&author=K.+Houck&author=N.+Ferrara&author=L.+T+Williams&title=The+fms-like+tyrosine+kinase%2C+a+receptor+for+vascular+endothelial+growth+factor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00008_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BVries%26aufirst%3DC.%26atitle%3DThe%2520fms-like%2520tyrosine%2520kinase%252C%2520a%2520receptor%2520for%2520vascular%2520endothelial%2520growth%2520factor%26jtitle%3DScience%26date%3D1992%26volume%3D255%26spage%3D991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm011022eb00009"><div class="reference"><strong class="refLabel"><a href="#jm011022eb00009" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-jm011022eb00009_1"><span><span class="NLM_string-ref">Terman, B. I.; Dougher-Vermazen, M.; Carrion, M. E.; Dimitrov, D.; Armellino, D. C.; Gospodarowicz, D.; Bohlen, P. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. <i>  Biochem. Biophys. Res. Commun.</i><b>1992</b>, <i>187</i>, 1579−1586.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=187&publication_year=1992&pages=1586&author=B.+I.+Terman&author=M.+Dougher-Vermazen&author=M.+E.+Carrion&author=D.+Dimitrov&author=D.+C.+Armellino&author=D.+Gospodarowicz&author=P+Bohlen&title=Identification+of+the+KDR+tyrosine+kinase+as+a+receptor+for+vascular+endothelial+cell+growth+factor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00009_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTerman%26aufirst%3DB.%2BI.%26atitle%3DIdentification%2520of%2520the%2520KDR%2520tyrosine%2520kinase%2520as%2520a%2520receptor%2520for%2520vascular%2520endothelial%2520cell%2520growth%2520factor%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1992%26volume%3D187%26spage%3D1586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm011022eb00010"><div class="reference"><div class="NLM_citation" id="rightTab-jm011022eb00010_1"><span><span class="NLM_string-ref">(a) Kim, K. L.; Li, B.; Winer, J.; Armanini, M.; Gillett, N.; Phillips, H. S.; Ferrara, N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. <i>  Nature </i><b>1993</b>, <i>362</i>, 841−844.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=362&publication_year=1993&pages=844&author=K.+L.+Kim&author=B.+Li&author=J.+Winer&author=M.+Armanini&author=N.+Gillett&author=H.+S.+Phillips&author=N+Ferrara&title=Inhibition+of+vascular+endothelial+growth+factor-induced+angiogenesis+suppresses+tumor+growth+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00010_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DK.%2BL.%26atitle%3DInhibition%2520of%2520vascular%2520endothelial%2520growth%2520factor-induced%2520angiogenesis%2520suppresses%2520tumor%2520growth%2520in%2520vivo%26jtitle%3DNature%26date%3D1993%26volume%3D362%26spage%3D844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm011022eb00010_2"><span><span class="NLM_string-ref">(b) Presta, L. G.; Chen, H.; O'Connor, S. J.; Chisholm, V.; Meng, Y. G.; Ktummen, L.; Winkler, M.; Ferrara, N. Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders. <i>  Cancer Res. </i><b>1997</b>, <i>57</i>, 4593−4599.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1997&pages=4599&author=L.+G.+Presta&author=H.+Chen&author=S.+J.+O%27Connor&author=V.+Chisholm&author=Y.+G.+Meng&author=L.+Ktummen&author=M.+Winkler&author=N+Ferrara&title=Humanization+of+an+anti-vascular+endothelial+growth+factor+monoclonal+antibody+for+the+therapy+of+solid+tumors+and+other+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00010_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPresta%26aufirst%3DL.%2BG.%26atitle%3DHumanization%2520of%2520an%2520anti-vascular%2520endothelial%2520growth%2520factor%2520monoclonal%2520antibody%2520for%2520the%2520therapy%2520of%2520solid%2520tumors%2520and%2520other%2520disorders%26jtitle%3DCancer%2520Res.%26date%3D1997%26volume%3D57%26spage%3D4599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm011022eb00010_3"><span><span class="NLM_string-ref">(c) Borgstrom, P.; Hillan, K. J.; Sriramarao, P.; Ferrara, N. Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralizing antibody:  novel concepts of angiostatic therapy from intavital videomicroscopy. <i>  Cancer Res. </i><b>1996</b>, <i>56</i>, 4032−4039.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1996&pages=4039&author=P.+Borgstrom&author=K.+J.+Hillan&author=P.+Sriramarao&author=N+Ferrara&title=Complete+inhibition+of+angiogenesis+and+growth+of+microtumors+by+anti-vascular+endothelial+growth+factor+neutralizing+antibody%3A%E2%80%89+novel+concepts+of+angiostatic+therapy+from+intavital+videomicroscopy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00010_3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBorgstrom%26aufirst%3DP.%26atitle%3DComplete%2520inhibition%2520of%2520angiogenesis%2520and%2520growth%2520of%2520microtumors%2520by%2520anti-vascular%2520endothelial%2520growth%2520factor%2520neutralizing%2520antibody%253A%25E2%2580%2589%2520novel%2520concepts%2520of%2520angiostatic%2520therapy%2520from%2520intavital%2520videomicroscopy%26jtitle%3DCancer%2520Res.%26date%3D1996%26volume%3D56%26spage%3D4039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm011022eb00011"><div class="reference"><strong class="refLabel"><a href="#jm011022eb00011" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-jm011022eb00011_1"><span><span class="NLM_string-ref">(a) Witte, L.; Hickling, D. J.; Zhu, Z.; Pytowski, B.; Kotanides, H.; Rockwell, P.; Bohlen, P. Monoclonal antibodies targetting the VEGF receptor-2 (Flk-1/KDR) as an anti-angiogenic therapeutic strategy. <i>  Cancer </i><i>Metastasis Rev. </i><b>1998</b>, <i>17</i>, 155−161.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1998&pages=161&author=L.+Witte&author=D.+J.+Hickling&author=Z.+Zhu&author=B.+Pytowski&author=H.+Kotanides&author=P.+Rockwell&author=P+Bohlen&title=Monoclonal+antibodies+targetting+the+VEGF+receptor-2+%28Flk-1%2FKDR%29+as+an+anti-angiogenic+therapeutic+strategy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00011_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWitte%26aufirst%3DL.%26atitle%3DMonoclonal%2520antibodies%2520targetting%2520the%2520VEGF%2520receptor-2%2520%2528Flk-1%252FKDR%2529%2520as%2520an%2520anti-angiogenic%2520therapeutic%2520strategy%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D1998%26volume%3D17%26spage%3D161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm011022eb00011_2"><span><span class="NLM_string-ref">(b) Skobe, M.; Rockwell, P.; Goldstein, N.; Vosseler, S.; Fusening, N. E. Halting angiogenesis suppresses carcinoma cell invasion. <i>  Nat. Med.</i><b>1997</b>, <i>3</i>, 1222−1227.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1997&pages=1227&author=M.+Skobe&author=P.+Rockwell&author=N.+Goldstein&author=S.+Vosseler&author=N.+E+Fusening&title=Halting+angiogenesis+suppresses+carcinoma+cell+invasion"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00011_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSkobe%26aufirst%3DM.%26atitle%3DHalting%2520angiogenesis%2520suppresses%2520carcinoma%2520cell%2520invasion%26jtitle%3DNat.%2520Med.%26date%3D1997%26volume%3D3%26spage%3D1227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm011022eb00012"><div class="reference"><strong class="refLabel"><a href="#jm011022eb00012" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-jm011022eb00012_1"><span><span class="NLM_string-ref">Prewett, M.; Huber, J.; Li, Y.; Santiago, A.; O'Connor, W.; King, K.; Overholser, J.; Hooper, A.; Pytowski, B.; Witte, L.; Bohlen, P.; Hicklin, D. J. Antivascular Endothelial Growth Factor Receptor (Fetal Liver Kinase 1) Monoclonal Antibody Inhibits Tumor Angiogenesis and Growth of Severeal Mouse and Human Tumors. <i>  Cancer Res.</i><b>1999</b>, <i>59</i>, 5209−5218.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=5218&author=M.+Prewett&author=J.+Huber&author=Y.+Li&author=A.+Santiago&author=W.+O%27Connor&author=K.+King&author=J.+Overholser&author=A.+Hooper&author=B.+Pytowski&author=L.+Witte&author=P.+Bohlen&author=D.+J+Hicklin&title=Antivascular+Endothelial+Growth+Factor+Receptor+%28Fetal+Liver+Kinase+1%29+Monoclonal+Antibody+Inhibits+Tumor+Angiogenesis+and+Growth+of+Severeal+Mouse+and+Human+Tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00012_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPrewett%26aufirst%3DM.%26atitle%3DAntivascular%2520Endothelial%2520Growth%2520Factor%2520Receptor%2520%2528Fetal%2520Liver%2520Kinase%25201%2529%2520Monoclonal%2520Antibody%2520Inhibits%2520Tumor%2520Angiogenesis%2520and%2520Growth%2520of%2520Severeal%2520Mouse%2520and%2520Human%2520Tumors%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26spage%3D5218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm011022eb00013"><div class="reference"><strong class="refLabel"><a href="#jm011022eb00013" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-jm011022eb00013_1"><span><span class="NLM_string-ref">Bold, G.; Altmann, K.-H.; Frei, J.; Lang, M.; Manley, P. W.; Traxler, P.; Wietfeld, B.; Bruggen, J.; Buchdunger, E.; Cozens, R.; Ferrari, S.; Furet, P.; Hofmann, F.; Martiny-Baron, G.; Mestan, J.; Rosel, J.; Sills, M.; Stover, D.; Acemoglu, F.; Boss, E.; Emmenegger, R.; Lasser, L.; Masso, E.; Roth, R.; Schlachter, C.; Vetterli, W.; Wyss, D.; Wood, J. M. New Anilinophthalazines as Potent and Orally well Absorbed Inhibitors of the VEGF Receptor Tyrosine Kinases Useful as antagonists of Tumor-Driven Angiogenesis. <i>  J. Med. Chem</i>. <b>2000</b>, <i>43</i>, 2310−2323.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=2323&author=G.+Bold&author=K.-H.+Altmann&author=J.+Frei&author=M.+Lang&author=P.+W.+Manley&author=P.+Traxler&author=B.+Wietfeld&author=J.+Bruggen&author=E.+Buchdunger&author=R.+Cozens&author=S.+Ferrari&author=P.+Furet&author=F.+Hofmann&author=G.+Martiny-Baron&author=J.+Mestan&author=J.+Rosel&author=M.+Sills&author=D.+Stover&author=F.+Acemoglu&author=E.+Boss&author=R.+Emmenegger&author=L.+Lasser&author=E.+Masso&author=R.+Roth&author=C.+Schlachter&author=W.+Vetterli&author=D.+Wyss&author=J.+M+Wood&title=New+Anilinophthalazines+as+Potent+and+Orally+well+Absorbed+Inhibitors+of+the+VEGF+Receptor+Tyrosine+Kinases+Useful+as+antagonists+of+Tumor-Driven+Angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00013_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBold%26aufirst%3DG.%26atitle%3DNew%2520Anilinophthalazines%2520as%2520Potent%2520and%2520Orally%2520well%2520Absorbed%2520Inhibitors%2520of%2520the%2520VEGF%2520Receptor%2520Tyrosine%2520Kinases%2520Useful%2520as%2520antagonists%2520of%2520Tumor-Driven%2520Angiogenesis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D2323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm011022eb00014"><div class="reference"><strong class="refLabel"><a href="#jm011022eb00014" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-jm011022eb00014_1"><span><span class="NLM_string-ref">Wood, J. M.; Bold, G.; Buchdunger, E.; Cozens, R.; Ferrari, S.; Frei, J.; Hofmann, F.; Mestan, J.; Mett, H.; O'Reilly, T.; Persohn, E.; Rosel, J.; Schnell, C.; Stover, D.; Theuer, A.; Towbin, H.; Wenger, F.; Woods-Cook, K.; Menrad, A.; Siemeister, G.; Schirner, M.; Thierauch, K.-H.; Schneider, M. R.; Drevs, J.; Martiny-Baron, G.; Totzke, F.; Marmé, D. <i>  Cancer Res.</i><b>2000</b>, <i>60</i>, 2178−2189.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Wood%2C+J.+M.%3B+Bold%2C+G.%3B+Buchdunger%2C+E.%3B+Cozens%2C+R.%3B+Ferrari%2C+S.%3B+Frei%2C+J.%3B+Hofmann%2C+F.%3B+Mestan%2C+J.%3B+Mett%2C+H.%3B+O%27Reilly%2C+T.%3B+Persohn%2C+E.%3B+Rosel%2C+J.%3B+Schnell%2C+C.%3B+Stover%2C+D.%3B+Theuer%2C+A.%3B+Towbin%2C+H.%3B+Wenger%2C+F.%3B+Woods-Cook%2C+K.%3B+Menrad%2C+A.%3B+Siemeister%2C+G.%3B+Schirner%2C+M.%3B+Thierauch%2C+K.-H.%3B+Schneider%2C+M.+R.%3B+Drevs%2C+J.%3B+Martiny-Baron%2C+G.%3B+Totzke%2C+F.%3B+Marm%C3%A9%2C+D.+Cancer+Res.+2000%2C+60%2C+2178%E2%88%922189.+Wood%2C+J.+M.%3B+Bold%2C+G.%3B+Buchdunger%2C+E.%3B+Cozens%2C+R.%3B+Ferrari%2C+S.%3B+Frei%2C+J.%3B+Hofmann%2C+F.%3B+Mestan%2C+J.%3B+Mett%2C+H.%3B+O%27Reilly%2C+T.%3B+Persohn%2C+E.%3B+Rosel%2C+J.%3B+Schnell%2C+C.%3B+Stover%2C+D.%3B+Theuer%2C+A.%3B+Towbin%2C+H.%3B+Wenger%2C+F.%3B+Woods-Cook%2C+K.%3B+Menrad%2C+A.%3B+Siemeister%2C+G.%3B+Schirner%2C+M.%3B+Thierauch%2C+K.-H.%3B+Schneider%2C+M.+R.%3B+Drevs%2C+J.%3B+Martiny-Baron%2C+G.%3B+Totzke%2C+F.%3B+Marm%C3%A9%2C+D.+Cancer+Res.2000%2C+60%2C+2178%E2%88%922189."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00014_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DJ.%2BM.%26jtitle%3DCancer%2520Res.%26date%3D2000%26volume%3D60%26spage%3D2189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm011022eb00015"><div class="reference"><strong class="refLabel"><a href="#jm011022eb00015" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-jm011022eb00015_1"><span><span class="NLM_string-ref">Sun, L.; Tran, N.; Liang, C.; Tang, F.; Rice, A.; Schreck, R.; Waltz, K.; Shawver, L. K.; McMahon, G.; Tang, C. Design, synthesis and evaluation of substituted 3-[(3- or 4-carboxyethylpyrrol-2-yl)methylidenyl]indolin-2-ones as inhibitors of VEGF, FGF, and PDGF receptor tyrosine kinases. <i>  J. Med. Chem.</i><b>1999</b>, <i>42</i>, 5120−5130.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=5130&author=L.+Sun&author=N.+Tran&author=C.+Liang&author=F.+Tang&author=A.+Rice&author=R.+Schreck&author=K.+Waltz&author=L.+K.+Shawver&author=G.+McMahon&author=C+Tang&title=Design%2C+synthesis+and+evaluation+of+substituted+3-%5B%283-+or+4-carboxyethylpyrrol-2-yl%29methylidenyl%5Dindolin-2-ones+as+inhibitors+of+VEGF%2C+FGF%2C+and+PDGF+receptor+tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00015_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DL.%26atitle%3DDesign%252C%2520synthesis%2520and%2520evaluation%2520of%2520substituted%25203-%255B%25283-%2520or%25204-carboxyethylpyrrol-2-yl%2529methylidenyl%255Dindolin-2-ones%2520as%2520inhibitors%2520of%2520VEGF%252C%2520FGF%252C%2520and%2520PDGF%2520receptor%2520tyrosine%2520kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D5130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm011022eb00016"><div class="reference"><strong class="refLabel"><a href="#jm011022eb00016" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-jm011022eb00016_1"><span><span class="NLM_string-ref">Laird, A. D.; Vajkoczy, P.; Shawver, L. K.; Thurnher, A.; Liang, C.; Mohammadi, M.; Schlessinger, J.; Ullrich, A.; Hubbard, S. R.; Blake, R. A.; Fong, T. A. T.; Strawn, L. M.; Sun, L.; Tang, C.; Hawtin, R.; Tang, F.; Shenoy, N.; Hirth, K. P.; McMahon, G.; Cherrington, J. M. SU6668 Is a Potent Antiangiogenic and Antitumour Agent That Induces Regression of Established Tumors. <i>  Cancer Res.</i><b>2000</b>, <i>60</i>, 4152−4160.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Laird%2C+A.+D.%3B+Vajkoczy%2C+P.%3B+Shawver%2C+L.+K.%3B+Thurnher%2C+A.%3B+Liang%2C+C.%3B+Mohammadi%2C+M.%3B+Schlessinger%2C+J.%3B+Ullrich%2C+A.%3B+Hubbard%2C+S.+R.%3B+Blake%2C+R.+A.%3B+Fong%2C+T.+A.+T.%3B+Strawn%2C+L.+M.%3B+Sun%2C+L.%3B+Tang%2C+C.%3B+Hawtin%2C+R.%3B+Tang%2C+F.%3B+Shenoy%2C+N.%3B+Hirth%2C+K.+P.%3B+McMahon%2C+G.%3B+Cherrington%2C+J.+M.+SU6668+Is+a+Potent+Antiangiogenic+and+Antitumour+Agent+That+Induces+Regression+of+Established+Tumors.+Cancer+Res.+2000%2C+60%2C+4152%E2%88%924160.+Laird%2C+A.+D.%3B+Vajkoczy%2C+P.%3B+Shawver%2C+L.+K.%3B+Thurnher%2C+A.%3B+Liang%2C+C.%3B+Mohammadi%2C+M.%3B+Schlessinger%2C+J.%3B+Ullrich%2C+A.%3B+Hubbard%2C+S.+R.%3B+Blake%2C+R.+A.%3B+Fong%2C+T.+A.+T.%3B+Strawn%2C+L.+M.%3B+Sun%2C+L.%3B+Tang%2C+C.%3B+Hawtin%2C+R.%3B+Tang%2C+F.%3B+Shenoy%2C+N.%3B+Hirth%2C+K.+P.%3B+McMahon%2C+G.%3B+Cherrington%2C+J.+M.+SU6668+Is+a+Potent+Antiangiogenic+and+Antitumour+Agent+That+Induces+Regression+of+Established+Tumors.+Cancer+Res.2000%2C+60%2C+4152%E2%88%924160."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00016_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLaird%26aufirst%3DA.%2BD.%26jtitle%3DCancer%2520Res.%26date%3D2000%26volume%3D60%26spage%3D4160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm011022eb00017"><div class="reference"><strong class="refLabel"><a href="#jm011022eb00017" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-jm011022eb00017_1"><span><span class="NLM_string-ref">Basser, R.; Hurwitz, H.; Barge, A.; Davis, I.; DeBoer, R.; Holden, S. N.; McArthur, G.; McKinley, M.; Nairn, K.; Persky, M.; Rischin, D.; Rosenthal, M.; Swaisland, H.; Eckhardt, S. G. Phase  1312  I Pharmacokinetic and Biological Study of the Angiogenesis Inhibitor, ZD6474, in Patients with solid tumors. Proceedings of the 37th Annual Meeting of the American Society of Clinical Oncology, San Francisco, May 2001; 21. Abstr. 396, 100a.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&conference=Proceedings+of+the+37th+Annual+Meeting+of+the+American+Society+of+Clinical+Oncology&author=R.+Basser&author=H.+Hurwitz&author=A.+Barge&author=I.+Davis&author=R.+DeBoer&author=S.+N.+Holden&author=G.+McArthur&author=M.+McKinley&author=K.+Nairn&author=M.+Persky&author=D.+Rischin&author=M.+Rosenthal&author=H.+Swaisland&author=S.+G.+Eckhardt&author=I+Phase&author=+Pharmacokinetic&title=Study+of+the+Angiogenesis+Inhibitor%2C+ZD6474%2C+in+Patients+with+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00017_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dproceeding%26sid%3Dliteratum%253Aachs%26aulast%3DBasser%26aufirst%3DR.%26atitle%3DStudy%2520of%2520the%2520Angiogenesis%2520Inhibitor%252C%2520ZD6474%252C%2520in%2520Patients%2520with%2520solid%2520tumors%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm011022eb00018"><div class="reference"><strong class="refLabel"><a href="#jm011022eb00018" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-jm011022eb00018_1"><span><span class="NLM_string-ref">Hennequin, L. F.; Thomas, A. P.; Johnstone, C.; Stokes, E. S. E.; Plé, P.; Lohmann, J.-J. M.; Ogilvie, D. J.; Dukes, M.; Wedge, S. R.; Curwen, J. O.; Kendrew, J.; Lambert-van-der-Brempt, C. Design and Structure−Activity Relationship of a New Class of Potent VEGF Receptor Tyrosine Kinase Inhibitors. <i>  J. Med. Chem.</i><b>1999</b>, <i>42</i>, 5369−5389.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=5389&author=L.+F.+Hennequin&author=A.+P.+Thomas&author=C.+Johnstone&author=E.+S.+E.+Stokes&author=P.+Pl%C3%A9&author=J.-J.+M.+Lohmann&author=D.+J.+Ogilvie&author=M.+Dukes&author=S.+R.+Wedge&author=J.+O.+Curwen&author=J.+Kendrew&author=+Lambert&title=Design+and+Structure%E2%88%92Activity+Relationship+of+a+New+Class+of+Potent+VEGF+Receptor+Tyrosine+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00018_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHennequin%26aufirst%3DL.%2BF.%26atitle%3DDesign%2520and%2520Structure%25E2%2588%2592Activity%2520Relationship%2520of%2520a%2520New%2520Class%2520of%2520Potent%2520VEGF%2520Receptor%2520Tyrosine%2520Kinase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D5389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm011022eb00019"><div class="reference"><strong class="refLabel"><a href="#jm011022eb00019" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-jm011022eb00019_1"><span><span class="NLM_string-ref">Wedge, S. R.; Ogilvie, D. J.; Dukes, M.; Kendrew, J.; Curwen, J. O.; Hennequin, L. F.; Thomas, A. P.; Stokes, E. S. E.; Curry, B.; Richmond, G. H.; Wadsworth, P. F. <i>  Cancer Res. </i><b>2000</b>, <i>60</i>, 970−975.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Wedge%2C+S.+R.%3B+Ogilvie%2C+D.+J.%3B+Dukes%2C+M.%3B+Kendrew%2C+J.%3B+Curwen%2C+J.+O.%3B+Hennequin%2C+L.+F.%3B+Thomas%2C+A.+P.%3B+Stokes%2C+E.+S.+E.%3B+Curry%2C+B.%3B+Richmond%2C+G.+H.%3B+Wadsworth%2C+P.+F.+Cancer+Res.+2000%2C+60%2C+970%E2%88%92975.+Wedge%2C+S.+R.%3B+Ogilvie%2C+D.+J.%3B+Dukes%2C+M.%3B+Kendrew%2C+J.%3B+Curwen%2C+J.+O.%3B+Hennequin%2C+L.+F.%3B+Thomas%2C+A.+P.%3B+Stokes%2C+E.+S.+E.%3B+Curry%2C+B.%3B+Richmond%2C+G.+H.%3B+Wadsworth%2C+P.+F.+Cancer+Res.+2000%2C+60%2C+970%E2%88%92975."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00019_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWedge%26aufirst%3DS.%2BR.%26jtitle%3DCancer%2520Res.%26date%3D2000%26volume%3D60%26spage%3D975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm011022eb00020"><div class="reference"><div class="NLM_citation" id="rightTab-jm011022eb00020_1"><span><span class="NLM_string-ref">Villalobos, A.; Blake, J. F.; Biggers, C. K.; Butler, T. W.; Chapin, D. S.; Chen, Y. L.; Ives, J. L.; Jones, S. B.; Liston, D. R.; Nagel, A. A.; Nason, D. M.; Nielsen, J. A.; Shalaby, I. A.; White, W. F. Novel Benzisoxazole Derivatives as Potent and selective Inhibitors of Acetylcholinesterase. <i>  J. </i><i>Med. Chem</i>. <b>1994</b>, <i>37</i>, 2721−2734.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=2734&author=A.+Villalobos&author=J.+F.+Blake&author=C.+K.+Biggers&author=T.+W.+Butler&author=D.+S.+Chapin&author=Y.+L.+Chen&author=J.+L.+Ives&author=S.+B.+Jones&author=D.+R.+Liston&author=A.+A.+Nagel&author=D.+M.+Nason&author=J.+A.+Nielsen&author=I.+A.+Shalaby&author=W.+F+White&title=Novel+Benzisoxazole+Derivatives+as+Potent+and+selective+Inhibitors+of+Acetylcholinesterase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00020_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DNovel%2520Benzisoxazole%2520Derivatives%2520as%2520Potent%2520and%2520selective%2520Inhibitors%2520of%2520Acetylcholinesterase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D2734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm011022eb00021"><div class="reference"><strong class="refLabel"><a href="#jm011022eb00021" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-jm011022eb00021_1"><span><span class="NLM_string-ref">Clark, R. D.; Eglen, R.; Jahangir, A.; Miller, A. B.; Gardner, J. O. Preparation of 1-(4-aminophenyl)-ω-amino-1-alkanones as 5-HT4 receptor ligands. <i>  WO 9427965 A1 19941208.</i> CA 123:143641.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1208&publication_year=1994&pages=143641&author=R.+D.+Clark&author=R.+Eglen&author=A.+Jahangir&author=A.+B.+Miller&author=J.+O+Gardner&title=Preparation+of+1-%284-aminophenyl%29-%CF%89-amino-1-alkanones+as+5-HT4+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00021_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DR.%2BD.%26atitle%3DPreparation%2520of%25201-%25284-aminophenyl%2529-%25CF%2589-amino-1-alkanones%2520as%25205-HT4%2520receptor%2520ligands%26jtitle%3DWO%25209427965%2520A1%26date%3D1994%26volume%3D1208%26spage%3D143641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm011022eb00022"><div class="reference"><strong class="refLabel"><a href="#jm011022eb00022" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-jm011022eb00022_1"><span><span class="NLM_string-ref">Campbell, S. F.; Roberts, D. A.; Stubbs, J. K. Quinazoline cardiac stimulants. <i>  EP 94766 A2 19831123.</i> CA 100:121105.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1123&publication_year=1983&pages=121105&author=S.+F.+Campbell&author=D.+A.+Roberts&author=J.+K+Stubbs&title=Quinazoline+cardiac+stimulants"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00022_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCampbell%26aufirst%3DS.%2BF.%26atitle%3DQuinazoline%2520cardiac%2520stimulants%26jtitle%3DEP%252094766%2520A2%26date%3D1983%26volume%3D1123%26spage%3D121105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm011022eb00023"><div class="reference"><strong class="refLabel"><a href="#jm011022eb00023" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-jm011022eb00023_1"><span><span class="NLM_string-ref">Hennequin, L. F.; Thomas, A. P.; Johnstone, C.; Stokes, E. S. E.; Plé, P.; Wedge, S. R.; Ogilvie, D. J.; Kendrew, J.; Curwen, J. O.; Dukes, M. ZD6474: Design, synthesis and structure activity relationship of a novel, orally active VEGF receptor tyrosine kinase inhibitor. Poster No. 3152, 92nd AACR meeting, New Orleans, 2001.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&conference=92nd+AACR+meeting&author=L.+F.+Hennequin&author=A.+P.+Thomas&author=C.+Johnstone&author=E.+S.+E.+Stokes&author=P.+Pl%C3%A9&author=S.+R.+Wedge&author=D.+J.+Ogilvie&author=J.+Kendrew&author=J.+O.+Curwen&author=M.+Dukes&title=Design%2C+synthesis+and+structure+activity+relationship+of+a+novel%2C+orally+active+VEGF+receptor+tyrosine+kinase+inhibitor.+Poster+No.+3152"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00023_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dproceeding%26sid%3Dliteratum%253Aachs%26aulast%3DHennequin%26aufirst%3DL.%2BF.%26atitle%3DDesign%252C%2520synthesis%2520and%2520structure%2520activity%2520relationship%2520of%2520a%2520novel%252C%2520orally%2520active%2520VEGF%2520receptor%2520tyrosine%2520kinase%2520inhibitor.%2520Poster%2520No.%25203152%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm011022eb00024"><div class="reference"><strong class="refLabel"><a href="#jm011022eb00024" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-jm011022eb00024_1"><span><span class="NLM_string-ref">Hennequin, L. F.; Stokes, E. S. E.; McKerrecher, D.; Plé P.; Ogilvie, D. J.; Dukes, M.; Wedge, S. R.; Kendrew, J. Structure Activity Relationship and In Vivo Efficacy of Indole-ether Quinazolines, a Novel Series of Orally Active Inhibitors of VEGF Receptor Tyrosine Kinase Activity (Flt-1 and KDR). Poster No. 3133, 92nd AACR meeting, New Orleans, 2001.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&conference=92nd+AACR+meeting&author=L.+F.+Hennequin&author=E.+S.+E.+Stokes&author=D.+McKerrecher&author=P.+Pl%C3%A9&author=D.+J.+Ogilvie&author=M.+Dukes&author=S.+R.+Wedge&author=J.+Kendrew&title=Structure+Activity+Relationship+and+In+Vivo+Efficacy+of+Indole-ether+Quinazolines%2C+a+Novel+Series+of+Orally+Active+Inhibitors+of+VEGF+Receptor+Tyrosine+Kinase+Activity+%28Flt-1+and+KDR%29.+Poster+No.+3133"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00024_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dproceeding%26sid%3Dliteratum%253Aachs%26aulast%3DHennequin%26aufirst%3DL.%2BF.%26atitle%3DStructure%2520Activity%2520Relationship%2520and%2520In%2520Vivo%2520Efficacy%2520of%2520Indole-ether%2520Quinazolines%252C%2520a%2520Novel%2520Series%2520of%2520Orally%2520Active%2520Inhibitors%2520of%2520VEGF%2520Receptor%2520Tyrosine%2520Kinase%2520Activity%2520%2528Flt-1%2520and%2520KDR%2529.%2520Poster%2520No.%25203133%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm011022eb00025"><div class="reference"><strong class="refLabel"><a href="#jm011022eb00025" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-jm011022eb00025_1"><span><span class="NLM_string-ref">(a) Lohmann, J.-J. M.; Hennequin, L. F. A.; Thomas, A. P. Preparation and antiangiogenic and/or vascular permeability reducing effect of quinazoline derivatives. <i>  WO 9722596 A1 970626</i>. CA 127:135808.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=%28a%29+Lohmann%2C+J.-J.+M.%3B+Hennequin%2C+L.+F.+A.%3B+Thomas%2C+A.+P.+Preparation+and+antiangiogenic+and%2For+vascular+permeability+reducing+effect+of+quinazoline+derivatives.+WO+9722596+A1+970626.+CA+127%3A135808.+%28a%29+Lohmann%2C+J.-J.+M.%3B+Hennequin%2C+L.+F.+A.%3B+Thomas%2C+A.+P.+Preparation+and+antiangiogenic+and%2For+vascular+permeability+reducing+effect+of+quinazoline+derivatives.+WO+9722596+A1+970626.+CA+127%3A135808."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00025_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dfootnote%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm011022eb00025_2"><span><span class="NLM_string-ref">(b) Thomas, A. P.; Hennequin, L. F. A.; Plé, P. A. Quinoline derivatives inhibiting the effect of growth factors such as VEGF. <i>  WO 9813350 A1 </i><i>980402. </i>CA 128:270546.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=%28b%29+Thomas%2C+A.+P.%3B+Hennequin%2C+L.+F.+A.%3B+Pl%C3%A9%2C+P.+A.+Quinoline+derivatives+inhibiting+the+effect+of+growth+factors+such+as+VEGF.+WO+9813350+A1+980402.+CA+128%3A270546.+%28b%29+Thomas%2C+A.+P.%3B+Hennequin%2C+L.+F.+A.%3B+Pl%C3%A9%2C+P.+A.+Quinoline+derivatives+inhibiting+the+effect+of+growth+factors+such+as+VEGF.+WO+9813350+A1+980402.+CA+128%3A270546."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00025_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dfootnote%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm011022eb00025_3"><span><span class="NLM_string-ref">(c) Thomas, A. P.; Hennequin, L. F. A.; Johnstone, C.; Stokes, E. S. E.; Lohmann, J.-J. M.; Clayton, E. Preparation of quinazoline derivatives and pharmaceuticals compositions containing them. <i>  WO 9813354 A1 980402.</i> CA 128:257441.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=%28c%29+Thomas%2C+A.+P.%3B+Hennequin%2C+L.+F.+A.%3B+Johnstone%2C+C.%3B+Stokes%2C+E.+S.+E.%3B+Lohmann%2C+J.-J.+M.%3B+Clayton%2C+E.+Preparation+of+quinazoline+derivatives+and+pharmaceuticals+compositions+containing+them.+WO+9813354+A1+980402.+CA+128%3A257441.+%28c%29+Thomas%2C+A.+P.%3B+Hennequin%2C+L.+F.+A.%3B+Johnstone%2C+C.%3B+Stokes%2C+E.+S.+E.%3B+Lohmann%2C+J.-J.+M.%3B+Clayton%2C+E.+Preparation+of+quinazoline+derivatives+and+pharmaceuticals+compositions+containing+them.+WO+9813354+A1+980402.+CA+128%3A257441."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00025_3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dfootnote%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm011022eb00025_4"><span><span class="NLM_string-ref">(d) Thomas, A. P.; Hennequin, L. F. A. Preparation of anilinocinnolines and related compounds as inhibitors of angiogenesis and vascular permeability. <i>  WO </i><i>9734876 A1 970925</i>. CA 127:307392.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=%28d%29+Thomas%2C+A.+P.%3B+Hennequin%2C+L.+F.+A.+Preparation+of+anilinocinnolines+and+related+compounds+as+inhibitors+of+angiogenesis+and+vascular+permeability.+WO+9734876+A1+970925.+CA+127%3A307392.+%28d%29+Thomas%2C+A.+P.%3B+Hennequin%2C+L.+F.+A.+Preparation+of+anilinocinnolines+and+related+compounds+as+inhibitors+of+angiogenesis+and+vascular+permeability.+WO+9734876+A1+970925.+CA+127%3A307392."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00025_4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dfootnote%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm011022eb00025_5"><span><span class="NLM_string-ref">(e) Thomas, A. P.; Hennequin, L. F. A.; Johnstone, C. Preparation of 4-anilinoquinazolines for use in the treatment of disease states associated with antiangiogenesis and/or increased vascular permeability. <i>  WO 9732856 A1 970912</i>. CA 127:278209.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=%28e%29+Thomas%2C+A.+P.%3B+Hennequin%2C+L.+F.+A.%3B+Johnstone%2C+C.+Preparation+of+4-anilinoquinazolines+for+use+in+the+treatment+of+disease+states+associated+with+antiangiogenesis+and%2For+increased+vascular+permeability.+WO+9732856+A1+970912.+CA+127%3A278209.+%28e%29+Thomas%2C+A.+P.%3B+Hennequin%2C+L.+F.+A.%3B+Johnstone%2C+C.+Preparation+of+4-anilinoquinazolines+for+use+in+the+treatment+of+disease+states+associated+with+antiangiogenesis+and%2For+increased+vascular+permeability.+WO+9732856+A1+970912.+CA+127%3A278209."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00025_5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dfootnote%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm011022eb00025_6"><span><span class="NLM_string-ref">(f) Thomas, A. P.; Johnstone, C.; Hennequin, L. F. A. Preparation of quinazolines as VEGF inhibitors. <i>  WO 9730035 A1 970821</i>. CA 127:262698.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=%28f%29+Thomas%2C+A.+P.%3B+Johnstone%2C+C.%3B+Hennequin%2C+L.+F.+A.+Preparation+of+quinazolines+as+VEGF+inhibitors.+WO+9730035+A1+970821.+CA+127%3A262698.+%28f%29+Thomas%2C+A.+P.%3B+Johnstone%2C+C.%3B+Hennequin%2C+L.+F.+A.+Preparation+of+quinazolines+as+VEGF+inhibitors.+WO+9730035+A1+970821.+CA+127%3A262698."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00025_6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dfootnote%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm011022eb00025_7"><span><span class="NLM_string-ref">(f) Hennequin, L. F.; Stokes, E. S. E.; Thomas, A. P. Preparation of 4-anilino-7-piperidinyloxyquinazolines as vascular endothelial growth factor inhibitors. <i>  WO 0132651 A1 20010510. </i>CA 134:353317.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=0510&publication_year=2001&pages=353317&author=L.+F.+Hennequin&author=E.+S.+E.+Stokes&author=A.+P+Thomas&title=Preparation+of+4-anilino-7-piperidinyloxyquinazolines+as+vascular+endothelial+growth+factor+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00025_7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHennequin%26aufirst%3DL.%2BF.%26atitle%3DPreparation%2520of%25204-anilino-7-piperidinyloxyquinazolines%2520as%2520vascular%2520endothelial%2520growth%2520factor%2520inhibitors%26jtitle%3DWO%25200132651%2520A1%26date%3D2001%26volume%3D0510%26spage%3D353317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm011022eb00026"><div class="reference"><strong class="refLabel"><a href="#jm011022eb00026" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-jm011022eb00026_1"><span><span class="NLM_string-ref">Wedge, S. R.; Ogilvie, D. J.; Dukes, M.; Kendrew, J.; Curwen, J. O.; Hennequin, L. F.; Stokes, E. S. E.; Curry, B.; Wadsworth, P. F.; Richmond, G. H. P. Pharmacological efficacy of ZD6474, a VEGF receptor tyrosine kinase inhibitor, in rat. Poster No. 3126, 92nd AACR meeting, New Orleans, 2001.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&conference=92nd+AACR+meeting&author=S.+R.+Wedge&author=D.+J.+Ogilvie&author=M.+Dukes&author=J.+Kendrew&author=J.+O.+Curwen&author=L.+F.+Hennequin&author=E.+S.+E.+Stokes&author=B.+Curry&author=P.+F.+Wadsworth&author=G.+H.+P.+Richmond&title=Pharmacological+efficacy+of+ZD6474%2C+a+VEGF+receptor+tyrosine+kinase+inhibitor%2C+in+rat.+Poster+No.+3126"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00026_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dproceeding%26sid%3Dliteratum%253Aachs%26aulast%3DWedge%26aufirst%3DS.%2BR.%26atitle%3DPharmacological%2520efficacy%2520of%2520ZD6474%252C%2520a%2520VEGF%2520receptor%2520tyrosine%2520kinase%2520inhibitor%252C%2520in%2520rat.%2520Poster%2520No.%25203126%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm011022eb00027"><div class="reference"><strong class="refLabel"><a href="#jm011022eb00027" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-jm011022eb00027_1"><span><span class="NLM_string-ref">Salvador, R. L.; Simon, D. A Study of the Mannich Reaction with Propargyl Alcohol. <i>  Can. J. Chem.</i><b>1966</b>, <i>44</i>, 2570−2575.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1966&pages=2575&author=R.+L.+Salvador&author=D+Simon&title=A+Study+of+the+Mannich+Reaction+with+Propargyl+Alcohol"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm011022eb00027_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSalvador%26aufirst%3DR.%2BL.%26atitle%3DA%2520Study%2520of%2520the%2520Mannich%2520Reaction%2520with%2520Propargyl%2520Alcohol%26jtitle%3DCan.%2520J.%2520Chem.%26date%3D1966%26volume%3D44%26spage%3D2575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="NLM_notes" id="rightTab-"><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23"><a href="/doi/suppl/10.1021%2Fjm011022e">Supporting Information Available</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43304" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43304" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">A description of the general procedures and the complete experimental procedures for the synthesis of as well as the corresponding <sup>1</sup>H NMR spectra, MS-ESI, and elemental analyses (16 pages) for <b>5</b>, <b>12</b>, <b>15</b>, <b>17</b>, <b>18</b>, <b>20</b>, <b>23</b>−<b>26</b>, <b>29</b>−<b>31</b>, <b>35</b>−<b>37</b>, <b>41</b>−<b>43</b>, <b>46</b>−<b>49</b>, <b>59</b>,<b> 63</b>, and <b>65</b>. This material is available free of charge via the Internet at <a class="ext-link" href="http://pubs.acs.org" target="_blank">http://pubs.acs.org</a>. </div></div></div><div class="article_supporting-info" id=""><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm011022e/suppl_file/jm011022e_s.pdf">jm011022e_s.pdf (697.16 kb)</a></li></ul></div></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm011022e&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2002.45.issue-6%3Barticle%3Aarticle%3A10.1021%2Fjm011022e%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm011022e" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                140KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677a74228c6324b2","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
